| |
这些材料很重要,需要您立即关注。他们要求哥伦比亚护理公司的股东做出一个重要的决定。如果您对如何做出这样的决定有疑问,请联系您的财务、法律或其他专业顾问。如果您对本文描述的交易或投票程序有任何疑问或需要更多信息,请联系公司在北美的代理征集代理Morrow Sodali,电话:1-888-999-2785,或致电北美以外的对方付费电话:1-289-695-3075,或发送电子邮件至assistate@morrowsodali.com。
|
| |
| | | | BY ORDER OF THE BOARD | |
| | | |
Nicholas Vita
董事和首席执行官 |
|
|
GENERAL MATTERS
|
| | | | 1 | | |
| SUMMARY | | | | | 3 | | |
|
致美国证券持有人的通知
|
| | | | 13 | | |
|
有关前瞻性信息的警示声明
|
| | | | 16 | | |
|
一般代理信息
|
| | | | 17 | | |
|
Solicitation of Proxies
|
| | | | 17 | | |
|
Appointment of Proxies
|
| | | | 17 | | |
|
Revocation of Proxies
|
| | | | 17 | | |
|
哥伦比亚关怀中心的非注册股东
|
| | | | 18 | | |
|
Voting of Proxies
|
| | | | 19 | | |
|
Voting at the Meeting
|
| | | | 19 | | |
|
如何出席和参与会议
|
| | | | 20 | | |
|
Quorum
|
| | | | 21 | | |
|
有投票权的证券和本金
HOLDERS THEREOF |
| | | | 21 | | |
|
THE ARRANGEMENT
|
| | | | 22 | | |
|
Purpose of the Arrangement
|
| | | | 22 | | |
|
安排的背景
|
| | | | 22 | | |
|
安排说明
|
| | | | 24 | | |
|
ATB Fairness Opinion
|
| | | | 25 | | |
|
CANACCORD GENINITY公平意见
|
| | | | 34 | | |
|
哥伦比亚关怀特别委员会的推荐
|
| | | | 38 | | |
|
哥伦比亚关怀委员会的推荐
|
| | | | 38 | | |
|
安排原因
|
| | | | 39 | | |
|
Arrangement Mechanics
|
| | | | 41 | | |
|
Downward Adjustment
|
| | | | 43 | | |
|
需要股东批准
|
| | | | 43 | | |
|
Voting Support Agreements
|
| | | | 43 | | |
|
Lock-up Agreements
|
| | | | 45 | | |
|
某些人在安排中的利益
|
| | | | 47 | | |
|
安排费用
|
| | | | 51 | | |
|
法院批准安排并完成安排
|
| | | | 51 | | |
|
安排协议
|
| | | | 52 | | |
|
陈述和保修
|
| | | | 52 | | |
|
Covenants
|
| | | | 52 | | |
|
完成安排的条件
|
| | | | 59 | | |
|
Notice and Cure
|
| | | | 62 | | |
|
关于非邀请权的其他公约
|
| | | | 62 | | |
|
收购建议通知
|
| | | | 63 | | |
|
回应收购建议
|
| | | | 63 | | |
|
Right to Match
|
| | | | 64 | | |
|
Termination of Arrangement
Agreement |
| | | | 65 | | |
|
Termination Fee
|
| | | | 67 | | |
|
未经审计的备考简明财务信息
|
| | | | 67 | | |
|
SECURITIES LAW MATTERS
|
| | | | 68 | | |
|
Canadian Securities Laws
|
| | | | 68 | | |
|
U.S. Securities Laws
|
| | | | 70 | | |
|
REGULATORY MATTERS
|
| | | | 72 | | |
|
U.S. Antitrust Matters
|
| | | | 72 | | |
|
Stock Exchange Matters
|
| | | | 73 | | |
|
Cannabis Licenses
|
| | | | 73 | | |
|
异议股东权利
|
| | | | 74 | | |
|
与安排有关的风险因素
|
| | | | 78 | | |
|
PROCEDURES FOR THE SURRENDER
OF SHARE CERTIFICATES AND PAYMENT OF CONSIDERATION |
| | | | 84 | | |
|
Letter of Transmittal
|
| | | | 84 | | |
|
Delivery of Consideration
|
| | | | 86 | | |
|
针对股东的某些加拿大联邦所得税考虑因素
|
| | | | 87 | | |
|
针对股东的重要美国联邦所得税考虑因素
|
| | | | 95 | | |
|
LEGAL MATTERS
|
| | | | 104 | | |
|
OTHER BUSINESS
|
| | | | 104 | | |
|
某些人在待采取行动的事项中的利益
|
| | | | 104 | | |
|
INDEBTEDNESS OF DIRECTORS AND
OFFICERS |
| | | | 104 | | |
|
知情人士在重大交易中的利益
|
| | | | 104 | | |
|
STATEMENT OF RIGHTS
|
| | | | 105 | | |
|
ADDITIONAL INFORMATION
|
| | | | 105 | | |
| APPROVAL | | | | | 106 | | |
|
CONSENT OF CANACCORD
GENUITY |
| | | | 107 | | |
|
ATB资本市场公司同意
|
| | | | 108 | | |
|
Appendix A
GLOSSARY OF TERMS
|
| | | | A-1 | | |
|
Appendix B
安排解决方案
|
| | | | B-1 | | |
|
Appendix C
PLAN OF ARRANGEMENT
|
| | | | C-1 | | |
|
Appendix D
INTERIM ORDER
|
| | | | D-1 | | |
|
Appendix E
申请最终订单通知
|
| | | | E-1 | | |
|
Appendix F
SECTION 237 TO 247 OF THE BCBCA
|
| | | | F-1 | | |
|
Appendix G
ATB FAIRNESS OPINION
|
| | | | G-1 | | |
|
Appendix H
CANACCORD GENINITY公平意见
|
| | | | H-1 | | |
|
Appendix I
有关哥伦比亚关怀中心的其他信息
|
| | | | I-1 | | |
|
Appendix J
关于Cresco的信息
|
| | | | J-1 | | |
|
Appendix K
形式财务报表
|
| | | | K-1 | | |
| | | | | | |
直接或间接实益拥有的哥伦比亚护理公司的证券,对其实施控制或指示(1)
|
| |||||||||||||||||||||
|
Name and
Position(s) / Relationship with Columbia Care |
| |
Number of
Columbia Care Common Shares Held(2) |
| |
Number of
Columbia Care PV Shares Held(3) |
| |
Percentage
of Voting Rights of Columbia Care Shares(4) |
| |
Number of
Columbia Care Options Held(5) |
| |
Number of
Columbia Care Warrants Held(6) |
| |
Number of
Columbia Care Convertible Notes Held(7) |
| |
Number of
Columbia Care RSUs Held(8) (%) |
| |
Number of
Columbia Care PSUs Held(9) (%) |
| |
Total Estimated
Value of Consideration to be Received from the Arrangement(10) |
|
|
尼古拉斯·维塔,
董事首席执行官兼首席执行官 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
迈克尔·阿博特,
董事执行主席兼首席执行官 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Frank Savage,
董事 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
詹姆斯·A·C·肯尼迪
董事 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Jonathan P. May,
董事 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Jeff Clarke,
董事 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
艾莉森·沃辛顿,
董事 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Julie Hill,
董事 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
菲利普·戈德堡
董事 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
David Hart,
首席运营官 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
拉尔斯·博斯加德,
前首席财务官 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Dr. Rosemary Mazanet,
首席科学官 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Bryan Olson,
行政首长和行政首长 军官 |
| | | | | | | | | | | | | | | | | | | | | | | | | | ||
|
盖伊·胡苏辛,
首席数据官 |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | |
直接或间接实益拥有的哥伦比亚护理公司的证券,对其实施控制或指示(1)
|
| | | | | |||||||||||||||||||||||||||||
|
Name and
Position(s) / Relationship with Columbia Care |
| |
Number of
Columbia Care Common Shares Held(2) |
| |
Number of
Columbia Care PV Shares Held(3) |
| |
Percentage
of Voting Rights of Columbia Care Shares(4) |
| |
Number of
Columbia Care Options Held(5) |
| |
Number of
Columbia Care Warrants Held(6) |
| |
Number of
Columbia Care Convertible Notes Held(7) |
| |
Number of
Columbia Care RSUs Held(8) (%) |
| |
Number of
Columbia Care PSUs Held(9) (%) |
| |
Total Estimated
Value of Consideration to be Received from the Arrangement(10) |
| | | | | ||||||||
|
杰西·钱农,
首席增长 军官 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||
|
Derek Watson,
首席财务官 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||
|
大卫·西罗利,
首席法务官兼总法律顾问 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | BY ORDER OF THE BOARD | |
| | | | Nicholas Vita | |
| | | | 董事和首席执行官 | |
| | | |
(Signed) “Canaccord Genuity Corp.”
|
|
| | | |
CANACCORD GENUITY CORP.
|
|
| | | |
Toronto, Ontario
|
|
| | | |
• , 2022
|
|
| | | |
(Signed) “ATB Capital Markets Inc.”
|
|
| | | |
ATB CAPITAL MARKETS INC.
|
|
| | | |
Toronto, Ontario
|
|
| | | |
• , 2022
|
|
| | | | CRESCO LABS INC. | | |||
| | | | Per: | | |
Name:
Title: |
|
| | | | COLUMBIA CARE INC. | | |||
| | | | Per: | | |
Name:
Title: |
|
|
|
| |
Canaccord Genuity Corp.
P.O. Box 516 161 Bay Street, Suite 3100 Toronto, ON M5J 2S1 Canada T: 416.869.7368 www.canaccurity.com |
|
Name of Company
|
| |
State of Organization
|
|
203 Organix, L.L.C.
|
| |
Arizona
|
|
Columbia Care – Arizona, Tempe, L.L.C. (90% owned)
|
| |
Arizona
|
|
Columbia Care – Arizona, Prescott, L.L.C.
|
| |
Arizona
|
|
健康健康诊所,Inc.
|
| |
Arizona
|
|
Access Bryant SPC (49.9% owned)
|
| |
California
|
|
CA Care LLC
|
| |
California
|
|
CC CA Realty LLC
|
| |
California
|
|
CC California LLC
|
| |
California
|
|
哥伦比亚关爱安西尼塔斯公司
|
| |
California
|
|
哥伦比亚关爱国家城市公司
|
| |
California
|
|
Focused Health LLC
|
| |
California
|
|
Mission Bay, LLC
|
| |
California
|
|
PHC Facilities, Inc.
|
| |
California
|
|
资源推荐服务公司
|
| |
California
|
|
圣地亚哥康复中心
|
| |
California
|
|
Name of Company
|
| |
State of Organization
|
|
The Wellness Earth Energy Dispensary Inc.
|
| |
California
|
|
Beacon Holdings, LLC
|
| |
Colorado
|
|
Columbia Care Thornton LLC
|
| |
Colorado
|
|
Dellock Digital, LLC
|
| |
Colorado
|
|
未来展望智库有限责任公司
|
| |
Colorado
|
|
Futurevision, Ltd.
|
| |
Colorado
|
|
High Rise Media, LLC
|
| |
Colorado
|
|
Infuzionz, LLC
|
| |
Colorado
|
|
Mj Brain Bank, LLC
|
| |
Colorado
|
|
落基山脉耕作有限责任公司
|
| |
Colorado
|
|
TGS Colorado Management,LLC
|
| |
Colorado
|
|
TGS Global, LLC
|
| |
Colorado
|
|
The Green Solution, LLC
|
| |
Colorado
|
|
The Launch Pad LLC
|
| |
Colorado
|
|
Columbia Care CT LLC
|
| |
Connecticut
|
|
14 Street Health, LLC
|
| |
Delaware
|
|
Avum, LLC
|
| |
Delaware
|
|
CC MergerSub, LLC
|
| |
Delaware
|
|
CC Procurement LLC
|
| |
Delaware
|
|
CC VA HoldCo LLC
|
| |
Delaware
|
|
Col. Care (Delaware) LLC
|
| |
Delaware
|
|
哥伦比亚关怀 - ,亚利桑那州,普雷斯科特,L.L.C.(拥有90%股权)
|
| |
Delaware
|
|
Columbia Care – Arizona, Tempe DE, L.L.C.
|
| |
Delaware
|
|
Columbia Care Co Inc.
|
| |
Delaware
|
|
Columbia Care DC LLC
|
| |
Delaware
|
|
哥伦比亚关爱DE管理公司(91%持股)
|
| |
Delaware
|
|
哥伦比亚关怀特拉华州有限责任公司
|
| |
Delaware
|
|
哥伦比亚关怀伊利诺伊州有限责任公司
|
| |
Delaware
|
|
哥伦比亚关怀国际控股有限公司
|
| |
Delaware
|
|
Columbia Care LLC
|
| |
Delaware
|
|
缅因州哥伦比亚护理控股公司
|
| |
Delaware
|
|
哥伦比亚关怀马里兰州有限责任公司
|
| |
Delaware
|
|
哥伦比亚关怀伙伴有限责任公司
|
| |
Delaware
|
|
Columbia Care PR LLC
|
| |
Delaware
|
|
哥伦比亚关怀-亚利桑那州有限责任公司
|
| |
Delaware
|
|
Deacon Merger Sub LLC
|
| |
Delaware
|
|
地区社会公平伙伴公司
|
| |
Delaware
|
|
Equity Health Partners DE LLC
|
| |
Delaware
|
|
Green Leaf Medical, LLC
|
| |
Delaware
|
|
La Yerba Buena LLC
|
| |
Delaware
|
|
Oveom LLC
|
| |
Delaware
|
|
Tetra FinCo LLC
|
| |
Delaware
|
|
Tetra Holdings LLC
|
| |
Delaware
|
|
Tetra OpCo LLC
|
| |
Delaware
|
|
Name of Company
|
| |
State of Organization
|
|
Columbia Care CA LLC
|
| |
Delaware
|
|
CCF HoldCo, LLC
|
| |
Delaware
|
|
哥伦比亚关怀佛罗里达有限责任公司
|
| |
Florida
|
|
治愈养生有限责任公司
|
| |
Illinois
|
|
Curative Health LLC
|
| |
Illinois
|
|
哥伦比亚关怀领养家庭公司
|
| |
Massachusetts
|
|
Patriot Care Corp
|
| |
Massachusetts
|
|
Columbia Care MD, LLC (96% owned)
|
| |
Maryland
|
|
Green Leaf Extracts, LLC
|
| |
Maryland
|
|
绿叶管理有限责任公司
|
| |
Maryland
|
|
Time For Healing, LLC
|
| |
Maryland
|
|
马里兰健康学院有限责任公司(拥有99%的股份)
|
| |
Maryland
|
|
Columbia Care ME LLC
|
| |
Maine
|
|
哥伦比亚关爱密歇根有限责任公司
|
| |
Michigan
|
|
哥伦比亚关怀新泽西有限责任公司(92.5%的股份)
|
| |
New Jersey
|
|
哥伦比亚关怀新泽西州房地产有限责任公司
|
| |
New Jersey
|
|
Columbia Care NM LLC
|
| |
New Mexico
|
|
CC物流服务有限责任公司(70%持股)
|
| |
New York
|
|
哥伦比亚关怀工业大麻有限责任公司
|
| |
New York
|
|
Columbia Care NY LLC
|
| |
New York
|
|
Columbia Care NY Realty LLC
|
| |
New York
|
|
Columbia Care NY RO LLC
|
| |
New York
|
|
Cannascend Alternative Logan,L.L.C.
|
| |
Ohio
|
|
Cannascend Alternative,LLC
|
| |
Ohio
|
|
CC OH Realty LLC
|
| |
Ohio
|
|
Columbia Care OH LLC
|
| |
Ohio
|
|
Corsa Verde LLC
|
| |
Ohio
|
|
俄亥俄州第二绿叶医疗有限责任公司
|
| |
Ohio
|
|
Ohio III,LLC绿叶医疗公司(持有99.9%的股份)
|
| |
Ohio
|
|
俄亥俄州绿叶医疗有限公司(49%持股)
|
| |
Ohio
|
|
CC PA Realty LLC
|
| |
Pennsylvania
|
|
CCPA Industrial Hemp LLC
|
| |
Pennsylvania
|
|
哥伦比亚关怀宾夕法尼亚有限责任公司
|
| |
Pennsylvania
|
|
Green Leaf Medicals LLC
|
| |
Pennsylvania
|
|
哥伦比亚关爱波多黎各有限责任公司(49%持股)
|
| |
Puerto Rico
|
|
CCUT Pharmacy LLC (94.5% owned)
|
| |
Utah
|
|
Columbia Care UT LLC
|
| |
Utah
|
|
哥伦比亚关爱东弗吉尼亚有限责任公司(92.75%的股份)
|
| |
Virginia
|
|
弗吉尼亚绿叶医疗有限责任公司
|
| |
Virginia
|
|
VentureForth, LLC
|
| |
Washington D.C.
|
|
哥伦比亚护理WV工业大麻有限责任公司
|
| |
West Virginia
|
|
Columbia Care WV LLC (95% owned)
|
| |
West Virginia
|
|
Columbia Care UK Ltd
|
| |
United Kingdom
|
|
Period
|
| |
High
|
| |
Low
|
| |
Volume
|
| |||||||||
May 2022 (through May • , 2022)
|
| | | 加元 | • | | | | | 加元 | • | | | | |
|
•
|
| |
April 2022
|
| | | 加元 | 3.82 | | | | | 加元 | 2.60 | | | | | | 4,905,358 | | |
March 2022
|
| | | 加元 | 4.20 | | | | | 加元 | 3.10 | | | | | | 9,350,744 | | |
February 2022
|
| | | 加元 | 4.29 | | | | | 加元 | 3.41 | | | | | | 5,131,673 | | |
January 2022
|
| | | 加元 | 4.16 | | | | | 加元 | 3.23 | | | | | | 3,408,249 | | |
December 2021
|
| | | 加元 | 4.25 | | | | | 加元 | 3.46 | | | | | | 4,850,856 | | |
November 2021
|
| | | 加元 | 4.83 | | | | | 加元 | 3.54 | | | | | | 12,165,438 | | |
Period
|
| |
High
|
| |
Low
|
| |
Volume
|
| |||||||||
May 2022 (through May • , 2022)
|
| | | 加元 | • | | | | | 加元 | • | | | | |
|
•
|
| |
April 2022
|
| | | 加元 | 3.82 | | | | | 加元 | 2.61 | | | | | | 2,098,359 | | |
March 2022
|
| | | 加元 | 4.20 | | | | | 加元 | 3.10 | | | | | | 3,937,013 | | |
February 2022
|
| | | 加元 | 4.28 | | | | | 加元 | 3.41 | | | | | | 2,355,652 | | |
January 2022
|
| | | 加元 | 4.18 | | | | | 加元 | 3.23 | | | | | | 3,050,416 | | |
December 2021
|
| | | 加元 | 4.24 | | | | | 加元 | 3.53 | | | | | | 2,803,070 | | |
November 2021
|
| | | 加元 | 4.83 | | | | | 加元 | 3.54 | | | | | | 4,405,502 | | |
Date of Distribution
|
| |
Issuance Price per
Columbia Care Common Share |
| |
Number of
Columbia Care Common Shares Issued |
| |
Aggregate
Gross Proceeds |
| |||||||||
May 4, 2021
|
| | | $ | 6.34 | | | | | | 236,306 | | | | | $ | 1,498,180.04 | | |
May 18, 2021
|
| | | $ | 4.29 | | | | | | 178,619 | | | | | $ | 766,275.51 | | |
May 31, 2021
|
| | | $ | 7.49 | | | | | | 263,200 | | | | | $ | 1,971,368 | | |
June 11, 2021
|
| | | $ | 4.44 | | | | | | 42,993,938 | | | | | $ | 190,893,084.72 | | |
June 24, 2021
|
| | | $ | 4.15 | | | | | | 1,499,043 | | | | | $ | 6,221,028.45 | | |
July 7, 2021
|
| | | $ | 6.85 | | | | | | 949,379 | | | | | $ | 6,503,246.15 | | |
November 1, 2021
|
| | | $ | 5.75 | | | | | | 4,857,184 | | | | | $ | 27,928,808 | | |
December 13, 2021
|
| | | $ | 3.80 | | | | | | 4,162,413 | | | | | $ | 15,817,169.40 | | |
April 7, 2022
|
| | | $ | 3.04 | | | | | | 1,099,549 | | | | | $ | 3,342,628.96 | | |
April 25, 2022
|
| | | $ | 2.81 | | | | | | 18,755,082 | | | | | $ | 52,701,780.42 | | |
| Schedule 1 | | |
—
|
| |
为2021年6月30日召开的年度股东大会和特别大会编写的Cresco管理信息通告,日期为2021年6月2日
|
|
| Schedule 2 | | |
—
|
| |
日期为2022年4月1日的重大变更报告,与Cresco与Columbia Care签订安排协议有关,根据该协议,Cresco将收购Columbia Care的所有已发行和流通股
|
|
Entity
|
| |
Location
|
| |
Purpose
|
| |
Percentage
Held |
|
Cresco Labs Inc. | | |
British Columbia,
Canada |
| | Parent Company | | | | |
CannaRoyalty Corp.(原产地)
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
Cali-AntiFragile Corp.
|
| | California | | | Holding Company | | |
100%
|
|
Alta Supply Inc. (Continuum)
|
| | California | | | Distribution | | |
100%
|
|
Kaya Management Inc.
|
| | California | | | Production | | |
100%
|
|
River Distributing Co., LLC
|
| | California | | | Distribution | | |
100%
|
|
FloraCal Farms
|
| | California | | | Cultivation | | |
100%
|
|
Cub City, LLC
|
| | California | | | Cultivation | | |
100%
|
|
CRHC Holdings Corp.
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
Laurel Harvest Labs, LLC
|
| | Pennsylvania | | |
栽培和药房
Facility |
| |
100%
|
|
JDRC Mount Joy, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
JDRC Scranton, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Bluma Wellness Inc.
|
| |
British Columbia,
Canada |
| | Holding Company | | |
100%
|
|
CannCure Investments Inc.
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
大麻治愈投资有限责任公司
|
| | Florida | | | Holding Company | | |
100%
|
|
3 Boys Farm,LLC(佛罗里达州一家工厂)
|
| | Florida | | |
种植、生产和
药房设施 |
| |
100%
|
|
Farm to Fresh Holdings, LLC
|
| | Florida | | |
种植、生产和
药房设施 |
| |
100%
|
|
Cresco U.S. Corp. | | | Illinois | | | Cresco Labs LLC经理 | | |
100%
|
|
MedMar Inc.
|
| | Illinois | | | Holding Company | | |
100%
|
|
MedMar Lakeview, LLC
|
| | Illinois | | | Dispensary | | |
88%
|
|
MedMar Rockford, LLC
|
| | Illinois | | | Dispensary | | |
75%
|
|
Gloucester Street Capital,LLC
|
| | New York | | | Holding Company | | |
100%
|
|
山谷农业有限责任公司
|
| | New York | | | Operating Entity | | |
100%
|
|
JRDC Ellenville, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
CMA Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
BL Real Estate, LLC
|
| | Massachusetts | | | Holding Company | | |
100%
|
|
培育许可有限责任公司
|
| | Massachusetts | | |
种植、生产和
药房设施 |
| |
100%
|
|
Cultivate Worcester, Inc
|
| | Massachusetts | | | Dispensary | | |
100%
|
|
Cultivate Leicester, Inc
|
| | Massachusetts | | |
种植、生产和
药房设施 |
| |
100%
|
|
培育Framingham,Inc.
|
| | Massachusetts | | | Dispensary | | |
100%
|
|
Cultivate Burncoat, Inc
|
| | Massachusetts | | | Holding Company | | |
100%
|
|
培植公司
|
| | Massachusetts | | |
种植和生产实体
|
| |
100%
|
|
Good News Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Wonder Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
BW Maryland Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
JRDC Seed, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
CP宾夕法尼亚控股有限责任公司
|
| | Illinois | | | Holding Company | | |
100%
|
|
Bay, LLC
|
| | Pennsylvania | | | Holding Company | | |
100%
|
|
Bay Asset Management, LLC
|
| | Pennsylvania | | | Holding Company | | |
100%
|
|
Ridgeback, LLC
|
| | Colorado | | | Holding Company | | |
100%
|
|
Cresco Labs, LLC | | | Illinois | | | Operating Entity | | |
57%
|
|
Cresco Labs Notes Issuer,LLC
|
| | Illinois | | | Holding Company | | | | |
Cresco Labs Ohio, LLC
|
| | Ohio | | |
种植、生产和
药房设施 |
| |
99%
|
|
Wellbeings, LLC
|
| | Delaware | | | CBD健康产品 | | |
100%
|
|
Entity
|
| |
Location
|
| |
Purpose
|
| |
Percentage
Held |
|
| | | | | | Development | | | | |
Cresco Labs SLO, LLC
|
| | California | | | Holding Company | | |
100%
|
|
SLO Cultivation Inc.
|
| | California | | |
种植和生产
Facility |
| |
80%
|
|
Cresco Labs Joliet, LLC
|
| | Illinois | | |
种植和生产
Facility |
| |
100%
|
|
Cresco Labs Kankakee, LLC
|
| | Illinois | | |
种植和生产
Facility |
| |
100%
|
|
Cresco Labs Logan, LLC
|
| | Illinois | | |
种植和生产
Facility |
| |
100%
|
|
Cresco Labs PA, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Cresco Yeltrah, LLC
|
| | Pennsylvania | | |
种植、生产和
药房设施 |
| |
100%
|
|
JDC Newark, LLC | | | Ohio | | | Holding Company | | |
100%
|
|
纽瓦克绿地创造有限责任公司
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Marion, LLC | | | Ohio | | | Holding Company | | |
100%
|
|
Verdant Creations Marion,LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Chillicothe, LLC | | | Ohio | | | Holding Company | | |
100%
|
|
Verdant Creations Chillicothe,LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Columbus, LLC | | | Ohio | | | Holding Company | | |
100%
|
|
Care Med Associates, LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
亚利桑那州Cresco Labs LLC | | | Arizona | | | Holding Company | | |
100%
|
|
亚利桑那州设施供应有限责任公司
|
| |
Arizona/Maryland
|
| |
种植、生产和
药房设施 |
| |
100%
|
|
Cresco Labs Tinad, LLC | | | Illinois | | | Holding Company | | |
100%
|
|
PDI Medical III, LLC
|
| | Illinois | | | Dispensary | | |
100%
|
|
克雷斯科实验室凤凰农场有限责任公司 | | | Illinois | | | Holding Company | | |
100%
|
|
伊利诺伊州凤凰农场有限责任公司
|
| | Illinois | | | Dispensary | | |
100%
|
|
JDC Elmwood, LLC | | | Illinois | | | Holding Company | | |
100%
|
|
FloraMedex, LLC
|
| | Illinois | | | Dispensary | | |
100%
|
|
Cresco Edibles, LLC | | | Illinois | | | Holding Company | | |
100%
|
|
TSC Cresco, LLC
|
| | Illinois | | | Licensing | | |
75%
|
|
Cresco HHH, LLC | | | Massachusetts | | |
种植、生产和
药房设施 |
| |
100%
|
|
Cresco Labs Michigan,LLC(A) | | | Michigan | | |
种植和生产设施
|
| |
85%
|
|
State
|
| |
Current Cultivation
Space (sq ft)12 |
| |
Planned Cultivation
Space (sq ft)13 |
| |
Total
|
| |||||||||
Illinois
|
| | | | 202,000 | | | | | | — | | | | | | 202,000 | | |
Pennsylvania
|
| | | | 85,000 | | | | | | — | | | | | | 85,000 | | |
Ohio
|
| | | | 27,000 | | | | | | 27,000 | | | | | | 54,000 | | |
California
|
| | | | 165,000 | | | | | | 193,000 | | | | | | 358,000 | | |
Massachusetts
|
| | | | 97,000 | | | | | | — | | | | | | 97,000 | | |
Arizona
|
| | | | 91,000 | | | | | | — | | | | | | 91,000 | | |
New York
|
| | | | — | | | | | | 145,000 | | | | | | 145,000 | | |
Michigan
|
| | | | 53,000 | | | | | | — | | | | | | 53,000 | | |
Florida
|
| | | | 66,000 | | | | | | — | | | | | | 66,000 | | |
Total
|
| | | | 786,000 | | | | | | 365,000 | | | | | | 1,151,000 | | |
State
|
| |
Offering
|
|
伊利诺伊州(目前为制造商) | | |
大麻干花、大麻雾化形式、胶囊中的大麻油、口服液和舌下液、大麻食用产品和其他大麻产品。产品线包括克雷斯科品牌的花卉、蒸汽笔和多种形式的提取物的重点产品;“High Supply®”产品,包括鲜花、蒸气和浓缩物;“Good News®”产品,包括蒸气和可食用产品;“Wonder Wellness Co.®”可食用产品;以及“RemediTM”产品,包括酊剂、胶囊和舌下油。Cresco授权“Kiva”品牌,生产注入大麻的可食用食品,包括但不限于巧克力糖果、口香糖、薄荷和馅饼。Cresco还通过与詹姆斯·比尔德奖获得者明迪·西格尔合作,以“Mindy‘s TM”的品牌销售注入大麻的可食用食品,包括但不限于:巧克力和太妃糖糖果、水果味口香糖、硬糖果和太妃糖。伊利诺伊州的零售点销售各种各样的这些品牌及其相应的产品。
|
|
宾夕法尼亚州(目前为制造商) | | |
大麻干花、大麻的雾化形式、胶囊中的大麻油、口服和舌下溶液、外用产品中的大麻以及其他大麻产品。产品线包括“Cresco®”品牌下的花卉、蒸汽笔和多种形式的萃取物;“High Supply®”品牌下的鲜花和蒸气笔以及“RemediTM”产品。
|
|
State
|
| |
Offering
|
|
| | |
包括精确剂量的不可燃产品,包括药酒、胶囊、药膏和舌下油。宾夕法尼亚州的零售点销售各种各样的这些品牌及其相应的产品。
|
|
俄亥俄州(目前为制造商) | | |
大麻干花、大麻雾化形式、胶囊中的大麻油、口服液和舌下液、大麻可食用产品和其他大麻产品。产品线包括以鲜花、蒸气笔和多种形式的萃取物为主的“Cresco®”品牌产品;“High Supply®”产品,包括花、蒸气和提取物;“Good News®”产品,包括蒸气和可食用产品;“Wonder Wellness Co.®”系列可食用产品;以及“RemediTM”产品,包括药酒、胶囊和舌下油。Cresco还通过与詹姆斯·比尔德奖获奖厨师明迪·西格尔合作,以“Mindy‘sTM”的品牌销售注入大麻的可食用食品,包括但不限于水果转发口香糖。
|
|
加州(目前为制造商) | | |
大麻干花、大麻蒸发剂、胶囊中的大麻油、大麻食用产品和其他大麻产品。产品线包括花卉、VAPE笔以及“FLORACAL®”、“CRESCO®”、“High Supply®”和“Good News®”品牌下的多种萃取物。克雷斯科还以“Mindy‘s TM”和“Good News®”的品牌销售注入大麻的可食用食品。所有品牌均由Cresco拥有的“Continuum”经销业务经销,在该经销业务中,上述自有产品与合作品牌一起销售给加利福尼亚州的特许零售药房。
|
|
亚利桑那州(目前为制造商) | | |
大麻干花、大麻蒸发剂、胶囊中的大麻油、大麻食用产品和其他大麻产品。产品线包括花卉、VAPE笔以及“Cresco®”和“High Supply®”品牌下的多种形式的提取物。所有品牌都出售给有执照的零售药房,包括克雷斯科旗下的一家门店,名为“Sunnyside*®”。
|
|
马萨诸塞州(目前为制造商) | | |
大麻干花、大麻雾化形式、胶囊中的大麻油、口服和舌下溶液、外用产品中的大麻、大麻可食用产品和其他大麻产品。这些产品系列包括“Cresco®”品牌的花卉、蒸汽笔和多种形式的提取物;“High Supply®”品牌的鲜花和蒸气笔;“RemediTM”产品,包括精确剂量的不可燃产品,包括酊剂、胶囊、药膏和舌下油。Cresco大麻通过与詹姆斯·比尔德奖获得者明迪·西格尔合作,以“Mindy‘s TM”的品牌注入可食用大麻。Cresco出售注入大麻的水果转发口香糖。马萨诸塞州的零售点销售各种各样的这些品牌及其相应的产品。
|
|
马里兰州(目前为制造商) | | |
产品线包括Cresco Liquid Live Resin、Cresco Live Resin和Cresco一次性钢笔。
|
|
纽约(目前在生产) | | |
大麻的雾化形式、胶囊中的大麻油、口服和舌下溶液、外用产品和其他大麻产品中的大麻。该产品线包括“RemediTM”产品,其中包括精确剂量的不可燃产品,包括药酒和胶囊。Sunnyside*®在纽约的零售点销售这些品牌和相应的产品。
|
|
佛罗里达州(目前为制造商) | | |
大麻干花、大麻雾化形式、大麻可食用产品以及舌下溶液和其他大麻产品中的大麻油。产品线包括花卉、电子烟笔和多种形式的萃取物;包括电子烟的“High Supply®”产品;包括电子烟的“Good News®”产品;以及包括香油、注射器在内的“RemediTM”产品
|
|
State
|
| |
Offering
|
|
| | |
和舌下油。Cresco授权“One Plants”品牌,生产花卉、蒸气、浓缩液和舌下油。克雷斯科还生产“Sunnyside*®”品牌的大麻食品。
|
|
密歇根州(目前为制造商) | | |
大麻干花、胶囊中的大麻油、口服液和舌下液、大麻食用产品和其他大麻产品。产品线包括电子烟笔中的重点产品和“Cresco®”品牌下的多种形式的提取物;“High Supply®”产品,包括鲜花、电子烟和提取物;“Good News®”产品,包括电子烟和可食用的“Wonder Wellness Co.®”系列食品;以及“RemediTM”产品,包括药酒、胶囊和舌下油。Cresco还通过与詹姆斯·比尔德奖获得者明迪·西格尔合作销售注入大麻的可食性食品,品牌为“Mindy‘sTM”。Cresco销售注入大麻的可食用食品,包括但不限于水果胶糖。
|
|
Description
|
| |
Stylized Design
|
| |
重新命名的风格化设计
(as applicable) |
|
“Cresco”的文本和风格化标志
|
| |
|
| |
|
|
“Cresco Labs”的文本和风格化标识
|
| |
|
| |
|
|
“Cresco Sun”的风格化标志
|
| | | | |
|
|
“Remedi”的文本和风格化标志
|
| |
|
| |
|
|
“Cresco Reserve”的文本和风格化标识
|
| |
|
| |
|
|
The stylized logo “r”
|
| |
|
| | | |
Description
|
| |
Stylized Design
|
| |
重新命名的风格化设计
(as applicable) |
|
《明迪的厨房》的文字和风格化标识
|
| |
|
| | | |
《明迪手工食品》的文字和风格化标识
|
| |
|
| | | |
“Mindy‘s Chef Lead手工食品”的文字和风格化标识
|
| |
|
| | | |
The text and stylized logo for “CY+”
|
| |
|
| | | |
“Sunnyside*”的文本和风格化标志
|
| |
|
| | | |
The stylized logo for “ * “
|
| |
|
| | | |
《Wonder Wellness Co.》的文字和风格化标识。和《Wonder Wellness》
|
| |
|
| | | |
“好消息”的文字和样式徽标
|
| |
|
| | | |
“高供应量”的文字和风格化标志
|
| |
|
| | | |
“Alta Supply”的文本和风格化标识
|
| |
|
| | | |
“Continuum”的文本和样式徽标
|
| |
|
| | | |
“Continuum”的风格化标识
|
| |
|
| | | |
“FloraCal Farm”和“FloraCal”的文本和样式徽标
|
| |
|
| | | |
“FloraCal”的风格化标志
|
| |
|
| | | |
Description
|
| |
Stylized Design
|
| |
重新命名的风格化设计
(as applicable) |
|
“FloraCal Farm”和“FloraCal”的文本和样式徽标
|
| |
|
| | | |
《起源之家》的文字和风格化标识
|
| |
|
| | | |
Jurisdiction
|
| |
No. Registration
已提交申请 |
| |
No. Registration
Awarded as of April 28, 2022 |
| |
Renewal Year
|
| |||||||||
美国专利商标局(1)
|
| | | | 49 | | | | | | 28 | | | | | | 2021 | | |
Arizona
|
| | | | 6 | | | | | | 6 | | | | | | 2029 | | |
California(1) | | | | | 19 | | | | | | 17 | | | | | | 2024 | | |
Florida(1) | | | | | 5 | | | | | | 5 | | | | | | 2026 | | |
Illinois
|
| | | | 45 | | | | | | 45 | | | | | | 2024 | | |
Maryland(1) | | | | | 4 | | | | | | 2 | | | | | | 2029 | | |
Massachusetts(1) | | | | | 9 | | | | | | 9 | | | | | | 2026 | | |
Michigan(1) | | | | | 16 | | | | | | 14 | | | | | | 2030 | | |
Nevada
|
| | | | 2 | | | | | | 2 | | | | | | 2024 | | |
New York
|
| | | | 3 | | | | | | 3 | | | | | | 2030 | | |
Ohio(1) | | | | | 6 | | | | | | 6 | | | | | | 2029 | | |
Pennsylvania
|
| | | | 11 | | | | | | 11 | | | | | | 2024 | | |
Canada(1) | | | | | 26 | | | | | | 2 | | | | | | 2031 | | |
Jurisdiction
|
| |
不。注册申请
Submitted |
| |
No. Registration Awarded
as of May 2, 2022 |
| ||||||
美国专利商标局(1)
|
| | | | 3 | | | | | | 2 | | |
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Cresco Labs, LLC
|
| |
提前批准成人用培植中心许可证
License Number: 1503060739-EA |
| |
Kankakee
|
| |
03/31/2022
|
| |
早期批准的成人使用培养中心的经营许可证
|
|
|
提前批准成人用培植中心许可证
License Number: 1503060740-EA |
| |
Lincoln
|
| |
03/31/2022
|
| |
早期批准的成人使用培养中心的经营许可证
|
| ||
|
提前批准成人用培植中心许可证
License Number: 1503060741-EA |
| |
Joliet
|
| |
03/31/2022
|
| |
早期批准的成人使用培养中心的经营许可证
|
| ||
|
医用大麻种植中心经营许可证
License Number: 1503060739 |
| |
Kankakee
|
| |
05/18/2022
|
| |
经营医用大麻种植中心许可证
|
| ||
|
医用大麻种植中心经营许可证
License Number: 1503060740 |
| |
Lincoln
|
| |
03/09/2023
|
| |
经营医用大麻种植中心许可证
|
| ||
|
医用大麻种植中心经营许可证
License Number: 1503060741 |
| |
Joliet
|
| |
03/09/2023
|
| |
经营医用大麻种植中心许可证
|
| ||
|
Industrial Hemp
Processor License License Number: 1204-301 |
| |
Kankakee
|
| |
12/31/2022
|
| |
工业大麻加工许可证
|
| ||
|
Industrial Hemp
Processor License License Number: 1204-302 |
| |
Joliet
|
| |
12/31/2022
|
| |
工业大麻加工许可证
|
| ||
|
Industrial Hemp
Processor License License Number: 1204-303 |
| |
Lincoln
|
| |
12/31/2022
|
| |
工业大麻加工许可证
|
| ||
|
Transporter License1503060741-TR
|
| |
Joliet
|
| |
07/14/2022
|
| |
运输大麻许可证
|
| ||
|
Transporter License1503060740-TR
|
| |
Lincoln
|
| |
07/14/2022
|
| |
运输大麻许可证
|
| ||
|
Transporter License1503060739-TR
|
| |
Kankakee
|
| |
07/14/2022
|
| |
运输大麻许可证
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Phoenix Farms of
Illinois, LLC |
| |
注册医用大麻配药组织证书
License: 280:000035 |
| |
Champaign
|
| |
04/26/2022
|
| |
经营医用大麻药房的许可证
|
|
|
注册医用大麻配药组织证书
License: 284:000006 |
| |
Champaign
|
| |
03/31/2022
|
| |
经营娱乐性大麻药房许可证
|
| ||
|
注册成人配药组织证书
License: 284:000056 |
| |
Danville
|
| |
03/31/2022
|
| |
经营娱乐性大麻药房许可证
|
| ||
PDI Medical III,
LLC |
| |
注册医用大麻配药组织证书
License: 280:000016 |
| |
Buffalo Grove
|
| |
12/07/2022
|
| |
经营医用大麻药房的许可证
|
|
|
注册成人配药组织证书
License: 284:000009 |
| |
Buffalo Grove
|
| |
03/31/2022
|
| |
经营娱乐性大麻药房许可证
|
| ||
|
注册成人配药组织证书
License: 284:000080 |
| |
Naperville
|
| |
03/31/2022
|
| |
经营娱乐性大麻药房许可证
|
| ||
FloraMedex, LLC
|
| |
注册医用大麻配药组织证书
License: 280:000034 |
| |
Elmwood Park
|
| |
04/18/2022
|
| |
经营医用大麻药房的许可证
|
|
|
注册成人配药组织证书
License: 284:000010 |
| |
Elmwood Park
|
| |
03/31/2022
|
| |
经营娱乐性大麻药房许可证
|
| ||
|
注册成人配药组织证书
License: 284:000061 |
| |
Schaumburg
|
| |
03/31/2022
|
| |
经营娱乐性大麻药房许可证
|
| ||
MedMar Lakeview,
LLC |
| |
注册成人配药组织证书
License: 284:000053 |
| |
Chicago
|
| |
01/13/2023
|
| |
经营医用大麻药房的许可证
|
|
|
注册成人配药组织证书
License: 284:000008 |
| |
Chicago
|
| |
03/31/2022
|
| |
经营娱乐性大麻药房许可证
|
| ||
|
注册成人配药组织证书
License: 284:000053 |
| |
Chicago
|
| |
03/31/2022
|
| |
经营娱乐性大麻药房许可证
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
MedMar Rockford,
LLC |
| |
注册医用大麻配药组织证书
License: 280:000013 |
| |
Rockford
|
| |
11/24/2022
|
| |
经营医用大麻药房的许可证
|
|
|
注册成人配药组织证书
License: 284:000007 |
| |
Rockford
|
| |
03/31/2022
|
| |
经营娱乐性大麻药房许可证
|
| ||
|
注册成人配药组织证书
License: 284:000059 |
| |
South Beloit
|
| |
03/31/2022
|
| |
经营娱乐性大麻药房许可证
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Cresco Yeltrah, LLC
|
| |
Medical Marijuana
Grower/ Processor Permit Applicant ID: GP-6012-17 |
| |
Brookville
|
| |
06/20/2022
|
| |
种植和加工医用大麻许可证
|
|
|
医用大麻药房许可证申请者ID:D-5016-17
|
| |
Butler
|
| |
06/29/2022
|
| |
经营医用大麻药房的许可证
|
| ||
|
医用大麻药房许可证申请者ID:D-5016-17
|
| |
Pittsburgh
|
| |
06/29/2022
|
| |
经营医用大麻药房的许可证
|
| ||
|
医用大麻药房许可证申请者ID:D-5016-17
|
| |
New Kensington
|
| |
06/29/2022
|
| |
经营医用大麻药房的许可证
|
| ||
|
医用大麻药房许可证申请者ID:D-18-1007
|
| |
Wyomissing
|
| |
12/18/2022
|
| |
经营医用大麻药房的许可证
|
| ||
|
医用大麻药房许可证申请者ID:D-18-1007
|
| |
Philadelphia
|
| |
12/18/2022
|
| |
经营医用大麻药房的许可证
|
| ||
|
医用大麻药房许可证申请者ID:D-18-1007
|
| |
Ambler
|
| |
12/18/2022
|
| |
经营医用大麻药房的许可证
|
| ||
Bay, LLC
|
| |
医用大麻药房许可证申请者ID:D-1069-17
|
| |
Lancaster
|
| |
06/29/2022
|
| |
经营医用大麻药房的许可证
|
|
|
医用大麻药房许可证申请者ID:D-1069-17
|
| |
Philadelphia
|
| |
06/29/2022
|
| |
经营医用大麻药房的许可证
|
| ||
|
医用大麻药房许可证申请者ID:D-1069-17
|
| |
Phoenixville
|
| |
06/29/2022
|
| |
经营医用大麻药房的许可证
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Laurel Harvest
Labs, LLC |
| |
医用大麻种植者/加工商许可证申请者ID:CR02-GP20-1202
|
| |
Mount Joy
|
| |
02/20/2023
|
| |
种植和加工医用大麻许可证
|
|
|
医用大麻药房许可证申请者ID:CR02-D20-2202
|
| |
Montgomeryville
|
| |
02/20/2023
|
| |
种植和加工医用大麻许可证
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Cresco Labs Ohio,
LLC |
| |
MMCPC00017
|
| |
Yellow Springs
|
| |
09/13/2022
|
| |
Cultivation License
|
|
| | |
MMD 0700002
|
| |
Wintersville
|
| |
07/01/2023
|
| |
Dispensary License
|
|
| | |
MMCP00041
|
| |
Yellow Springs
|
| |
06/10/2022
|
| |
医用大麻加工商许可证
|
|
Verdant Creations
Newark, LLC |
| |
MMD.0700061
|
| |
Newark
|
| |
12/04/2022
|
| |
Dispensary License
|
|
Verdant Creation
Marion, LLC |
| |
MMD.0700062
|
| |
Marion
|
| |
12/04/2022
|
| |
Dispensary License
|
|
Care Med
Associates, LLC |
| |
MMD.0700063
|
| |
Cincinnati
|
| |
12/04/2022
|
| |
Dispensary License
|
|
Verdant Creations
Chillicothe, LLC |
| |
MMD.0700064
|
| |
Chillicothe
|
| |
12/04/2022
|
| |
Dispensary License
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
SLO Cultivation Inc.
|
| |
临时制造编号:cdph-10003334
|
| |
Mendota
|
| |
05/31/2022
|
| |
医疗和成人用制造
|
|
|
Provisional License Number: C11-0000193-LIC
|
| |
Mendota
|
| |
05/28/2022
|
| |
医疗和成人用制造
|
| ||
|
Provisional License Number: CCL18-0002726
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002733
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002727
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002728
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002729
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002731
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002765
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002764
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002763
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002762
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002761
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002760
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002759
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002757
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002756
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002755
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002754
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002753
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002752
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002766
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
Provisional License Number: CCL18-0002751
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
临时苗圃许可证编号:CCL18-0002750
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
| ||
|
临时处理器许可证号:CCL18-0002749
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
种植小混光,第1级
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
| | |
临时处理器许可证号:CCL18-0002816
|
| |
Carpinteria
|
| |
05/31/2022
|
| |
Nursery
|
|
| | |
临时处理器许可证号:CCL18-0002817
|
| |
Carpinteria
|
| |
05/31/2022
|
| |
Processor
|
|
FloraCal Farms | | |
栽培基质(暂定)CCL18-0002186
|
| |
Santa Rosa
|
| |
03/21/2023
|
| |
栽培:医用介质室内:
|
|
| | |
Processor (Provisional) CCL19-0000639
|
| |
Santa Rosa
|
| |
06/27/2022
|
| |
Processor
|
|
| | |
Distribution (Provisional) C11-0001222-LIC
|
| |
Santa Rosa
|
| |
06/25/2022
|
| |
Distribution
|
|
Cub City, LLC | | |
小型室内栽培(暂定)CCL18-0002062
|
| |
Santa Rosa
|
| |
03/21/2023
|
| |
种植:医用小型室内
|
|
River Distributing
Co., LLC |
| |
Distribution (Provisional) C11-0000933-LIC
|
| |
Sacramento
|
| |
07/29/2022
|
| |
Distribution
|
|
| | |
Distribution (Provisional) C11-0000608-LIC
|
| |
La Habra
|
| |
07/01/2022
|
| |
Distribution
|
|
Holding Entity
|
| |
Permit/License
|
| |
Registration Number
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Encanto
Green Cross Dispensary |
| |
医用大麻药房和种植场所登记证;批准经营
|
| |
00000080DCQI00709964
|
| |
Phoenix
|
| |
08/07/2022
|
| |
批准种植和分发医用大麻
|
|
Encanto
Green Cross Dispensary |
| |
医用大麻药房登记证;批准经营
|
| |
00000080DCQI00709964
|
| |
Salome
|
| |
08/07/2022
|
| |
批准种植医用大麻
|
|
Encanto
Green Cross Dispensary |
| |
成人使用大麻药房现场登记证;批准经营
|
| |
00000101ESZO30906924
|
| |
Phoenix
|
| |
01/28/2023
|
| |
批准发放成人用大麻
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
山谷农业有限责任公司
|
| |
Certificate of
Registration Number: MM0801M |
| |
Middletown
|
| |
07/31/2023
|
| |
Acquiring,
possession, manufacture, sale, transporting and distributing medical marijuana |
|
|
Certificate of
Registration Number: MM0802D |
| |
Brooklyn
|
| |
07/31/2023
|
| |
Acquiring,
possession, sale, transporting, distributing, and dispensing medical marijuana |
| ||
|
Certificate of
Registration Number: MM0803D |
| |
Huntington
|
| |
07/31/2023
|
| |
Acquiring,
possession, sale, transporting, distributing, and dispensing medical marijuana |
| ||
|
Certificate of
Registration Number: MM0804D |
| |
Bardonia
|
| |
07/31/2023
|
| |
Acquiring,
possession, sale, transporting, cutting, and dispensing medical marijuana |
| ||
|
Certificate of
Registration Number: MM0805D |
| |
New Hartford
|
| |
07/31/2023
|
| |
Acquiring,
possession, sale, transporting, distributing, and dispensing medical marijuana |
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Cresco HHH, LLC
|
| |
RMD-686
|
| |
Fall River
|
| |
11/20/2022
|
| |
Medical cultivation,
manufacturing and processing and it establishes and allows for dispensary operations |
|
|
MC281478
|
| |
Fall River
|
| |
06/08/2022
|
| |
Marijuana
Cultivator-Tier 4 |
| ||
|
MP281361
|
| |
Fall River
|
| |
06/18/2022
|
| |
Marijuana Product
Manufacturer |
| ||
Cultivate
Cultivation, LLC |
| |
MP281305
|
| |
Leicester
|
| |
09/24/2022
|
| |
Marijuana Product
Manufacturer |
|
| | |
MC281266
|
| |
Leicester
|
| |
09/26/2022
|
| |
Marijuana
Cultivator |
|
| | |
MR282522
|
| |
Framingham
|
| |
02/10/2023
|
| |
Marijuana Retailer
|
|
| | |
RMD-3193
|
| |
Framingham
|
| |
10/14/2022
|
| |
Medical cultivation,
manufacturing and processing and it establishes and allows for dispensary operations |
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Cultivate Leicester,
Inc |
| |
MC282053
|
| |
Uxbridge
|
| |
03/12/2023
|
| |
Marijuana
Cultivator |
|
|
MP281742
|
| |
Uxbridge
|
| |
03/12/2023
|
| |
Marijuana Product
Manufacturer |
| ||
| | |
MR281843
|
| |
Worcester
|
| |
05/05/2022
|
| |
Marijuana Retailer
|
|
| | |
MR28126
|
| |
Leicester
|
| |
09/26/2022
|
| |
Marijuana Retailer
|
|
| | |
RMD-485
|
| |
Leicester
|
| |
11/18/2022
|
| |
Medical cultivation,
manufacturing and processing and it establishes and allows for dispensary operations |
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
| ||||||
Cresco Labs
Michigan, LLC |
| |
PR-000067
|
| | | | 马歇尔 | | | | | | 03/04/2023 | | | |
医疗加工证
|
|
|
AU-P-000127
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
成人使用处理器许可证
|
| ||
|
AU-G-C-000351
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
| ||
| | |
AU-G-C-000352
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-C-000353
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-C-000354
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-C-000355
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
GR-C-21-001012
|
| | | | 马歇尔 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001013
|
| | | | 马歇尔 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001014
|
| | | | 马歇尔 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001015
|
| | | | 马歇尔 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001016
|
| | | | 马歇尔 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001017
|
| | | | 马歇尔 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001018
|
| | | | 马歇尔 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001019
|
| | | | 马歇尔 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-000726
|
| | | | 马歇尔 | | | | | | 03/04/2023 | | | |
Medical Cultivation
|
|
| | |
GR-C-000727
|
| | | | 马歇尔 | | | | | | 03/04/2023 | | | |
Medical Cultivation
|
|
| | |
AU-G-EX-000239
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000240
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000241
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000242
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000243
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000244
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000245
|
| | | | 马歇尔 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
3 Boys Farms, LLC | | |
MMTC-2017-0008
|
| |
Vertically-
integrated State License for all activities and locations |
| |
06/02/2022
|
| |
Cultivation,
manufacturing and processing and it establishes and allows for dispensary operations |
|
| 通知权和投票权 | | |
Cresco股票持有人将有权获得Cresco任何股东大会的通知并出席该会议,但只有Cresco其他特定类别或系列股票的持有人才有权在该会议上投票。在每次这样的会议上,Cresco股票的持有者将有权就所持有的每股Cresco股票投一票。
|
|
| 阶级权利和优先购买权 | | |
只要任何Cresco股票仍未发行,Cresco将不会损害或干扰Cresco股票附带的任何权利,除非Cresco股票持有人通过单独的特别决议同意。Cresco股票的持有者现在或将来将无权认购、购买或接收任何发行的Cresco股票或Cresco的债券、债券或其他证券的任何部分。
|
|
| Dividends | | |
Cresco股票的持有者将有权在Cresco董事宣布时获得Cresco的现金或财产股息。
|
|
| Participation | | |
如果Cresco发生清算、解散或清盘,无论是自愿或非自愿的,或Cresco的资产在股东之间进行任何其他分配以清盘其事务,Cresco股份的持有人应有权与Cresco股份、SSVS(按转换为Cresco股份的基准)和PVS(按转换为Cresco股份的基准)的所有其他持有人一起按比例参与,但须遵守Cresco股份(包括但不限于MVS)的任何股份持有人的优先权利。
|
|
| Changes | | |
Cresco股份不得拆分或合并,除非同时以相同方式拆分或合并Cresco股份、SSVS、PVS及MVS,或作出该等其他调整,以维持及保留上述各类别股份持有人的相对权利。
|
|
| Conversion | | |
如果提出购买PVS的要约,并且根据适用的证券法或PVS随后上市的证券交易所的上市规则或条件,该要约必须向这些要求适用的加拿大给定省份或地区的所有或几乎所有PVS持有者提出,在要约生效期间的任何时间,每股Cresco股份应根据持有人的选择按当时有效的转换比率的倒数转换为PVS,直至适用证券法例规定要约人认购并支付根据要约收购的股份的时间后一天为止。换股权利只能就Cresco股份行使,目的是根据要约存入所产生的PVS,而不是出于其他原因。在这种情况下,Cresco的转让代理人应代表持有人存入由此产生的PVS。如果转换时发行并响应要约而投标的PVS被股东撤回或未被要约人接受,或要约被放弃或撤回,则转换产生的PVS应自动按当时有效的转换比率重新转换为Cresco股票,而Cresco方面或持有人方面不会进一步干预。
|
|
| Right to Vote | | |
PVS的持有人将有权获得Cresco的任何股东大会的通知并出席,但只有Cresco的另一特定类别或系列股票的持有人才有权在该会议上投票。在每次此类会议上,PVS的持有人将有权就该PVS最终可转换为的每股Cresco股份投一票,为了更好地确定,该投票权最初应等于每PVS 200票(可由Cresco董事会酌情调整,取决于保持外国私人发行人地位所需的比率)。
|
|
| Class Rights | | |
只要任何PVS仍未结清,Cresco将不会在未经PVS和MVS持有人通过单独的特别决议同意的情况下,损害或干扰PVS附带的任何权利或特别权利。任何授权或设立优先于已发行PVS或与PVS平价的任何类别股份的行动,均须征得已发行PVS及MVS的过半数持有人同意。就行使上述投票权而言,每名自愿书持有人对所持有的每一份自愿书有一票投票权。
|
|
| 认购权;优先购买权 | | |
PVS的持有人无权认购、购买或接收任何发行的Cresco股票或Cresco的债券、债券或其他证券的任何部分。
|
|
| Dividends | | |
PVS的持有人有权从任何可合法获得的现金或其他资产中收取股息,因此,就股息和任何宣布或支付Cresco股份的任何股息而言,同等权益(按折算基准,假设所有PVS转换为Cresco股份)。除非Cresco同时宣布或支付(如适用)Cresco股份的等值股息(按转换为Cresco股份的基准),否则不会在PVS上宣布或支付股息。
|
|
| Participation | | |
如果Cresco发生清算、解散或清盘,无论是自愿的还是非自愿的,或者如果Cresco的资产在股东之间进行了任何其他分配以了结其事务,则PVS的持有人将有权与PVS(以转换为Cresco股份的基准)和Cresco股份的所有其他持有人一起按比例参与,但须受优先于PVS的任何Cresco股份(包括但不限于MVS)持有人的优先权利的限制。
|
|
| Changes | | |
除非同时以相同方式拆分或合并Cresco股份、PVS及MVS,或作出其他调整以维持及保留上述各类别股份持有人的相对权利,否则不得拆分或合并PVS。
|
|
| Conversion | | |
PVS各自拥有转换为200股Cresco股票的受限权利(“转换比率”),但须根据某些惯常的公司变动和外国私人发行人的考虑进行调整。转换PVS的能力受Cresco股票、PVS和MV总数的限制
|
|
| | | |
由美国居民直接或间接持有的(根据1934年证券交易法(修订本)第3B-4和12G3-2(A)规则确定的)不得超过Cresco股份、PVS和MV在实施该等转换后已发行和发行的股份总数的40%(40%)(视调整而定),并受超过某些水平的Cresco股份实益所有权的限制。此外,在某些情况下,Cresco有权将PVS转换为Cresco股票,包括在Cresco股票根据修订后的1933年美国证券法登记时。
|
|
| Right to Vote | | |
MVS的持有人有权获得通知并出席Cresco的任何股东大会,但只有Cresco的另一特定类别或系列股票的持有人才有权在该会议上投票。在每次会议上,MVS持有人有权就所持有的每一MVS投2,000票,但如在任何时间,(I)Cresco资本中的Cresco可赎回股份(如适用)及(Ii)Cresco资本中的Cresco可赎回单位(或Cresco Corp或Cresco的任何继承人不时存在的证券)直接或间接由MVS持有人(“持有人”)及持有人的前身或转让人、准许受让人及准许继承人实益拥有,及任何先前转让人的转让人及任何先前核准受让人的许可受让人(“持有人集团”)除以(I)Cresco可赎回股份(如适用)及(Ii)持有人及持有人集团于涉及Cresco、Cresco Corp及Cresco(其中包括)的企业合并交易完成日期直接或间接实益拥有的Cresco可赎回单位总数少于50%(“触发事件”),则持有人自该日起有权就所持有的每一MVS享有50票。应Cresco的要求,MVS的持有人应不时向Cresco提供有关持有人对Cresco可赎回股份(如适用)和Cresco可赎回单位的直接和间接实益所有权(及其允许受让人和允许继承人的所有权)的证据,以便Cresco能够确定MVS的投票权。就这些计算而言, 持有人应被视为实益拥有由中间公司或基金持有的Cresco可赎回股票(如果适用),比例为他们在该公司或基金的股权。
|
|
| Class Rights | | |
只要任何MVS仍未解决,Cresco将不会在未经MVS持有人通过单独的特别决议同意的情况下,损害或干扰MVS附带的任何权利或特别权利。任何授权或设立任何类别股份的行动,均须征得已发行MVS的过半数持有人同意,而该等股份的优先程度高于MVS或与MVS相同。在行使该等投票权时,每名持票人可就持有的每一张票投一票。
|
|
| 认购权;优先购买权 | | |
MVS的持有人无权认购、购买或接收任何发行的Cresco股票、或Cresco的债券、债权证或其他不可在现在或将来转换为MVS的证券的任何部分。
|
|
| Dividends | | | MVS的持有者无权获得股息。 | |
| Participation | | |
如果Cresco发生清算、解散或清盘,无论是自愿的还是非自愿的,或者如果Cresco的资产在股东之间进行了任何其他分配,以了结其事务,Cresco将首先分配其资产,并优先于Cresco任何其他类别股份的持有人(包括Cresco股票和PVS的持有人)向其持有人返还MVS的发行价的权利,如果没有足够的资产将MVS的发行价全额返还给MVS的持有人,该等持有人将收到
|
|
| | | |
相当于其MVS与所有其他MVS持有者的发行价比例的比例份额的金额。MVS的持有人无权作为MVS的持有人直接或间接获得Cresco的任何其他资产或财产,他们的唯一权利将是根据本款返还该MVS的发行价。
|
|
| Changes | | |
除非同时以同样的方式拆分或合并MVS、PVS和Cresco股份,以维护和维护上述每一类别股份持有人的相对权利,否则不得对MVS进行拆分或合并。
|
|
| Conversion | | | MVS的持有者无权转换。 | |
| Redemption Rights | | |
一旦触发事件发生,Cresco有权赎回导致触发事件发生的持有人及持有人集团的全部或部分MV,方法是提前两天向该MV的持有人及持有人集团发出书面通知,金额相当于每一MV的发行价,并以现金支付给如此赎回的MV的持有人。Cresco不需要在持有人或持有人集团之间按比例赎回MV。将由Cresco赎回的MVS的持有人应将代表该MVS的一张或多张证书交回Cresco的档案处,以便转让给Cresco(或随附与此相关的妥为签立的股份转让)。
每张已交回的股票将被注销,此后Cresco将以保兑支票、银行汇票或电汇向该股票的登记持有人支付适用的赎回金额;但如果被赎回的股票所代表的MV少于所有MV,则应以被注销股票的适用登记持有人的名义发行代表该证书所代表的MV未赎回余额的新股票。如在适用的赎回日期,任何MVS的赎回价格已就任何MVS支付(或提交付款),则在该日期,如此赎回及支付或投标的MVS的持有人在该MVS上的所有权利将终止,而该等已赎回MVS的持有人将不再被视为已发行及尚未赎回,不论该MVS的持有人是否已向Cresco交付代表该等证券的证书,而自该日期起及之后,先前代表撤回的MVS的证书只证明该MVS的前持有人有权收取该持有人有权获得的赎回价格。
|
|
| Transfer | | |
MVS的持有人不得转让任何MVS,除非此类转让是转让给直系亲属,或转让给由该持有人或其直系亲属全资实益拥有的公司或个人,或该持有人或其直系亲属是其唯一受益人。为使转让生效,任何转让必须事先获得Cresco的书面同意。
|
|
|
Investment
Agreement |
| |
为补充MVS附带的权利、特权、限制和条件,作为MVS的初始持有人,Cresco和创办人签订了一项投资协议,自企业合并完成时生效,其中规定:(I)每个MVS只能转让给持有者的直系亲属或关联实体,或转让给其他创始人或与其他创始人关联的实体,以及(Ii)在将MVS出售给第(I)款中未列出的第三方购买者时,此类MV将立即由Cresco以其发行价赎回。
|
|
| Right to Vote | | | SSVS的持有人有权获得通知并出席Cresco的任何股东大会,但只有Cresco的另一特定类别或系列股票的持有人才有权在该会议上投票。在每次会议上,SSV的持有人将有权就该SSV最终可转换为的每股Cresco股份投一票,为提高确定性,该投票权最初应等于每个SSVS的0.00001的投票权。 | |
| Class Rights | | |
只要任何SSV仍未解决,Cresco将不会损害或干扰SSV附带的任何权利或特殊权利,除非SSV持有人通过单独的特别决议同意。在行使这些投票权时,每名社会保障计划持有人可就每一份社会保障计划投一票。
|
|
| 认购权;优先购买权 | | |
SSVS的持有人无权认购、购买或接收现在或将来发行的任何Cresco股票、债券、债权证或其他证券的任何部分。
|
|
| Dividends | | |
因此,SSVS的持有人有权从任何现金或其他合法可用资产中收取股息(假设所有SSVS按特别换股比率转换为Cresco股份),并有权就Cresco股份的任何股息及任何宣布或支付股息。除非Cresco同时宣布或支付(如适用)Cresco股份及PVS的等值股息(按转换为Cresco股份的基准),否则不会在SSVS上宣派或支付股息。
|
|
| Participation | | |
如果Cresco发生清算、解散或清盘,无论是自愿的还是非自愿的,或者如果Cresco的资产在股东之间进行任何其他分配以结束其事务,SSVS的持有人将有权与Cresco股票的所有其他持有人(在转换为Cresco股票的基础上)享有优先于SSVS的任何Cresco股份(包括但不限于MVS)的优先权利,PVS(在转换为Cresco股票的基础上)和Cresco股票。
|
|
| Changes | | |
可通过董事(或其委员会)的决议将SSV拆分或合并,而无需以相同方式同时拆分或合并Cresco股份、PVS和MVS,前提是相应地调整特别换股比率,并相应调整SSV的投票权,使所有SSV持有人在拆分或合并前持有的总投票权等于拆分或合并后所有SSVS持有人持有的总投票数。
|
|
| 所有权限制 | | |
SSVS只能由一名或多名非指定的美国人直接或间接实益拥有或控制。
|
|
| 转移限制 | | |
未经Cresco董事会(或其委员会)事先书面同意,SSV或其中的任何权利或权益不得由SSV持有人以合法、实益或任何其他方式转让,Cresco董事会(或其委员会)可全权酌情予以扣留。
|
|
| Redemption Rights | | |
Cresco有权随时通过向任何持有人提供提前两天的书面通知(“赎回通知”)赎回全部或部分SSV:(I)现金,其价格等于特别换股比率(可根据其条款调整)乘以紧接赎回通知日期前10个交易日Cresco股票在CSE(或该等其他证券交易所或报价系统)的平均成交量加权平均交易价;或(Ii)按可根据其条款调整的特别换股比率购入Cresco股份。Cresco不需要在SSVS持有人中按比例赎回SSVS。
|
|
| Conversion | | |
SSV的持有者有权转换为每股SSV 0.00001的Cresco股票(“特别换股比率”),但须受某些公司变动的惯例调整所限。转换SSV的能力须事先获得Cresco董事会或其委员会的书面同意。Cresco可要求每个SSV持有人按适用的特殊转换比率转换所有SSV,前提是在任何时间满足以下所有条件(或SSV持有人的特别决议以其他方式放弃):(A)Cresco不再是“外国私人发行人”(根据美国交易所法案3b-4规则确定);或(B)Cresco董事会(或其委员会)确定不再需要或不再需要SSV。
|
|
CSE
|
| ||||||||||||||||||
Period
|
| |
High Trading Price (C$)
|
| |
Low Trading Price (C$)
|
| |
Volume
|
| |||||||||
April 2021
|
| | | | 16.9700 | | | | | | 14.0000 | | | | | | 6,865,875 | | |
May 2021
|
| | | | 16.7600 | | | | | | 13.3000 | | | | | | 6,764,181 | | |
June 2021
|
| | | | 14.9400 | | | | | | 12.4400 | | | | | | 5,371,470 | | |
July 2021
|
| | | | 14.9700 | | | | | | 12.6800 | | | | | | 6,498,345 | | |
August 2021
|
| | | | 14.3700 | | | | | | 12.1200 | | | | | | 4,185,734 | | |
September 2021
|
| | | | 12.5100 | | | | | | 10.1400 | | | | | | 5,857,624 | | |
October 2021
|
| | | | 11.7700 | | | | | | 9.2200 | | | | | | 3,951,944 | | |
November 2021
|
| | | | 13.0400 | | | | | | 9.3900 | | | | | | 8,826,438 | | |
December 2021
|
| | | | 11.0500 | | | | | | 7.8000 | | | | | | 7,844,152 | | |
January 2022
|
| | | | 9.2500 | | | | | | 6.5200 | | | | | | 5,390,428 | | |
February 2022
|
| | | | 10.3600 | | | | | | 7.8400 | | | | | | 6,961,238 | | |
March 2022
|
| | | | 8.7900 | | | | | | 6.7400 | | | | | | 7,690,492 | | |
April 2022
|
| | | | 7.9000 | | | | | | 5.6000 | | | | | | 6,020,478 | | |
Date Issued
|
| |
Number of
Cresco Securities |
| |
Issue Price
per Unit ($) |
| |
Aggregate
Issue Price ($) |
| |
对价的性质
|
| |||||||||
April 02, 2021
|
| | | | 13,950 | | | | | $ | 3.75 | | | | | $ | 52,313 | | | |
Cash (exercise of options)
|
|
April 02, 2021
|
| | | | 300,000 | | | | | $ | 12.72 | | | | | $ | 3,815,360 | | | |
换股(可赎回股份)
|
|
April 02, 2021
|
| | | | 78,977 | | | | | $ | 13.42 | | | | | $ | 1,059,871 | | | |
股份转换(与收购Origin House有关)
|
|
April 13, 2021
|
| | | | 15,875,449 | | | | | $ | 12.17 | | | | | $ | 193,170,508 | | | |
购买考虑事项(在
中
connection with Bluma) |
|
April 15, 2021
|
| | | | 50,000 | | | | | $ | 1.14 | | | | | $ | 57,000 | | | |
Cash (exercise of options)
|
|
April 15, 2021
|
| | | | 192,604 | | | | | $ | 12.98 | | | | | $ | 2,500,000 | | | |
购买考虑事项(在
中
connection with the acquisition of Origin House) |
|
April 15, 2021
|
| | | | 12,986 | | | | | $ | 12.63 | | | | | $ | 164,013 | | | |
股票发行(行使限制性股票单位)
|
|
Date Issued
|
| |
Number of
Cresco Securities |
| |
Issue Price
per Unit ($) |
| |
Aggregate
Issue Price ($) |
| |
对价的性质
|
| |||||||||
April 15, 2021
|
| | | | 6,963 | | | | | $ | 12.63 | | | | | $ | 87,943 | | | |
股票发行(行使限制性股票单位)
|
|
April 22, 2021
|
| | | | 55,917 | | | | | $ | 10.06 | | | | | $ | 562,525 | | | |
购买考虑事项(在
中
connection with the acquisition of Origin House) |
|
May 10, 2021
|
| | | | 159,259 | | | | | $ | 11.64 | | | | | $ | 1,854,005 | | | |
Cash (exercise of warrants)
|
|
May 10, 2021
|
| | | | 100,000 | | | | | $ | 12.79 | | | | | $ | 1,279,041 | | | |
换股(可赎回股份)
|
|
May 10, 2021
|
| | | | 4,620 | | | | | $ | 6.00 | | | | | $ | 27,720 | | | |
股票发行(行使限制性股票单位)
|
|
May 10, 2021
|
| | | | 61,700 | | | | | $ | 11.25 | | | | | $ | 694,125 | | | |
股票发行(与认购协议有关)
|
|
May 28, 2021
|
| | | | 945.00 | | | | | $ | 11.25 | | | | | $ | 10,631 | | | |
Cash (exercise of options)
|
|
May 28, 2021
|
| | | | 25,770.00 | | | | | $ | 11.64 | | | | | $ | 300,000 | | | |
Cash (exercise of warrants)
|
|
May 28, 2021
|
| | | | 2,900,000.00 | | | | | $ | 12.24 | | | | | $ | 35,488,168 | | | |
换股(可赎回股份)
|
|
May 28, 2021
|
| | | | 58,233 | | | | | $ | 6.00 | | | | | $ | 349,398 | | | |
股票发行(行使限制性股票单位)
|
|
May 28, 2021
|
| | | | 232 | | | | | $ | 5.96 | | | | | $ | 1,383 | | | |
股票发行(行使限制性股票单位)
|
|
June 01, 2021
|
| | | | 136,340 | | | | | $ | 6.00 | | | | | $ | 818,040 | | | |
股票发行(行使限制性股票单位)
|
|
June 03, 2021
|
| | | | 500,000 | | | | | $ | 11.71 | | | | | $ | 5,853,921 | | | |
换股(可赎回股份)
|
|
June 08, 2021
|
| | | | 50,000 | | | | | $ | 2.25 | | | | | $ | 112,500 | | | |
Cash (exercise of options)
|
|
June 10, 2021
|
| | | | 11,500 | | | | | $ | 1.14 | | | | | $ | 13,062 | | | |
Cash (exercise of options)
|
|
June 10, 2021
|
| | | | 760,000 | | | | | $ | 11.63 | | | | | $ | 8,835,456 | | | |
换股(可赎回股份)
|
|
June 17, 2021
|
| | | | 4,500 | | | | | $ | 2.99 | | | | | $ | 13,455 | | | |
Cash (exercise of options)
|
|
June 18, 2021
|
| | | | 179,250 | | | | | $ | 1 — $2.99 | | | | | $ | 207,968 | | | |
Cash (exercise of options)
|
|
June 22, 2021
|
| | | | 5,000 | | | | | $ | 2.25 | | | | | $ | 11,250 | | | |
Cash (exercise of options)
|
|
June 25, 2021
|
| | | | 3,000,000 | | | | | $ | 11.29 | | | | | $ | 33,870,181 | | | |
换股(可赎回股份)
|
|
July 05, 2021
|
| | | | 1,000 | | | | | $ | 2.99 | | | | | $ | 2,990 | | | |
Cash (exercise of options)
|
|
July 08, 2021
|
| | | | 2,000 | | | | | $ | 2.99 | | | | | $ | 5,980 | | | |
Cash (exercise of options)
|
|
July 08, 2021
|
| | | | 65,626 | | | | | $ | 2.25 | | | | | $ | 147,659 | | | |
Cash (exercise of options)
|
|
July 12, 2021
|
| | | | 100,000 | | | | | $ | 1.14 | | | | | $ | 114,000 | | | |
Cash (exercise of options)
|
|
July 12, 2021
|
| | | | 360,000 | | | | | $ | 11.38 | | | | | $ | 4,096,223 | | | |
换股(可赎回股份)
|
|
July 12, 2021
|
| | | | 17,084 | | | | | $ | 12.17 | | | | | $ | 207,876 | | | |
股票发行(行使与Bluma有关的限制性股票单位)
|
|
Date Issued
|
| |
Number of
Cresco Securities |
| |
Issue Price
per Unit ($) |
| |
Aggregate
Issue Price ($) |
| |
对价的性质
|
| |||||||||
July 12, 2021
|
| | | | 2,993 | | | | | $ | 11.40 | | | | | $ | 34,120 | | | |
股票发行(行使限制性股票单位)
|
|
July 13, 2021
|
| | | | 1,000 | | | | | $ | 1.00 | | | | | $ | 1,000 | | | |
Cash (exercise of options)
|
|
July 14, 2021
|
| | | | 42,500 | | | | | $ | 6.5 – $6.86 | | | | | $ | 278,950 | | | |
Cash (exercise of options)
|
|
July 16, 2021
|
| | | | 13,662 | | | | | $ | 3.75 | | | | | $ | 51,233 | | | |
Cash (exercise of options)
|
|
July 16, 2021
|
| | | | 132,357 | | | | | $ | 12.17 | | | | | $ | 1,610,504 | | | |
股票发行(行使与Bluma有关的限制性股票单位)
|
|
July 16, 2021
|
| | | | 3,688 | | | | | $ | 5.96 | | | | | $ | 21,980 | | | |
股票发行(与收购Origin House有关)
|
|
July 26, 2021
|
| | | | 1,000 | | | | | $ | 3.75 | | | | | $ | 3,750 | | | |
Cash (exercise of options)
|
|
August 03, 2021
|
| | | | 2,500 | | | | | $ | 2.99 | | | | | $ | 7,475 | | | |
Cash (exercise of options)
|
|
August 05, 2021
|
| | | | 6,000 | | | | | $ | 4.24 | | | | | $ | 25,440 | | | |
Cash (exercise of warrants)
|
|
August 05, 2021
|
| | | | 3,870 | | | | | $ | 2.51 | | | | | $ | 9,714 | | | |
股票发行(行使限制性股票单位)
|
|
August 05, 2021
|
| | | | 7,661 | | | | | $ | 6.86 | | | | | $ | 52,554 | | | |
股票发行(行使限制性股票单位)
|
|
August 10, 2021
|
| | | | 3,000 | | | | | $ | 2.25 | | | | | $ | 6,750 | | | |
Cash (exercise of options)
|
|
August 13, 2021
|
| | | | 25,000 | | | | | $ | 3.75 | | | | | $ | 93,750 | | | |
Cash (exercise of options)
|
|
August 17, 2021
|
| | | | 1,000 | | | | | $ | 1.00 | | | | | $ | 1,000 | | | |
Cash (exercise of options)
|
|
September 02, 2021
|
| | | | 1,750 | | | | | $ | 2.99 | | | | | $ | 5,233 | | | |
Cash (exercise of options)
|
|
September 02, 2021
|
| | | | 4,818,472 | | | | | $ | 9.68 | | | | | $ | 46,642,896 | | | |
购买考虑事项(在
中
connection with Cultivate) |
|
September 09, 2021
|
| | | | 80,000 | | | | | $ | 1.14 | | | | | $ | 91,200 | | | |
Cash (exercise of options)
|
|
September 09, 2021
|
| | | | 100,000 | | | | | $ | 8.52 | | | | | $ | 851,905 | | | |
换股(可赎回股份)
|
|
September 09, 2021
|
| | | | 500,000 | | | | | $ | 8.52 | | | | | $ | 4,259,523 | | | |
换股(可赎回股份)
|
|
September 10, 2021
|
| | | | 10,000 | | | | | $ | 3.75 | | | | | $ | 37,500 | | | |
Cash (exercise of options)
|
|
September 10, 2021
|
| | | | 10,500 | | | | | $ | 1.13 – $2.25 | | | | | $ | 12,425 | | | |
Cash (exercise of options)
|
|
September 14, 2021
|
| | | | 500 | | | | | $ | 2.25 | | | | | $ | 1,125 | | | |
Cash (exercise of options)
|
|
September 27, 2021
|
| | | | 15,000 | | | | | $ | 2.99 | | | | | $ | 44,850 | | | |
Cash (exercise of options)
|
|
September 29, 2021
|
| | | | 3,750 | | | | | $ | 2.99 | | | | | $ | 11,213 | | | |
Cash (exercise of options)
|
|
September 30, 2021
|
| | | | 1,000 | | | | | $ | 1.14 | | | | | $ | 1,136 | | | |
Cash (exercise of options)
|
|
October 04, 2021
|
| | | | 2,500 | | | | | $ | 3.75 | | | | | $ | 9,375 | | | |
Cash (exercise of options)
|
|
October 05, 2021
|
| | | | 1,000 | | | | | $ | 1.00 | | | | | $ | 1,000 | | | |
Cash (exercise of options)
|
|
October 13, 2021
|
| | | | 100,000 | | | | | $ | 3.75 | | | | | $ | 375,000 | | | |
Cash (exercise of options)
|
|
October 18, 2021
|
| | | | 2,000 | | | | | $ | 2.25 | | | | | $ | 4,500 | | | |
Cash (exercise of options)
|
|
October 25, 2021
|
| | | | 2,000 | | | | | $ | 1.00 | | | | | $ | 2,000 | | | |
Cash (exercise of options)
|
|
October 28, 2021
|
| | | | 5,000 | | | | | $ | 1 – $2.25 | | | | | $ | 7,500 | | | |
Cash (exercise of options)
|
|
November 08, 2021
|
| | | | 10,000 | | | | | $ | 1.14 | | | | | $ | 11,400 | | | |
Cash (exercise of options)
|
|
Date Issued
|
| |
Number of
Cresco Securities |
| |
Issue Price
per Unit ($) |
| |
Aggregate
Issue Price ($) |
| |
对价的性质
|
| |||||||||
November 09, 2021
|
| | | | 4,169 | | | | | $ | 8.86 | | | | | $ | 36,937 | | | |
股票发行(行使限制性股票单位)
|
|
November 10, 2021
|
| | | | 18,750 | | | | | $ | 3.75 | | | | | $ | 70,313 | | | |
Cash (exercise of options)
|
|
November 12, 2021
|
| | | | 10,000 | | | | | $ | 2.25 | | | | | $ | 22,500 | | | |
Cash (exercise of options)
|
|
November 12, 2021
|
| | | | 241,430 | | | | | $ | 1.14 – $6 | | | | | $ | 365,495 | | | |
Cash (exercise of options)
|
|
November 12, 2021
|
| | | | 400,000 | | | | | $ | 9.57 | | | | | $ | 3,826,502 | | | |
换股(可赎回股份)
|
|
November 12, 2021
|
| | | | 74,899 | | | | | $ | 11.42 – $12.17 | | | | | $ | 908,850 | | | |
股票发行(行使限制性股票单位)
|
|
November 15, 2021
|
| | | | 1,000,000 | | | | | $ | 9.13 | | | | | $ | 9,131,581 | | | |
换股(可赎回股份)
|
|
November 16, 2021
|
| | | | 50,000 | | | | | $ | 3.75 | | | | | $ | 187,500 | | | |
Cash (exercise of options)
|
|
November 17, 2021
|
| | | | 5,000 | | | | | $ | 5.90 | | | | | $ | 29,500 | | | |
Cash (exercise of options)
|
|
November 18, 2021
|
| | | | 11,000 | | | | | $ | 3.75 – $5.9 | | | | | $ | 62,750 | | | |
Cash (exercise of options)
|
|
November 19, 2021
|
| | | | 9,050 | | | | | $ | 1 – $3.75 | | | | | $ | 20,188 | | | |
Cash (exercise of options)
|
|
November 22, 2021
|
| | | | 3,250 | | | | | $ | 2.99 | | | | | $ | 9,718 | | | |
Cash (exercise of options)
|
|
November 23, 2021
|
| | | | 2,500 | | | | | $ | 2.99 | | | | | $ | 7,475 | | | |
Cash (exercise of options)
|
|
November 24, 2021
|
| | | | 1,555 | | | | | $ | 3.75 | | | | | $ | 5,831 | | | |
Cash (exercise of options)
|
|
November 24, 2021
|
| | | | 6,166,861 | | | | | $ | 8.80 | | | | | $ | 54,240,357 | | | |
购买考虑事项(在
中
connection with Cure Penn) |
|
November 26, 2021
|
| | | | 25,000 | | | | | $ | 6.86 | | | | | $ | 171,500 | | | |
Cash (exercise of options)
|
|
December 01, 2021
|
| | | | 125,000 | | | | | $ | 1.14 | | | | | $ | 142,500 | | | |
Cash (exercise of options)
|
|
December 02, 2021
|
| | | | 12,500 | | | | | $ | 1.14 | | | | | $ | 14,198 | | | |
Cash (exercise of options)
|
|
December 02, 2021
|
| | | | 418 | | | | | $ | 9.13 | | | | | $ | 3,816 | | | |
股票发行(行使限制性股票单位)
|
|
December 02, 2021
|
| | | | 177 | | | | | $ | 9.13 | | | | | $ | 1,616 | | | |
股票发行(行使限制性股票单位)
|
|
December 06, 2021
|
| | | | 1,170 | | | | | $ | 3.75 | | | | | $ | 4,388 | | | |
Cash (exercise of options)
|
|
December 07, 2021
|
| | | | 18,500 | | | | | $ | 2.25 – $2.99 | | | | | $ | 54,575 | | | |
Cash (exercise of options)
|
|
December 09, 2021
|
| | | | 182,358 | | | | | $ | 7.88 | | | | | $ | 1,437,323 | | | |
购买考虑事项(在
中
connection with Laurel Harvest) |
|
December 13, 2021
|
| | | | 12,000 | | | | | $ | 4.24 | | | | | $ | 50,880 | | | |
Cash (exercise of warrants)
|
|
December 14, 2021
|
| | | | 35,000 | | | | | $ | 2.25 | | | | | $ | 78,750 | | | |
Cash (exercise of options)
|
|
December 14, 2021
|
| | | | 7,526,270 | | | | | $ | 7.88 | | | | | $ | 59,321,112 | | | |
购买考虑事项(在
中
connection with Laurel Harvest) |
|
December 20, 2021
|
| | | | 77,899 | | | | | $ | 2.25 – $3.75 | | | | | $ | 183,371 | | | |
Cash (exercise of options)
|
|
December 24, 2021
|
| | | | 10,000 | | | | | $ | 2.25 | | | | | $ | 22,500 | | | |
Cash (exercise of options)
|
|
December 28, 2021
|
| | | | 645,161 | | | | | $ | 7.88 | | | | | $ | 5,085,078 | | | |
购买考虑事项(在
中
connection with Laurel Harvest) |
|
January 03, 2022
|
| | | | 10,000 | | | | | $ | 2.91 | | | | | $ | 29,100 | | | |
Cash (exercise of options)
|
|
Date Issued
|
| |
Number of
Cresco Securities |
| |
Issue Price
per Unit ($) |
| |
Aggregate
Issue Price ($) |
| |
对价的性质
|
| |||||||||
January 04, 2022
|
| | | | 55,000 | | | | | $ | 2.25 | | | | | $ | 123,750 | | | |
Cash (exercise of options)
|
|
January 05, 2022
|
| | | | 12,500 | | | | | $ | 2.99 | | | | | $ | 37,375 | | | |
Cash (exercise of options)
|
|
January 10, 2022
|
| | | | 12,000 | | | | | $ | 4.24 | | | | | $ | 50,880 | | | |
Cash (exercise of warrants)
|
|
January 11, 2022
|
| | | | 62,500 | | | | | $ | 1.47 | | | | | $ | 91,875 | | | |
Cash (exercise of options)
|
|
January 13, 2022
|
| | | | 10,000 | | | | | $ | 2.91 | | | | | $ | 29,100 | | | |
Cash (exercise of options)
|
|
January 14, 2022
|
| | | | 37,000 | | | | | $ | 1.40 | | | | | $ | 51,800 | | | |
Cash (exercise of options)
|
|
January 14, 2022
|
| | | | 195,000 | | | | | $ | 1.25 | | | | | $ | 243,750 | | | |
Cash (exercise of options)
|
|
January 15, 2022
|
| | | | 25,000 | | | | | $ | 4.24 | | | | | $ | 106,000 | | | |
Cash (exercise of options)
|
|
January 17, 2022
|
| | | | 10,000 | | | | | $ | 2.91 | | | | | $ | 29,100 | | | |
Cash (exercise of options)
|
|
January 18, 2022
|
| | | | 16,320 | | | | | $ | 11.92 | | | | | $ | 194,534 | | | |
股票发行(行使限制性股票单位)
|
|
January 19, 2022
|
| | | | 10,000 | | | | | $ | 2.91 | | | | | $ | 29,100 | | | |
Cash (exercise of options)
|
|
January 24, 2022
|
| | | | 20,000 | | | | | $ | 2.91 | | | | | $ | 58,200 | | | |
Cash (exercise of options)
|
|
January 25, 2022
|
| | | | 20,000 | | | | | $ | 2.91 | | | | | $ | 58,200 | | | |
Cash (exercise of options)
|
|
January 26, 2022
|
| | | | 30,000 | | | | | $ | 2.91 | | | | | $ | 87,300 | | | |
Cash (exercise of options)
|
|
February 1, 2022
|
| | | | 1,720 | | | | | $ | 5.96 | | | | | $ | 10,251.20 | | | |
股票发行(与收购Origin House有关)
|
|
February 3, 2022
|
| | | | 16,334 | | | | | $ | 11.42 | | | | | $ | 186,534.28 | | | |
股票发行(行使限制性股票单位)
|
|
February 4, 2022
|
| | | | 75,562 | | | | | $ | 6.86 | | | | | $ | 518,355.32 | | | |
股票发行(行使限制性股票单位)
|
|
February 10, 2022
|
| | | | 1,000,000 | | | | | $ | 7.52 | | | | | $ | 7,520,000 | | | |
换股(可赎回股份)
|
|
February 10, 2022
|
| | | | 6,250 | | | | | $ | 5.90 | | | | | $ | 36,875 | | | |
Cash (exercise of options)
|
|
February 21, 2022
|
| | | | 37,500 | | | | | $ | 6.86 | | | | | $ | 257,250 | | | |
股票发行(行使限制性股票单位)
|
|
March 7, 2022
|
| | | | 10,000 | | | | | $ | 4.85 | | | | | $ | 48,500 | | | |
Cash (exercise of options)
|
|
March 9, 2022
|
| | | | 7,500 | | | | | $ | 4.85 | | | | | $ | 37,125 | | | |
Cash (exercise of options)
|
|
March 15, 2022
|
| | | | 1,253 | | | | | $ | 13.41 | | | | | $ | 16,802.73 | | | |
股票发行(行使限制性股票单位)
|
|
March 23, 2022
|
| | | | 700,000 | | | | | $ | 6.51 | | | | | $ | 4,557,000 | | | |
换股(可赎回股份)
|
|
Options Issued
|
| |||||||||||||||||||||
Date Issued
|
| |
Number of
Units |
| |
Exercise Price
per Unit ($) |
| |
Total Aggregate
Proceeds Assuming the Exercise of all Options |
| |
Nature of
Consideration |
| |||||||||
April 28, 2021
|
| |
200,000 Options to
purchase Subordinate Voting Shares |
| | | $ | 12.26 | | | | | $ | 2,452,000 | | | | | | 现金 | | |
Options Issued
|
| |||||||||||||||||||||
Date Issued
|
| |
Number of
Units |
| |
Exercise Price
per Unit ($) |
| |
Total Aggregate
Proceeds Assuming the Exercise of all Options |
| |
Nature of
Consideration |
| |||||||||
June 30, 2021
|
| |
1,144,355 Options to
purchase Subordinate Voting Shares |
| | | $ | 11.42 | | | | | $ | 13,068,534 | | | | | | 现金 | | |
September 30, 2021
|
| |
511,100 Options to
purchase Subordinate Voting Shares |
| | | $ | 9.41 | | | | | $ | 4,809,451 | | | | | | 现金 | | |
December 31, 2021
|
| |
453,750 Options to
purchase Subordinate Voting Shares |
| | | $ | 6.62 | | | | | $ | 3,003,825 | | | | | | 现金 | | |
January 4, 2022
|
| |
1,293,073 Options to
purchase Subordinate Voting Shares |
| | | $ | 6.49 | | | | | $ | 8,392,044 | | | | | | 现金 | | |
January 15, 2022
|
| |
250,000 Options to
purchase Subordinate Voting Shares |
| | | $ | 6.91 | | | | | $ | 1,727,500 | | | | | | 现金 | | |
March 15, 2022
|
| |
284,971 Options to
purchase Subordinate Voting Shares |
| | | $ | 6.62 | | | | | $ | 1,886,508 | | | | | | 现金 | | |
March 31, 2022
|
| |
441,204 Options to
purchase Subordinate Voting Shares |
| | | $ | 6.03 | | | | | $ | 2,660,460 | | | | | | 现金 | | |
PVS转换为Cresco股票
|
| ||||||||||||
Date Issued
|
| |
Number of PVS
|
| |
转换时发行的Cresco股票数量
|
| ||||||
May 2, 2021 – May 2, 2022
|
| | | | 9,256 | | | | | | 1,851,172 | | |
Industry Involvement
|
| |
公平呈现所有重大事实、风险和不确定性所需的具体披露
|
| |
附录J对照参考
|
|
所有从事美国大麻相关活动的发行商
|
| | 描述发行人参与美国大麻行业的性质,并包括下表所示的至少一种直接、间接和辅助行业参与类型的披露。 | | |
业务总体发展
Description of the
商业 - 州级美国大麻业务 |
|
| | | 突出表示,根据美国联邦法律,大麻是非法的,执行相关法律是一个重大风险。 | | |
Risk Factors
|
|
| | |
讨论联邦当局或检察官就发行者进行美国大麻相关活动的任何司法管辖区的执法行动风险所作的任何声明和其他可用的指导。概述相关风险,其中包括第三方服务提供商可能暂停或撤回服务的风险,以及监管机构可能对发行人在美国的运营能力施加某些限制的风险。
|
| |
风险因素 - 美国联邦法规
危险因素 - 食品和药物管理局或烟酒枪械和爆炸物管理局法规
风险因素国家规定的 - 变化
风险因素 - 反洗钱法律法规
Risk Factors — Access to Banks
风险因素 - 在美国的投资可能会受到
|
|
Industry Involvement
|
| |
公平呈现所有重大事实、风险和不确定性所需的具体披露
|
| |
附录J对照参考
|
|
| | | | | |
Heightened Scrutiny
营销产品的风险因素 - 约束
风险因素 - 知识产权
风险因素 - 无法获得美国破产保护
风险因素合同的 - 合法性
民事资产没收的风险因素 - 风险
|
|
| | | 鉴于根据美国联邦法律,大麻是非法的,讨论发行人获得公共和私人资本的能力,并指出为了支持持续运营,可以/不可以使用哪些融资选择。 | | |
风险因素法律、监管或政治变革的 - 风险
Risk Factors — Access to Banks
|
|
| | | 量化发行人对美国大麻相关活动的资产负债表和经营报表敞口。 | | | 注:Cresco的主要业务仅在美国。 | |
| | | 披露是否未以法律意见或其他形式获得关于(A)遵守适用的州监管框架和(B)美国联邦法律可能产生的风险和影响的法律意见。 | | | 已获得法律咨询。 | |
直接参与种植或分销的美国大麻发行商
|
| | 概述发行人所在的美国各州的法规,并确认发行人如何遵守适用的许可要求以及适用的美国州制定的监管框架。 | | |
商业 - 州级美国大麻业务说明
|
|
| | | 讨论发行人持续监测美国州法律合规性的计划,概述内部合规程序,并提供积极的声明,表明发行人遵守美国州法律和相关的许可框架。及时披露任何可能影响发行人的违规行为、传票或违规通知 | | |
商业 - 美国行业背景和趋势的总体发展
商业 - 州级美国大麻业务说明
风险因素 - 美国州监管不确定性
|
|
Industry Involvement
|
| |
公平呈现所有重大事实、风险和不确定性所需的具体披露
|
| |
附录J对照参考
|
|
| | | 许可证、业务活动或运营。 | | | | |
间接参与种植或分销的美国大麻发行商
|
| | 概述发行人投资对象所在的美国各州的法规。 | | | Not applicable. | |
| | | 通过正面或负面声明提供合理保证,确保被投资方的业务符合适用的许可要求和适用的美国州制定的监管框架。 | | | Cresco不知道有任何违规行为。 | |
有重大辅助参与的美国大麻发行商
|
| | 通过正面或负面声明提供合理保证,即适用客户或被投资人的业务符合适用的许可要求和适用的美国州制定的监管框架。 | | | Not applicable. | |
| | |
As at
December 31, 2021 (before Arrangement) |
| |
Pro Forma
Adjustment |
| |
Pro Forma as
at December 31, 2021(after Arrangement) |
| |||||||||
Indebtedness | | | | | | | | | | | | | | | | | | | |
长期应付票据和应付贷款合计(美元)
|
| | | | 465,079,000 | | | | | | | | | | | | 465,079,000 | | |
股东权益 | | | | | | | | | | | | | | | | | | | |
MVS(1) | | | | | 500,000 | | | | | | | | | | | | 500,000 | | |
Cresco Shares(2)
|
| | | | 269,971,332 | | | | | | 234,854,332(3) | | | | | | 504,825,664 | | |
PVS(4) | | | | | 20,667,285 | | | | | | | | | | | | 20,667,285 | | |
Cresco Redeemable Units(5)
|
| | | | 109,440,971 | | | | | | | | | | | | 109,440,971 | | |
SSVS
(以转换为Cresco股票的方式列报) |
| | | | 639 | | | | | | | | | | | | 639 | | |
Cresco股票未偿还
(按转换后的Cresco股票计算) |
| | | | 400,580,227 | | | | | | | | | | | | 400,580,227 | | |
Options
|
| | | | 23,610,000 | | | | | | | | | | | | 23,610,000 | | |
Warrants(6) | | | | | 9,841,959 | | | | | | | | | | | | 9,841,959 | | |
Restricted share units
|
| | | | 1,093,031 | | | | | | | | | | | | 1,093,031 | | |
完全稀释的未偿还股份(7)
|
| | | | 435,125,217 | | | | | | | | | | | | 435,125,217 | | |
|
独立注册会计师事务所报告
|
| | | | J-136 | | |
| 合并财务报表: | | | | | | | |
|
合并资产负债表
|
| | | | J-137 | | |
|
合并业务报表
|
| | | | J-138 | | |
|
全面亏损合并报表
|
| | | | J-139 | | |
|
股东权益变动合并报表
|
| | | | J-140 | | |
|
现金流量表合并报表
|
| | | | J-141 | | |
|
合并财务报表附注
|
| | | | J-143 | | |
| | |
December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
ASSETS | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | 223,543 | | | | | $ | 136,339 | | |
Restricted cash
|
| | | | 2,559 | | | | | | 4,435 | | |
Accounts receivable, net
|
| | | | 43,379 | | | | | | 29,943 | | |
Inventory, net
|
| | | | 136,643 | | | | | | 67,183 | | |
短期应收贷款
|
| | | | 1,312 | | | | | | 2,438 | | |
Other current assets
|
| | | | 14,319 | | | | | | 9,129 | | |
Total current assets
|
| | | | 421,755 | | | | | | 249,467 | | |
Non-current assets: | | | | | | | | | | | | | |
财产和设备,净额
|
| | | | 369,092 | | | | | | 228,804 | | |
Right-of-use assets
|
| | | | 88,017 | | | | | | 71,794 | | |
Intangible assets, net
|
| | | | 437,644 | | | | | | 195,541 | | |
长期应收贷款
|
| | | | 505 | | | | | | 21,223 | | |
Investments
|
| | | | 5,912 | | | | | | 4,360 | | |
Goodwill
|
| | | | 446,767 | | | | | | 450,569 | | |
Deferred tax asset
|
| | | | 6,561 | | | | | | 7,130 | | |
Other non-current assets
|
| | | | 4,210 | | | | | | 3,708 | | |
Total non-current assets
|
| | | | 1,358,708 | | | | | | 983,129 | | |
TOTAL ASSETS
|
| | | $ | 1,780,463 | | | | | $ | 1,232,596 | | |
负债和股东权益 | | | | | | | | | | | | | |
流动负债: | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 32,278 | | | | | $ | 23,231 | | |
Accrued liabilities
|
| | | | 95,442 | | | | | | 130,469 | | |
Short-term borrowings
|
| | | | 19,928 | | | | | | 25,924 | | |
Income tax payable
|
| | | | 46,949 | | | | | | 36,067 | | |
租赁负债的当期部分
|
| | | | 20,792 | | | | | | 18,040 | | |
延期对价、或有对价和其他应付款项,短期
|
| | | | 71,833 | | | | | | 19,115 | | |
短期衍生负债
|
| | | | 1,172 | | | | | | — | | |
流动负债总额
|
| | | | 288,394 | | | | | | 252,846 | | |
非流动负债: | | | | | | | | | | | | | |
长期应付票据和应付贷款
|
| | | | 465,079 | | | | | | 255,439 | | |
长期衍生负债
|
| | | | — | | | | | | 17,505 | | |
Lease liabilities
|
| | | | 118,936 | | | | | | 74,468 | | |
Deferred tax liability
|
| | | | 85,666 | | | | | | 41,202 | | |
延期对价和或有对价、长期对价
|
| | | | 17,651 | | | | | | 7,247 | | |
其他长期负债
|
| | | | 7,001 | | | | | | 8,557 | | |
非流动负债合计
|
| | | | 694,333 | | | | | | 404,418 | | |
TOTAL LIABILITIES
|
| | | $ | 982,727 | | | | | $ | 657,264 | | |
承付款和或有事项(附注15) | | | | | | | | | | | | | |
SHAREHOLDERS’ EQUITY | | | | | | | | | | | | | |
超级投票权股份,无面值;500,000股分别于2021年12月31日和2020年12月31日授权、发行和发行
|
| | | | | | | | | | | | |
次表决权股份,无面值;授权无限股份;分别于2021年12月31日和2020年12月31日发行和发行270,033,270和194,085,616股
|
| | | | | | | | | | | | |
比例投票权股份(1),无面值;授权无限股份;分别于2021年12月31日和2020年12月31日发行和发行20,667,206股和29,311,088股
|
| | | | | | | | | | | | |
特殊从属表决权股份(2股),无面值;639股分别于2021年12月31日和2020年12月31日授权、发行和发行
|
| | | | | | | | | | | | |
Share capital
|
| | | | 1,597,715 | | | | | | 802,264 | | |
累计其他综合损失
|
| | | | (254) | | | | | | (647) | | |
Accumulated deficit
|
| | | | (841,907) | | | | | | (328,380) | | |
Equity of Cresco Labs Inc.
|
| | | | 755,554 | | | | | | 473,237 | | |
非控股权益
|
| | | | 42,182 | | | | | | 102,095 | | |
股东权益总额
|
| | | | 797,736 | | | | | | 575,332 | | |
总负债和股东权益
|
| | | $ | 1,780,463 | | | | | $ | 1,232,596 | | |
| | |
Year ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Revenue, net
|
| | | $ | 821,682 | | | | | $ | 476,251 | | |
Costs of goods sold
|
| | | | 415,335 | | | | | | 269,550 | | |
Gross profit
|
| | | | 406,347 | | | | | | 206,701 | | |
Operating expenses: | | | | | | | | | | | | | |
销售、一般和行政管理
|
| | | | 317,804 | | | | | | 228,946 | | |
Impairment loss
|
| | | | 305,894 | | | | | | 1,217 | | |
总运营费用
|
| | | | 623,698 | | | | | | 230,163 | | |
Loss from operations
|
| | | | (217,351) | | | | | | (23,462) | | |
Other (expense) income: | | | | | | | | | | | | | |
Interest expense, net
|
| | | | (51,211) | | | | | | (31,229) | | |
Other income (expense), net
|
| | | | 13,031 | | | | | | (8,295) | | |
权益法投资(亏损)
|
| | | | (1,196) | | | | | | (1,181) | | |
Total other (expense), net
|
| | | | (39,376) | | | | | | (40,705) | | |
所得税前亏损
|
| | | | (256,727) | | | | | | (64,167) | | |
Income tax (expense)
|
| | | | (40,107) | | | | | | (28,604) | | |
Net (loss)
|
| | | $ | (296,834) | | | | | $ | (92,771) | | |
可归因于非控股权益的税后净收入
|
| | | | 22,763 | | | | | | 9,386 | | |
可归因于Cresco Labs Inc.的净(亏损)
|
| | | $ | (319,597) | | | | | $ | (102,157) | | |
可归因于Cresco Labs Inc.股东的每股净(亏损) - : | | | | | | | | | | | | | |
每股基本和摊薄(亏损)
|
| | | $ | (1.22) | | | | | $ | (0.49) | | |
基本和稀释后的加权平均流通股数量
|
| | | | 262,326,138 | | | | | | 210,465,988 | | |
| | |
Year ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Net (loss)
|
| | | $ | (296,834) | | | | | $ | (92,771) | | |
外币折算差额,税后净额
|
| | | | 393 | | | | | | (647) | | |
该期间的全面(亏损)总额
|
| | | $ | (296,441) | | | | | $ | (93,418) | | |
可归因于非控股权益的税后净额综合收入
|
| | | | 22,763 | | | | | | 9,386 | | |
可归因于Cresco Labs Inc.的全面(损失)总额
|
| | | $ | (319,204) | | | | | $ | (102,804) | | |
| | |
Share capital
|
| |
Accumulated
deficit |
| |
Accumulated
other comprehensive loss, net of tax |
| |
Non-controlling
interests |
| |
Total
|
| |||||||||||||||
Balance as of January 1, 2020
|
| | | $ | 291,723 | | | | | $ | (132,474) | | | | | $ | — | | | | | $ | 119,266 | | | | | $ | 278,515 | | |
行使期权和认股权证
|
| | | | 3,238 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,238 | | |
股权薪酬
|
| | | | 8,565 | | | | | | — | | | | | | — | | | | | | — | | | | | | 8,565 | | |
某些股份支付安排的员工税
|
| | | | 2,825 | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,825 | | |
所有权权益变更
|
| | | | — | | | | | | — | | | | | | — | | | | | | (249) | | | | | | (249) | | |
Income tax reserve
|
| | | | — | | | | | | (115) | | | | | | — | | | | | | — | | | | | | (115) | | |
应收税金应付
agreements |
| | | | (823) | | | | | | — | | | | | | — | | | | | | — | | | | | | (823) | | |
股东赎回带来的税收优惠
|
| | | | 967 | | | | | | — | | | | | | — | | | | | | — | | | | | | 967 | | |
与收购相关的股权发行
|
| | | | 436,168 | | | | | | — | | | | | | — | | | | | | — | | | | | | 436,168 | | |
对非控股股东的分配
|
| | | | (49,602) | | | | | | — | | | | | | — | | | | | | (16,793) | | | | | | (66,395) | | |
Equity issuances
|
| | | | 6,054 | | | | | | — | | | | | | — | | | | | | — | | | | | | 6,054 | | |
Cresco LLC股票已赎回
|
| | | | 103,149 | | | | | | (93,634) | | | | | | — | | | | | | (9,515) | | | | | | — | | |
外币折算
|
| | | | — | | | | | | — | | | | | | (647) | | | | | | — | | | | | | (647) | | |
Net income (loss)
|
| | | | — | | | | | | (102,157) | | | | | | — | | | | | | 9,386 | | | | | | (92,771) | | |
Ending Balance as of December 31, 2020
|
| | | $ | 802,264 | | | | | $ | (328,380) | | | | | $ | (647) | | | | | $ | 102,095 | | | | | $ | 575,332 | | |
行使期权和认股权证
|
| | | | 6,947 | | | | | | — | | | | | | — | | | | | | — | | | | | | 6,947 | | |
股权薪酬
|
| | | | 28,215 | | | | | | — | | | | | | — | | | | | | — | | | | | | 28,215 | | |
某些股份支付安排的员工税
|
| | | | 11,458 | | | | | | — | | | | | | — | | | | | | — | | | | | | 11,458 | | |
Income tax reserve
|
| | | | — | | | | | | 311 | | | | | | — | | | | | | — | | | | | | 311 | | |
应收税金应付
agreements |
| | | | (1,803) | | | | | | — | | | | | | — | | | | | | — | | | | | | (1,803) | | |
股东赎回带来的税收优惠
|
| | | | 1,983 | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,983 | | |
与收购相关的股权发行
|
| | | | 380,452 | | | | | | — | | | | | | — | | | | | | — | | | | | | 380,452 | | |
私募发行,扣除成本
|
| | | | 123,469 | | | | | | — | | | | | | — | | | | | | — | | | | | | 123,469 | | |
Equity issuances
|
| | | | 15,521 | | | | | | — | | | | | | — | | | | | | — | | | | | | 15,521 | | |
对非控股股东的分配
|
| | | | 25,877 | | | | | | (1,985) | | | | | | — | | | | | | (71,600) | | | | | | (47,708) | | |
Cresco LLC股票已赎回
|
| | | | 203,332 | | | | | | (192,256) | | | | | | — | | | | | | (11,076) | | | | | | — | | |
外币折算
|
| | | | — | | | | | | — | | | | | | 393 | | | | | | — | | | | | | 393 | | |
Net income (loss)
|
| | | | — | | | | | | (319,597) | | | | | | — | | | | | | 22,763 | | | | | | (296,834) | | |
Ending Balance as of December 31, 2021
|
| | | $ | 1,597,715 | | | | | $ | (841,907) | | | | | $ | (254) | | | | | $ | 42,182 | | | | | $ | 797,736 | | |
| | |
Year ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
经营活动现金流: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (296,834) | | | | | $ | (92,771) | | |
将净亏损与经营活动提供(用于)的现金净额进行调整:
|
| | | | | | | | | | | | |
折旧及摊销
|
| | | | 38,640 | | | | | | 31,788 | | |
经营性租赁资产摊销
|
| | | | 6,309 | | | | | | 4,967 | | |
坏账费用和预期信贷损失拨备费用
|
| | | | 3,544 | | | | | | 1,747 | | |
基于共享的薪酬费用
|
| | | | 27,536 | | | | | | 18,839 | | |
(Gain) loss on investments
|
| | | | (930) | | | | | | 2,117 | | |
(收益)递延和或有对价的公允价值变动
|
| | | | (14,775) | | | | | | (2,029) | | |
衍生工具和权证的(收益)损失
|
| | | | (16,663) | | | | | | 8,500 | | |
(收益),净亏损,应收贷款
|
| | | | — | | | | | | (921) | | |
Impairment loss
|
| | | | 305,894 | | | | | | 1,194 | | |
库存核销和拨备损失
|
| | | | 2,669 | | | | | | 3,259 | | |
Change in deferred taxes
|
| | | | (34,931) | | | | | | (11,152) | | |
债务安排的贴现和递延融资成本增加
|
| | | | 11,304 | | | | | | 4,619 | | |
债务清偿损失
|
| | | | 10,342 | | | | | | — | | |
Foreign currency loss
|
| | | | 730 | | | | | | 1,521 | | |
Other losses, net of gains
|
| | | | 721 | | | | | | 15,246 | | |
经营性资产和负债变动:
|
| | | | | | | | | | | | |
Accounts receivable
|
| | | | (10,964) | | | | | | (6,602) | | |
Inventory
|
| | | | (18,420) | | | | | | (17,063) | | |
Other assets
|
| | | | (6,215) | | | | | | (507) | | |
应付账款和应计费用
|
| | | | 21,155 | | | | | | 15,351 | | |
经营性租赁负债
|
| | | | (16,436) | | | | | | (12,312) | | |
Other liabilities
|
| | | | (90) | | | | | | 278 | | |
Income tax payable
|
| | | | 1,901 | | | | | | 26,083 | | |
经营活动提供(用于)的现金净额
|
| | | | 14,487 | | | | | | (7,848) | | |
投资活动的现金流: | | | | | | | | | | | | | |
购置房产和设备
|
| | | | (93,875) | | | | | | (87,154) | | |
购买无形资产
|
| | | | (3,178) | | | | | | (2,105) | | |
销售和回租交易收益以及租户改善津贴
|
| | | | 33,157 | | | | | | 45,945 | | |
收购对价的支付,扣除收购现金的净额
|
| | | | (75,814) | | | | | | (14,768) | | |
资产剥离收益,扣除转账现金后的净额
|
| | | | 69 | | | | | | — | | |
贷款和垫款收款收据
|
| | | | 2,000 | | | | | | — | | |
拟收购实体的贷款和垫款
|
| | | | (26,292) | | | | | | (6,667) | | |
净现金(用于)投资活动
|
| | | | (163,933) | | | | | | (64,749) | | |
| | |
Year ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
融资活动的现金流: | | | | | | | | | | | | | |
从1月发售开始的收益
|
| | | | 124,105 | | | | | | — | | |
行使股票期权、认股权证和认股权证的收益
|
| | | | 20,096 | | | | | | 6,200 | | |
在市场上发行的收益
|
| | | | — | | | | | | 3,521 | | |
发行长期债务的收益
|
| | | | 387,000 | | | | | | 186,000 | | |
偿还债务、融资发行成本和非延期贷款费
|
| | | | (6,461) | | | | | | (7,605) | | |
支付债务预付款和清偿债务费用
|
| | | | (16,202) | | | | | | — | | |
Repayment of debt
|
| | | | (200,000) | | | | | | (10,340) | | |
支付与收购相关的或有对价
|
| | | | — | | | | | | (1,719) | | |
收购非控股权益
|
| | | | — | | | | | | (203) | | |
分配给非控股权益可赎回单位持有人和其他成员
|
| | | | (69,803) | | | | | | (16,372) | | |
与限制性股票单位股票净结算相关的税款支付
|
| | | | (143) | | | | | | (8,672) | | |
融资租赁交易收益
|
| | | | — | | | | | | 11,754 | | |
融资租赁债务本金支付
|
| | | | (3,587) | | | | | | (1,078) | | |
融资活动提供的现金净额
|
| | | | 235,005 | | | | | | 161,486 | | |
汇率变动对现金和现金等价物的影响
|
| | | | (231) | | | | | | (1,124) | | |
现金和现金等价物净增长
|
| | | | 85,328 | | | | | | 87,765 | | |
年初现金和现金等价物以及受限现金
|
| | | | 140,774 | | | | | | 53,009 | | |
现金和现金等价物,年终
|
| | | | 223,543 | | | | | | 136,339 | | |
受限现金,年终
|
| | | | 2,559 | | | | | | 4,435 | | |
现金和现金等价物以及受限现金,年终
|
| | | $ | 226,102 | | | | | $ | 140,774 | | |
补充披露现金流信息: | | | | | | | | | | | | | |
本年度已支付现金: | | | | | | | | | | | | | |
Income tax, net
|
| | | $ | 73,955 | | | | | $ | 13,491 | | |
Interest
|
| | | | 39,118 | | | | | | 29,183 | | |
非现金交易: | | | | | | | | | | | | | |
根据企业合并和
发行股票、股票期权和认股权证
acquisitions |
| | | $ | 380,452 | | | | | $ | 435,705 | | |
企业合并的非现金对价
|
| | | | 47,921 | | | | | | — | | |
赎回股权的非控股权益
|
| | | | 11,074 | | | | | | 11,389 | | |
增加租赁净负债
|
| | | | 28,143 | | | | | | 53,444 | | |
购买财产、设备和无形资产所产生的责任
|
| | | | 7,207 | | | | | | 11,155 | | |
无现金行使股票期权和认股权证
|
| | | | 3,879 | | | | | | 2,784 | | |
未向非控股权益可赎回单位申报的分配
holders |
| | | | 36,450 | | | | | | 63,994 | | |
债务、融资发行成本和非延期贷款费的负债
|
| | | | 7,000 | | | | | | 8,570 | | |
非征集无形资产发行股份
|
| | | | 3,000 | | | | | | — | | |
发行股票结算
|
| | | | 12,790 | | | | | | — | | |
Entity
|
| |
Location
|
| |
Purpose
|
| |
Percentage
Held |
|
Cresco Labs Inc. | | |
British Columbia, Canada
|
| | Parent Company | | | | |
CannaRoyalty Corp.(原产地)
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
Cali-AntiFragile Corp.
|
| | California | | | Holding Company | | |
100%
|
|
Alta Supply Inc. (Continuum)
|
| | California | | | Distribution | | |
100%
|
|
Kaya Management Inc.
|
| | California | | | Production | | |
100%
|
|
River Distributing Co., LLC
|
| | California | | | Distribution | | |
100%
|
|
FloraCal Farms
|
| | California | | | Cultivation | | |
100%
|
|
Cub City, LLC
|
| | California | | | Cultivation | | |
100%
|
|
CRHC Holdings Corp.
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
Laurel Harvest Labs, LLC
|
| | Pennsylvania | | | 种植和配给设施 | | |
100%
|
|
JDRC Mount Joy, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
JDRC Scranton, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Bluma Wellness Inc.
|
| |
British Columbia, Canada
|
| | Holding Company | | |
100%
|
|
CannCure Investments Inc.
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
大麻治愈投资有限责任公司
|
| | Florida | | | Holding Company | | |
100%
|
|
3 Boys Farm,LLC(佛罗里达州一家工厂)
|
| | Florida | | |
种植、生产和配给设施
|
| |
100%
|
|
Farm to Fresh Holdings, LLC
|
| | Florida | | |
种植、生产和配给设施
|
| |
100%
|
|
Cresco U.S. Corp.
|
| | Illinois | | | Cresco Labs LLC经理 | | |
100%
|
|
MedMar Inc.
|
| | Illinois | | | Holding Company | | |
100%
|
|
MedMar Lakeview, LLC
|
| | Illinois | | | Dispensary | | |
88%
|
|
MedMar Rockford, LLC
|
| | Illinois | | | Dispensary | | |
75%
|
|
Gloucester Street Capital,LLC
|
| | New York | | | Holding Company | | |
100%
|
|
山谷农业有限责任公司
|
| | New York | | | Operating Entity | | |
100%
|
|
CMA Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
BL Real Estate, LLC
|
| | Massachusetts | | | Holding Company | | |
100%
|
|
培育许可有限责任公司
|
| | Massachusetts | | | 种植、生产和配给设施 | | |
100%
|
|
Cultivate Worcester, Inc
|
| | Massachusetts | | | Dispensary | | |
100%
|
|
Cultivate Leicester, Inc
|
| | Massachusetts | | | 种植、生产和配给设施 | | |
100%
|
|
培育Framingham,Inc.
|
| | Massachusetts | | | Dispensary | | |
100%
|
|
Cultivate Burncoat, Inc
|
| | Massachusetts | | | Holding Company | | |
100%
|
|
培植公司
|
| | Massachusetts | | | 种植和生产实体 | | |
100%
|
|
Good News Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Wonder Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
BW Maryland Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
CP宾夕法尼亚控股有限责任公司
|
| | Illinois | | | Holding Company | | |
100%
|
|
Bay, LLC
|
| | Pennsylvania | | | Holding Company | | |
100%
|
|
Bay Asset Management, LLC
|
| | Pennsylvania | | | Holding Company | | |
100%
|
|
Ridgeback, LLC
|
| | Colorado | | | Holding Company | | |
100%
|
|
Cresco Labs, LLC
|
| | Illinois | | | Operating Entity | | |
57%
|
|
Entity
|
| |
Location
|
| |
Purpose
|
| |
Percentage
Held |
|
Cresco Labs Notes Issuer,LLC
|
| | Illinois | | | Holding Company | | | | |
Cresco Labs Ohio, LLC
|
| | Ohio | | | 种植、生产和配给设施 | | |
99%
|
|
Wellbeings, LLC
|
| | Delaware | | | CBD健康产品开发 | | |
100%
|
|
Cresco Labs SLO, LLC
|
| | California | | | Holding Company | | |
100%
|
|
SLO Cultivation Inc.
|
| | California | | | 种植和生产设施 | | |
80%
|
|
Cresco Labs Joliet, LLC
|
| | Illinois | | | 种植和生产设施 | | |
100%
|
|
Cresco Labs Kankakee, LLC
|
| | Illinois | | | 种植和生产设施 | | |
100%
|
|
Cresco Labs Logan, LLC
|
| | Illinois | | | 种植和生产设施 | | |
100%
|
|
Cresco Labs PA, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Cresco Yeltrah, LLC
|
| | Pennsylvania | | |
种植、生产和配给设施
|
| |
100%
|
|
JDC Newark, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
纽瓦克绿地创造有限责任公司
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Marion, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
Verdant Creations Marion,LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Chillicothe, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
Verdant Creations Chillicothe,LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Columbus, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
Care Med Associates, LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
Cresco Labs Arizona, LLC
|
| | Arizona | | | Holding Company | | |
100%
|
|
亚利桑那州设施供应有限责任公司
|
| | Arizona/Maryland | | | 种植、生产和配给设施 | | |
100%
|
|
Cresco Labs Tinad, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
PDI Medical III, LLC
|
| | Illinois | | | Dispensary | | |
100%
|
|
克雷斯科实验室凤凰农场有限责任公司
|
| | Illinois | | | Holding Company | | |
100%
|
|
伊利诺伊州凤凰农场有限责任公司
|
| | Illinois | | | Dispensary | | |
100%
|
|
JDC Elmwood, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
FloraMedex, LLC
|
| | Illinois | | | Dispensary | | |
100%
|
|
Cresco Edibles, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
TSC Cresco, LLC
|
| | Illinois | | | Licensing | | |
75%
|
|
Cresco HHH, LLC
|
| | Massachusetts | | | 种植、生产和配给设施 | | |
100%
|
|
Cresco Labs Michigan, LLC(a)
|
| | Michigan | | | 种植和生产设施 | | |
85%
|
|
Category
|
| |
Methodology
|
| |
Estimated
Useful Life |
|
租赁改进
|
| | 按租赁年限或改善工程的预计使用年限中较短的时间摊销 | | | 1 – 15 years | |
机械设备
|
| | 资产的预计使用寿命 | | | 5 – 15 years | |
Furniture and Fixtures
|
| | 资产的预计使用寿命 | | | 3 – 8 years | |
Vehicles | | | 资产的预计使用寿命 | | | 5 years | |
Website and Software
|
| | 资产的预计使用寿命 | | | 3 – 7 years | |
Computer Equipment
|
| | 资产的预计使用寿命 | | | 3 – 7 years | |
建筑和建筑改进
|
| | 资产的预计使用寿命 | | | 5 – 39 years | |
Category
|
| |
Estimated
Useful Life |
|
客户关系
|
| | 7 – 19 years | |
Non-Compete Agreements
|
| | 4 – 5 years | |
Trade Names
|
| | 10 years | |
许可证申请费
|
| | 1 – 2 years | |
非招标协议
|
| | 1 – 2 years | |
(in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Redeemable shares
|
| | | | 115,136 | | | | | | 136,077 | | |
Options
|
| | | | 23,609 | | | | | | 9,402 | | |
Warrants
|
| | | | 9,842 | | | | | | 532 | | |
RSUs
|
| | | | 999 | | | | | | 145 | | |
潜在稀释股份总数
|
| | | | 149,586 | | | | | | 146,156 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Raw materials
|
| | | $ | 38,618 | | | | | $ | 23,203 | | |
Raw materials – non-cannabis
|
| | | | 22,260 | | | | | | 15,288 | | |
Work-in-process
|
| | | | 26,561 | | | | | | 7,530 | | |
Finished goods
|
| | | | 49,204 | | | | | | 21,162 | | |
Total Inventory
|
| | | $ | 136,643 | | | | | $ | 67,183 | | |
($ in thousands)
|
| |
Land and
Buildings |
| |
Machinery
and Equipment |
| |
Furniture
and Fixtures |
| |
Leasehold
Improvements |
| |
Website,
Computer Equipment and Software |
| |
Vehicles
|
| |
Construction
In Progress |
| |
Total
|
| ||||||||||||||||||||||||
Cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance as of January 1, 2020
|
| | | $ | 72,803 | | | | | $ | 15,650 | | | | | $ | 10,458 | | | | | $ | 41,638 | | | | | $ | 2,715 | | | | | $ | 715 | | | | | $ | 42,048 | | | | |
$
|
186,027
|
| |
Additions
|
| | | | 6,278 | | | | | | 5,915 | | | | | | 4,820 | | | | | | 5,198 | | | | | | 2,414 | | | | | | 879 | | | | | | 45,193 | | | | | | 70,697 | | |
Transfers
|
| | | | 27,581 | | | | | | 1,290 | | | | | | 2,191 | | | | | | 30,548 | | | | | | 125 | | | | | | 21 | | | | | | (61,756) | | | | | | — | | |
Disposals
|
| | | | — | | | | | | (110) | | | | | | (33) | | | | | | (214) | | | | | | (24) | | | | | | — | | | | | | — | | | | | | (381) | | |
与销售和回租交易相关的销售
|
| | | | (10,136) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (11,403) | | | | | | (21,539) | | |
收购带来的额外收益
|
| | | | — | | | | | | 455 | | | | | | 473 | | | | | | 11,069 | | | | | | 585 | | | | | | 331 | | | | | | 5,166 | | | | | | 18,079 | | |
外汇和其他调整的影响
|
| | |
|
—
|
| | | | | 6 | | | | | | (273) | | | | | | 130 | | | | | | (43) | | | | | | — | | | | | | (51) | | | | | | (231) | | |
As of December 31, 2020
|
| | | $ | 96,526 | | | | | $ | 23,206 | | | | | $ | 17,636 | | | | | $ | 88,369 | | | | | $ | 5,772 | | | | | $ | 1,946 | | | | | $ | 19,197 | | | | | $ | 252,652 | | |
Additions
|
| | | | 7,873 | | | | | | 5,772 | | | | | | 4,484 | | | | | | 12,339 | | | | | | 1,650 | | | | | | 921 | | | | | | 63,413 | | | | | | 96,452 | | |
Transfers
|
| | | | 4,021 | | | | | | 4,923 | | | | | | 3,560 | | | | | | 39,494 | | | | | | 580 | | | | | | 65 | | | | | | (52,646) | | | | | | (3) | | |
Disposals
|
| | | | — | | | | | | (130) | | | | | | (407) | | | | | | (811) | | | | | | (23) | | | | | | (30) | | | | | | — | | | | | | (1,401) | | |
收购带来的额外收益
|
| | | | 39,106 | | | | | | 5,279 | | | | | | 834 | | | | | | 12,448 | | | | | | 111 | | | | | | 377 | | | | | | 12,839 | | | | | | 70,994 | | |
外汇和其他调整的影响
|
| | | | (642) | | | | | | (82) | | | | | | 120 | | | | | | 939 | | | | | | 58 | | | | | | (21) | | | | | | 44 | | | | | | 416 | | |
As of December 31, 2021
|
| | | $ | 146,884 | | | | | $ | 38,968 | | | | | $ | 26,227 | | | | | $ | 152,778 | | | | | $ | 8,148 | | | | | $ | 3,258 | | | | | $ | 42,847 | | | | | $ | 419,110 | | |
累计折旧 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance as of January 1, 2020
|
| | | $ | (511) | | | | | $ | (1,248) | | | | | $ | (994) | | | | | $ | (3,142) | | | | | $ | (743) | | | | | $ | (160) | | | | | $ | — | | | | | $ | (6,798) | | |
Depreciation
|
| | | | (1,522) | | | | | | (1,987) | | | | | | (2,205) | | | | | | (10,197) | | | | | | (1,263) | | | | | | (333) | | | | | | — | | | | | | (17,507) | | |
与销售和回租交易相关的销售
|
| | | | — | | | | | | — | | | | | | — | | | | | | 457 | | | | | | — | | | | | | — | | | | | | — | | | | | | 457 | | |
As of December 31, 2020
|
| | | $ | (2,033) | | | | | $ | (3,235) | | | | | $ | (3,199) | | | | | $ | (12,882) | | | | | $ | (2,006) | | | | | $ | (493) | | | | | $ | — | | | | | $ | (23,848) | | |
($ in thousands)
|
| |
Land and
Buildings |
| |
Machinery
and Equipment |
| |
Furniture
and Fixtures |
| |
Leasehold
Improvements |
| |
Website,
Computer Equipment and Software |
| |
Vehicles
|
| |
Construction
In Progress |
| |
Total
|
| ||||||||||||||||||||||||
Depreciation
|
| | | | (5,465) | | | | | | (3,603) | | | | | | (4,387) | | | | | | (10,358) | | | | | | (1,882) | | | | | | (588) | | | | | | — | | | | | | (26,283) | | |
Disposals
|
| | | | — | | | | | | 74 | | | | | | 140 | | | | | | 297 | | | | | | 13 | | | | | | 19 | | | | | | — | | | | | | 543 | | |
Adjustments
|
| | | | — | | | | | | (57) | | | | | | (133) | | | | | | (206) | | | | | | (52) | | | | | | 18 | | | | | | — | | | | | | (430) | | |
As of December 31, 2021
|
| | | $ | (7,498) | | | | | $ | (6,821) | | | | | $ | (7,579) | | | | | $ | (23,149) | | | | | $ | (3,927) | | | | | $ | (1,044) | | | | | $ | — | | | | | $ | (50,018) | | |
Net book value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
As of December 31, 2020
|
| | | $ | 94,493 | | | | | $ | 19,971 | | | | | $ | 14,437 | | | | | $ | 75,487 | | | | | $ | 3,766 | | | | | $ | 1,453 | | | | | $ | 19,197 | | | | | $ | 228,804 | | |
As of December 31, 2021
|
| | | $ | 139,386 | | | | | $ | 32,147 | | | | | $ | 18,648 | | | | | $ | 129,629 | | | | | $ | 4,221 | | | | | $ | 2,214 | | | | | $ | 42,847 | | | | | $ | 369,092 | | |
($ in thousands)
|
| |
Total
|
| |
Operating
Leases |
| |
Finance
Leases |
| |||||||||
2022
|
| | | $ | 24,242 | | | | | $ | 18,971 | | | | | $ | 5,271 | | |
2023
|
| | | | 24,260 | | | | | | 18,832 | | | | | | 5,428 | | |
2024
|
| | | | 24,593 | | | | | | 18,989 | | | | | | 5,604 | | |
2025
|
| | | | 26,102 | | | | | | 20,348 | | | | | | 5,754 | | |
2026
|
| | | | 26,423 | | | | | | 20,528 | | | | | | 5,895 | | |
Thereafter
|
| | | | 207,288 | | | | | | 174,141 | | | | | | 33,147 | | |
Total lease payments
|
| | | $ | 332,908 | | | | | $ | 271,809 | | | | | $ | 61,099 | | |
Less: imputed interest
|
| | | | (184,810) | | | | | | (154,871) | | | | | | (29,939) | | |
少:租户改善津贴
|
| | | | (8,370) | | | | | | (7,671) | | | | | | (699) | | |
租赁负债现值
|
| | | | 139,728 | | | | | | 109,267 | | | | | | 30,461 | | |
减去:当期租赁负债
|
| | | | (20,792) | | | | | | (16,348) | | | | | | (4,444) | | |
长期租赁负债现值
|
| | | $ | 118,936 | | | | | $ | 92,919 | | | | | $ | 26,017 | | |
($ in thousands)
|
| |
Financing
Liabilities |
| |||
2022
|
| | | $ | 12,881 | | |
2023
|
| | | | 13,204 | | |
2024
|
| | | | 13,535 | | |
2025
|
| | | | 13,875 | | |
2026
|
| | | | 14,223 | | |
Thereafter
|
| | | | 126,445 | | |
Total finance payments
|
| | | $ | 194,163 | | |
Less: interest
|
| | | | (96,094) | | |
少:租户改善津贴
|
| | | | (273) | | |
金融负债现值
|
| | | | 97,796 | | |
减去:短期金融负债
|
| | | | (10,217) | | |
长期金融负债现值
|
| | | $ | 87,579 | | |
| | |
2021
|
| |
2020
|
| ||||||||||||||||||
($ in thousands)
|
| |
Operating
Leases |
| |
Finance
Leases |
| |
Operating
Leases |
| |
Finance
Leases |
| ||||||||||||
Right-of-use assets
|
| | | $ | 62,329 | | | | | $ | 25,688 | | | | | $ | 47,765 | | | | | $ | 24,029 | | |
租赁负债(流动)
|
| | | | 16,348 | | | | | | 4,444 | | | | | | 14,013 | | | | | | 4,027 | | |
租赁负债(非流动)
|
| | | | 92,919 | | | | | | 26,017 | | | | | | 47,528 | | | | | | 26,940 | | |
加权平均剩余租期(1)
|
| | | | 4.7 | | | | | | 11.2 | | | | | | 13.3 | | | | | | 12.1 | | |
加权平均剩余贴现率
|
| | | | 13.5% | | | | | | 13.8% | | | | | | 14.8% | | | | | | 14.0% | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
融资租赁支付的利息
|
| | | $ | 4,742 | | | | | $ | 2,268 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
420 Capital
|
| | | $ | 68 | | | | | $ | 68 | | |
Lighthouse
|
| | | | 542 | | | | | | 1,049 | | |
Fleurish
|
| | | | — | | | | | | 51 | | |
Old Pal
|
| | | | 592 | | | | | | — | | |
IMC
|
| | | | 4,710 | | | | | | — | | |
Total Investments
|
| | | $ | 5,912 | | | | | $ | 1,168 | | |
($ in thousands)
|
| |
Customer
Relationships |
| |
Trade
Names |
| |
Permit
Application Costs |
| |
Licenses
|
| |
Other
Intangibles(a) |
| |
Goodwill
|
| |
Total
|
| |||||||||||||||||||||
Cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at January 1, 2020
|
| | | $ | 6,929 | | | | | $ | — | | | | | $ | 6,842 | | | | | $ | 83,447 | | | | | $ | 2,133 | | | | | $ | 134,735 | | | | | $ | 234,086 | | |
Additions
|
| | | | — | | | | | | — | | | | | | 1,910 | | | | | | — | | | | | | 2,720 | | | | | | — | | | | | | 4,630 | | |
收购带来的额外收益
|
| | | | 52,200 | | | | | | 41,800 | | | | | | — | | | | | | 5,900 | | | | | | 2,865 | | | | | | 321,928 | | | | | | 424,693 | | |
Foreign exchange
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 5 | | | | | | 5 | | |
Impairment
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (1,217) | | | | | | — | | | | | | (1,217) | | |
测算期调整
|
| | | | 11,400 | | | | | | (2,100) | | | | | | — | | | | | | — | | | | | | (111) | | | | | | (6,099) | | | | | | 3,090 | | |
Balance at December 31, 2020
|
| | | $ | 70,529 | | | | | $ | 39,700 | | | | | $ | 8,752 | | | | | $ | 89,347 | | | | | $ | 6,390 | | | | | $ | 450,569 | | | | | $ | 665,287 | | |
Additions
|
| | | | — | | | | | | — | | | | | | 3,169 | | | | | | | | | | | | 3,002 | | | | | | — | | | | | | 6,171 | | |
收购带来的额外收益
|
| | | | 24,250 | | | | | | 1,400 | | | | | | — | | | | | | 317,200 | | | | | | 1,151 | | | | | | 212,140 | | | | | | 556,141 | | |
Foreign exchange
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Impairment
|
| | | | (62,900) | | | | | | (39,000) | | | | | | — | | | | | | — | | | | | | (3,783) | | | | | | (215,551) | | | | | | (321,234) | | |
测算期调整
|
| | | | — | | | | | | — | | | | | | — | | | | | | (2,240) | | | | | | — | | | | | | (391) | | | | | | (2,631) | | |
Disposals
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (476) | | | | | | — | | | | | | (476) | | |
Balance at December 31, 2021
|
| | | $ | 31,879 | | | | | $ | 2,100 | | | | | $ | 11,921 | | | | | $ | 404,307 | | | | | $ | 6,284 | | | | | $ | 446,767 | | | | | $ | 903,258 | | |
累计摊销 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at January 1, 2020
|
| | | $ | (858) | | | | | $ | — | | | | | $ | (3,265) | | | | | $ | — | | | | | $ | (1,022) | | | | | $ | — | | | | | $ | (5,145) | | |
Amortization
|
| | | | (4,271) | | | | | | (3,970) | | | | | | (3,853) | | | | | | — | | | | | | (1,938) | | | | | | — | | | | | | (14,032) | | |
Balance at December 31, 2020
|
| | | | (5,129) | | | | | | (3,970) | | | | | | (7,118) | | | | | | — | | | | | | (2,960) | | | | | | — | | | | | $ | (19,177) | | |
Amortization
|
| | | | 932 | | | | | | 3,275 | | | | | | (3,330) | | | | | | — | | | | | | (642) | | | | | | — | | | | | | 235 | | |
Disposals
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 95 | | | | | | — | | | | | | 95 | | |
Balance at December 31, 2021
|
| | | $ | (4,197) | | | | | $ | (695) | | | | | $ | (10,448) | | | | | $ | — | | | | | $ | (3,507) | | | | | $ | — | | | | | $ | (18,847) | | |
Net book value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
December 31, 2020
|
| | | $ | 65,401 | | | | | $ | 35,730 | | | | | $ | 1,632 | | | | | $ | 89,347 | | | | | $ | 3,431 | | | | | $ | 450,569 | | | | | $ | 646,110 | | |
December 31, 2021
|
| | | $ | 27,682 | | | | | $ | 1,405 | | | | | $ | 1,473 | | | | | $ | 404,307 | | | | | $ | 2,777 | | | | | $ | 446,767 | | | | | $ | 884,411 | | |
($ in thousands)
|
| |
Estimated
Amortization |
| |||
2022
|
| | | $ | 8,672 | | |
2023
|
| | | | 4,786 | | |
2024
|
| | | | 4,276 | | |
2025
|
| | | | 4,349 | | |
2026
|
| | | | 4,200 | | |
Thereafter
|
| | | | 7,054 | | |
预计摊销总额
|
| | | $ | 33,337 | | |
(in thousands)
|
| |
Redeemable
Units |
| |
Subordinate
Voting Shares (SVS)* |
| |
Proportionate
Voting Shares (PVS)** |
| |
Super
Voting Shares (MVS) |
| |
Special Subordinate
Voting Shares |
| |||||||||||||||
Beginning balance, January 1, 2020
|
| | | | 142,172 | | | | | | 73,600 | | | | | | 57,937 | | | | | | 500 | | | | | | — | | |
行使期权和认股权证
|
| | | | — | | | | | | 1,711 | | | | | | 12 | | | | | | — | | | | | | — | | |
RSU issued
|
| | | | — | | | | | | 2,062 | | | | | | — | | | | | | — | | | | | | — | | |
与收购相关的股票发行
|
| | | | — | | | | | | 69,929 | | | | | | 233 | | | | | | — | | | | | | — | | |
发行与分销协议相关的股票
|
| | | | — | | | | | | 249 | | | | | | — | | | | | | — | | | | | | — | | |
Cresco LLC redemption
|
| | | | (15,834) | | | | | | 15,681 | | | | | | — | | | | | | — | | | | | | — | | |
PVS converted to SVS
|
| | | | — | | | | | | 28,871 | | | | | | (28,871) | | | | | | — | | | | | | — | | |
与某些股份支付安排的员工税有关的问题
|
| | | | — | | | | | | 1,336 | | | | | | — | | | | | | — | | | | | | — | | |
Share issuances
|
| | |
|
—
|
| | | | | 792 | | | | |
|
—
|
| | | |
|
—
|
| | | | | 1 | | |
Ending balance, December 31, 2020
|
| | | | 126,338 | | | | | | 194,231 | | | | | | 29,311 | | | | | | 500 | | | | | | 1 | | |
行使期权和认股权证
|
| | | | — | | | | | | 3,030 | | | | | | — | | | | | | — | | | | | | — | | |
RSUs issued
|
| | | | — | | | | | | 351 | | | | | | — | | | | | | — | | | | | | — | | |
与收购相关的股票发行
|
| | | | — | | | | | | 35,425 | | | | | | — | | | | | | — | | | | | | — | | |
发行与分销协议相关的股票
|
| | | | — | | | | | | (249) | | | | | | — | | | | | | — | | | | | | — | | |
Cresco LLC redemption
|
| | | | (16,897) | | | | | | 16,897 | | | | | | — | | | | | | — | | | | | | — | | |
PVS converted to SVS
|
| | | | — | | | | | | 8,644 | | | | | | (8,644) | | | | | | — | | | | | | — | | |
与某些股份支付安排的员工税有关的问题
|
| | | | — | | | | | | 173 | | | | | | — | | | | | | — | | | | | | — | | |
Share issuances
|
| | | | — | | | | | | 11,469 | | | | | | — | | | | | | — | | | | | | — | | |
Ending balance, December 31, 2021
|
| | | | 109,441 | | | | | | 269,971 | | | | | | 20,667 | | | | | | 500 | | | | | | 1 | | |
(in thousands)
|
| |
Acquisition date
|
| |
SVS shares
issued |
| |
Replacement
shares issued |
| |
Equity-based
consideration |
| |||||||||
Verdant
|
| |
February 16, 2021
|
| | | | 127 | | | | | | — | | | | | $ | 2,004 | | |
Bluma
|
| |
April 14, 2021
|
| | | | 15,061 | | | | | | 814 | | | | | | 193,310 | | |
Cultivate
|
| |
September 02, 2021
|
| | | | 4,818 | | | | | | — | | | | | | 46,643 | | |
Cure Penn
|
| |
November 25, 2021
|
| | | | 6,167 | | | | | | — | | | | | | 54,240 | | |
Laurel Harvest
|
| |
December 10, 2021
|
| | | | 8,354 | | | | | | — | | | | | | 65,844 | | |
| | |
Number of warrants*
(in thousands) |
| |
Weighted-average
exercise price |
| ||||||
Balance as of January 1, 2020
|
| | | | 6,454 | | | | | $ | 7.73 | | |
Exercised
|
| | | | (271) | | | | | | 6.05 | | |
Balance as of December 31, 2020
|
| | | | 6,183 | | | | | $ | 7.80 | | |
Bluma更换认股权证
|
| | | | 4,665 | | | | | | 11.64 | | |
Exercised
|
| | | | (721) | | | | | | 6.15 | | |
Forfeited
|
| | | | (285) | | | | | | 11.64 | | |
Balance as of December 31, 2021
|
| | | | 9,842 | | | | | $ | 9.63 | | |
($ in thousands)
|
| |
TSC
Cresco, LLC |
| |
MedMar
Inc. (Lakeview) |
| |
MedMar
Inc. (Rockford) |
| |
Cresco
Labs Ohio, LLC |
| |
SLO
Cultivation Inc. |
| |
Other
entities including Cresco Labs |
| |
Eliminations
|
| |
Total
|
| ||||||||||||||||||||||||
Non-current assets
|
| | | $ | 5,208 | | | | | $ | 33,698 | | | | | $ | 22,934 | | | | | $ | 16,093 | | | | | $ | 23,422 | | | | | $ | 1,257,353 | | | | | $ | — | | | | | $ | 1,358,708 | | |
Current assets
|
| | | | 54,506 | | | | | | 95,522 | | | | | | 154,929 | | | | | | 64,897 | | | | | | 97,276 | | | | | | 250,029 | | | | | | (295,404) | | | | | | 421,755 | | |
非流动负债
|
| | | | — | | | | | | (11,213) | | | | | | (3,443) | | | | | | (12,286) | | | | | | (14,071) | | | | | | (653,320) | | | | | | — | | | | | | (694,333) | | |
Current liabilities
|
| | | | (49,726) | | | | | | (92,049) | | | | | | (124,597) | | | | | | (73,441) | | | | | | (147,993) | | | | | | (107,143) | | | | | | 306,555 | | | | | | (288,394) | | |
Net assets
|
| | | $ | 9,988 | | | | | $ | 25,958 | | | | | $ | 49,823 | | | | | $ | (4,737) | | | | | $ | (41,366) | | | | | $ | 746,919 | | | | | $ | 11,151 | | | | | $ | 797,736 | | |
Net assets
attributable to NCI |
| | | $ | 2,850 | | | | | $ | 3,910 | | | | | $ | 6,123 | | | | | $ | 18 | | | | | $ | (9,143) | | | | | $ | 38,424 | | | | | $ | — | | | | | $ | 42,182 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | — | | |
Revenue
|
| | | $ | 21,549 | | | | | $ | 48,435 | | | | | $ | 84,932 | | | | | $ | 22,661 | | | | | $ | 21,011 | | | | | $ | 663,602 | | | | | $ | (40,508) | | | | | $ | 821,682 | | |
Gross profit
|
| | | | 13,592 | | | | | | 32,020 | | | | | | 47,922 | | | | | | 10,650 | | | | | | (6,250) | | | | | | 320,419 | | | | | | (12,006) | | | | | | 406,347 | | |
Net income (loss)
|
| | | $ | 12,387 | | | | | $ | 12,043 | | | | | $ | 30,666 | | | | | $ | (4,627) | | | | | $ | (19,247) | | | | | $ | (328,056) | | | | | $ | — | | | | | $ | (296,834) | | |
Net income (loss)
allocated to NCI |
| | | $ | 3,097 | | | | | $ | 1,493 | | | | | $ | 7,666 | | | | | $ | (46) | | | | | $ | (3,849) | | | | | $ | 14,402 | | | | | $ | — | | | | | $ | 22,763 | | |
NCI percentage at December 31, 2021
|
| | | | 25.0% | | | | | | 12.4% | | | | | | 25.0% | | | | | | 1.0% | | | | | | 20.0% | | | | | | 43.3% | | | | | | | | | | | | | | |
($ in thousands)
|
| |
TSC
Cresco, LLC |
| |
MedMar
Inc. (Lakeview) |
| |
MedMar
Inc. (Rockford) |
| |
Cresco
Labs Ohio, LLC |
| |
SLO
Cultivation Inc. |
| |
Other
entities including Cresco Labs |
| |
Eliminations
|
| |
Total
|
| ||||||||||||||||||||||||
Non-current assets
|
| | | $ | 4,064 | | | | | $ | 32,397 | | | | | $ | 20,957 | | | | | $ | 13,626 | | | | | $ | 22,744 | | | | | $ | 889,341 | | | | | $ | — | | | | | $ | 983,129 | | |
Current assets
|
| | | | 31,099 | | | | | | 26,022 | | | | | | 38,178 | | | | | | 42,934 | | | | | | 80,219 | | | | | | 184,871 | | | | | | (153,856) | | | | | | 249,467 | | |
非流动负债
|
| | | | — | | | | | | (11,755) | | | | | | (2,188) | | | | | | (12,328) | | | | | | (10,666) | | | | | | (367,481) | | | | | | — | | | | | | (404,418) | | |
Current liabilities
|
| | | | (24,852) | | | | | | (32,922) | | | | | | (28,248) | | | | | | (46,953) | | | | | | (118,870) | | | | | | (164,422) | | | | | | 163,421 | | | | | | (252,846) | | |
Net assets
|
| | | $ | 10,311 | | | | | $ | 13,742 | | | | | $ | 28,699 | | | | | $ | (2,721) | | | | | $ | (26,573) | | | | | $ | 542,309 | | | | | $ | 9,565 | | | | | $ | 575,332 | | |
Net assets
attributable to NCI |
| | | $ | 2,521 | | | | | $ | 3,308 | | | | | $ | 4,334 | | | | | $ | 64 | | | | | $ | (5,293) | | | | | $ | 97,161 | | | | | $ | — | | | | | $ | 102,095 | | |
Revenue
|
| | | $ | 16,874 | | | | | $ | 31,320 | | | | | $ | 38,417 | | | | | $ | 14,646 | | | | | $ | 19,772 | | | | | $ | 386,257 | | | | | $ | (31,035) | | | | | $ | 476,251 | | |
Gross profit
|
| | | | 10,033 | | | | | | 16,411 | | | | | | 20,092 | | | | | | 5,097 | | | | | | (4,461) | | | | | | 164,116 | | | | | | (4,587) | | | | | | 206,701 | | |
Net income (loss)
|
| | | $ | 7,884 | | | | | $ | 3,606 | | | | | $ | 10,430 | | | | | $ | (6,238) | | | | | $ | (11,219) | | | | | $ | (97,234) | | | | | $ | — | | | | | $ | (92,771) | | |
Net income (loss)
allocated to NCI |
| | | $ | 1,971 | | | | | $ | 447 | | | | | $ | 2,607 | | | | | $ | (62) | | | | | $ | (2,244) | | | | | $ | 6,667 | | | | | $ | — | | | | | $ | 9,386 | | |
NCI percentage at December 31,
2020 |
| | | | 25.0% | | | | | | 12.4% | | | | | | 25.0% | | | | | | 1.0% | | | | | | 20.0% | | | | | | 50.1% | | | | | | | | | | | | | | |
(Shares in thousands)
|
| |
Number of
stock options outstanding |
| |
Weighted-average
exercise price |
| |
Weighted-average
remaining contractual life (years) |
| |
Aggregate
intrinsic value |
| ||||||||||||
Outstanding – January 1, 2020
|
| | | | 22,920 | | | | | $ | 3.18 | | | | | | 8.60 | | | | | $ | 99,142 | | |
Granted
|
| | | | 6,628 | | | | | | 5.04 | | | | | | | | | | | | | | |
Exercised
|
| | | | (1,820) | | | | | | 2.12 | | | | | | | | | | | | | | |
原产地房屋更换奖
|
| | | | 629 | | | | | | 4.24 | | | | | | | | | | | | | | |
Forfeited
|
| | | | (5,850) | | | | | | 2.77 | | | | | | | | | | | | | | |
Outstanding – December 31, 2020
|
| | | | 22,507 | | | | | $ | 3.96 | | | | | | 8.10 | | | | | $ | 133,604 | | |
Exercisable – December 31, 2020
|
| | | | 9,853 | | | | | $ | 3.19 | | | | | | 3.40 | | | | | $ | 65,743 | | |
Granted
|
| | | | 5,227 | | | | | | 11.29 | | | | | | | | | | | | | | |
Exercised
|
| | | | (2,589) | | | | | | 1.97 | | | | | | | | | | | | | | |
Forfeited
|
| | | | (1,535) | | | | | | 9.51 | | | | | | | | | | | | | | |
Outstanding – December 31, 2021
|
| | | | 23,610 | | | | | $ | 5.54 | | | | | | 7.70 | | | | | $ | 53,455 | | |
Exercisable – December 31, 2021
|
| | | | 12,772 | | | | | $ | 3.69 | | | | | | 7.20 | | | | | $ | 40,209 | | |
| | |
Year Ended December 31,
|
| |||||||||
(单位为千,每股数据除外)
|
| |
2021
|
| |
2020
|
| ||||||
授予股票期权单位的加权平均授予日公允价值(每股)
|
| | | $ | 7.39 | | | | | $ | 3.05 | | |
按行权日市场价格计算的行权股票期权单位内在价值
|
| | | $ | 21,131 | | | | | $ | 7,000 | | |
| | |
2021
|
| |
2020
|
|
无风险年利率
|
| |
0.4% – 1.2%
|
| |
0.6% – 1.8%
|
|
预期年度股息收益率
|
| |
0%
|
| |
0%
|
|
预期股价波动
|
| |
67% to 82.2%
|
| |
64.9% to 81.0%
|
|
股票期权的预期期限
|
| |
5 to 7 years
|
| |
5 to 7 years
|
|
Forfeiture rate
|
| |
7.5% – 24.9%
|
| |
5.0% – 15.0%
|
|
Fair value at grant date
|
| |
$4.47 to $8.78
|
| |
$1.84 to $6.33
|
|
Stock price at grant date
|
| |
$6.62 to $13.10
|
| |
$2.99 to $9.86
|
|
Exercise price range
|
| |
$6.62 to $13.10
|
| |
$2.99 to $9.86
|
|
(Shares in thousands)
|
| |
Number of
RSUs outstanding |
| |
Weighted
average fair value |
| ||||||
Outstanding – January 1, 2020
|
| | | | 404 | | | | | $ | 8.58 | | |
Granted
|
| | | | 661 | | | | | | 6.00 | | |
原产地房屋更换奖
|
| | | | 3,431 | | | | | | 5.96 | | |
Vested and settled
|
| | | | (3,436) | | | | | | 5.23 | | |
Forfeited
|
| | | | (66) | | | | | | 8.91 | | |
Outstanding – December 31, 2020
|
| | | | 994 | | | | | $ | 6.54 | | |
Granted
|
| | | | 544 | | | | | | 11.78 | | |
Bluma更换奖
|
| | | | 207 | | | | | | 12.17 | | |
Vested and settled
|
| | | | (501) | | | | | | 9.20 | | |
Forfeited
|
| | | | (151) | | | | | | 8.21 | | |
Outstanding – December 31, 2021
|
| | | | 1,093 | | | | | $ | 8.83 | | |
负债-截至2021年12月31日分类
|
| | | | 4 | | | | | $ | 6.62 | | |
| | |
Year Ended December 31,
|
| |||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
归属RSU的总公允价值,按归属日期的市场价格计算
|
| | | $ | 4,783 | | | | | $ | 20,528 | | |
(单位为千,每股数据除外)
|
| |
Shares issued
|
| |
Fair value
(per share) |
| |
Compensation
expense |
| |||||||||
Bluma更换共享
|
| | | | 814 | | | | | $ | 12.17 | | | | | $ | 239 | | |
Subscription award
|
| | | | 62 | | | | | $ | 11.25 | | | | | $ | 694 | | |
($ in thousands)
|
| |
Verdant (i)
|
| |
Bluma (ii)
|
| |
Cultivate
(iii) |
| |
Cure Penn
(iv) |
| |
Laurel
Harvest (v) |
| |
Total
|
| ||||||||||||||||||
总体考虑 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common shares issued
|
| | | $ | 2,000 | | | | | $ | 183,262 | | | | | $ | 46,643 | | | | | $ | 52,610 | | | | | $ | 65,844 | | | | | $ | 350,359 | | |
Cash
|
| | | | 1,500 | | | | | | — | | | | | | — | | | | | | 33,304 | | | | | | 20,480 | | | | | | 55,284 | | |
贷款无现金行权选项
|
| | | | 10,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 10,000 | | |
Settlement of leases
|
| | | | 90 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 90 | | |
Loan settlement
|
| | | | 11,414 | | | | | | 21,226 | | | | | | 1,852 | | | | | | — | | | | | | 3,339 | | | | | | 37,831 | | |
Warrants issued
|
| | | | — | | | | | | 18,415 | | | | | | — | | | | | | — | | | | | | — | | | | | | 18,415 | | |
Replacement RSU awards
|
| | | | — | | | | | | 10,048 | | | | | | — | | | | | | — | | | | | | — | | | | | | 10,048 | | |
代表被收购方支付与收购相关的交易成本
|
| | | | — | | | | | | 3,373 | | | | | | 1,001 | | | | | | 3,135 | | | | | | 331 | | | | | | 7,840 | | |
代表被收购方支付第三方债务
|
| | | | — | | | | | | — | | | | | | 20,125 | | | | | | — | | | | | | — | | | | | | 20,125 | | |
延期考虑
|
| | | | — | | | | | | 1,806 | | | | | | — | | | | | | — | | | | | | 46,677 | | | | | | 48,483 | | |
或有对价
|
| | | | — | | | | | | — | | | | | | 29,642 | | | | | | — | | | | | | — | | | | | | 29,642 | | |
Total consideration
|
| | | $ | 25,004 | | | | | $ | 238,130 | | | | | $ | 99,263 | | | | | $ | 89,049 | | | | | $ | 136,671 | | | | | $ | 588,117 | | |
取得的可确认净资产(负债) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash
|
| | | $ | 1,360 | | | | | $ | 1,623 | | | | | $ | 2,938 | | | | | $ | 751 | | | | | $ | 937 | | | | | $ | 7,609 | | |
Accounts receivable
|
| | | | — | | | | | | — | | | | | | 6,494 | | | | | | 33 | | | | | | — | | | | | | 6,527 | | |
Inventory
|
| | | | 1,519 | | | | | | 19,244 | | | | | | 24,862 | | | | | | 2,963 | | | | | | 506 | | | | | | 49,094 | | |
短期应收贷款
|
| | | | — | | | | | | 1,600 | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,600 | | |
Other current assets
|
| | | | 76 | | | | | | 1,205 | | | | | | 662 | | | | | | 134 | | | | | | 36 | | | | | | 2,113 | | |
Property & equipment
|
| | | | 996 | | | | | | 26,152 | | | | | | 30,128 | | | | | | 1,845 | | | | | | 11,873 | | | | | | 70,994 | | |
Right-of-use assets
|
| | | | 127 | | | | | | 13,709 | | | | | | 1,304 | | | | | | 1,834 | | | | | | 859 | | | | | | 17,833 | | |
Other non-current assets
|
| | | | 47 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 47 | | |
客户关系
|
| | | | 1,370 | | | | | | 6,700 | | | | | | 13,600 | | | | | | 2,320 | | | | | | 260 | | | | | | 24,250 | | |
License
|
| | | | 16,320 | | | | | | 117,000 | | | | | | 12,000 | | | | | | 70,950 | | | | | | 98,690 | | | | | | 314,960 | | |
Trade name
|
| | | | — | | | | | | — | | | | | | 1,400 | | | | | | — | | | | | | — | | | | | | 1,400 | | |
Non-compete agreements
|
| | | | — | | | | | | — | | | | | | 800 | | | | | | 270 | | | | | | 80 | | | | | | 1,150 | | |
Investments
|
| | | | — | | | | | | 693 | | | | | | — | | | | | | — | | | | | | — | | | | | | 693 | | |
获得的可识别资产总额
|
| | | $ | 21,815 | | | | | $ | 187,926 | | | | | $ | 94,188 | | | | | $ | 81,100 | | | | | $ | 113,241 | | | | | $ | 498,270 | | |
Short-term liabilities
|
| | | | (1,601) | | | | | | (3,733) | | | | | | (14,585) | | | | | | (1,186) | | | | | | (151) | | | | | | (21,256) | | |
Lease liability
|
| | | | (127) | | | | | | (13,685) | | | | | | (1,304) | | | | | | (1,834) | | | | | | (859) | | | | | | (17,809) | | |
合同责任-忠诚度计划
|
| | | | — | | | | | | (456) | | | | | | — | | | | | | (355) | | | | | | — | | | | | | (811) | | |
Deferred tax liability
|
| | | | (3,968) | | | | | | (36,940) | | | | | | (10,597) | | | | | | — | | | | | | (30,753) | | | | | | (82,258) | | |
已获得的可确认负债总额
|
| | | | (5,696) | | | | | | (54,814) | | | | | | (26,486) | | | | | | (3,375) | | | | | | (31,763) | | | | | | (122,134) | | |
取得的可确认净资产
|
| | | $ | 16,119 | | | | | $ | 133,112 | | | | | $ | 67,702 | | | | | $ | 77,725 | | | | | $ | 81,478 | | | | | $ | 376,136 | | |
采购价格分配 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
取得的可确认净资产
|
| | | | 16,119 | | | | | | 133,112 | | | | | | 67,702 | | | | | | 77,725 | | | | | | 81,478 | | | | | | 376,136 | | |
Goodwill
|
| | | | 8,885 | | | | | | 105,018 | | | | | | 31,561 | | | | | | 11,324 | | | | | | 55,193 | | | | | | 211,981 | | |
Total consideration
|
| | | $ | 25,004 | | | | | $ | 238,130 | | | | | $ | 99,263 | | | | | $ | 89,049 | | | | | $ | 136,671 | | | | | $ | 588,117 | | |
($ in thousands)
|
| |
Verdant (i)
|
| |
Bluma (ii)
|
| |
Cultivate
(iii) |
| |
Cure Penn
(iv) |
| |
Laurel
Harvest (v) |
| |
Total
|
| ||||||||||||||||||
Contributed revenue
|
| | | $ | 26,547 | | | | | $ | 26,642 | | | | | $ | 29,279 | | | | | $ | 2,966 | | | | | $ | 328 | | | | | $ | 85,762 | | |
Net (loss) income
|
| | | | 5,352 | | | | | | (8,382) | | | | | | 14,944 | | | | | | (50) | | | | | | (136) | | | | | $ | 11,728 | | |
| | |
For the year ended December 31, 2021
|
| ||||||||||||||||||||||||||||||||||||||||||
| | |
Cresco Labs Inc.
|
| |
Verdant (i)
|
| |
Bluma (ii)
|
| |
Cultivate
(iii) |
| |
Cure Penn
(iv) |
| |
Laurel
Harvest (v) |
| |
Total
|
| | |||||||||||||||||||||||
($ in thousands)
|
| | | | | | | |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| | ||||||||||||||||||||
Pro forma revenue
|
| | | $ | 821,682 | | | | | $ | 2,677 | | | | | $ | 7,906 | | | | | $ | 39,033 | | | | | $ | 29,281 | | | | | $ | 1,966 | | | | | $ | 902,545 | | | | ||
Pro forma net income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
收购前净收益
|
| | | | | | | | | | (846) | | | | | | (13,784) | | | | | | 4,550 | | | | | | 8,161 | | | | | | (2,121) | | | | | | | | | | ||
Pro forma adjustments:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
(a) Transaction
costs |
| | | | | | | | | | 399 | | | | | | 1,461 | | | | | | 1,555 | | | | | | 439 | | | | | | 1,081 | | | | | | | | | | ||
(B)收购后股份薪酬
|
| | | | | | | | | | — | | | | | | 2,440 | | | | | | — | | | | | | — | | | | | | — | | | | | | | | | | ||
(C)无形摊销
|
| | | | | | | | | | (150) | | | | | | (599) | | | | | | (860) | | | | | | (355) | | | | | | (68) | | | | | | | | | | ||
预计调整总额
|
| | | | | | | | | $ | 250 | | | | | $ | 3,302 | | | | | $ | 695 | | | | | $ | 84 | | | | | $ | 1,013 | | | | | | | | | | ||
预计净收入合计
|
| | | $ | (296,834) | | | | | $ | (596) | | | | | $ | (10,482) | | | | | $ | 5,245 | | | | | $ | 8,245 | | | | | $ | (1,109) | | | | | $ | (295,531) | | | |
| | |
For the year ended December 31, 2020
|
| ||||||||||||||||||||||||||||||||||||||||||
| | |
Cresco
Labs Inc. |
| |
Verdant
(i) |
| |
Bluma (ii)
|
| |
Cultivate
(iii) |
| |
Cure Penn
(iv) |
| |
Laurel
Harvest (v) |
| |
Total
|
| | |||||||||||||||||||||||
($ in thousands)
|
| | | | | | | |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| | ||||||||||||||||||||
Pro forma revenue
|
| | | $ | 476,251 | | | | | $ | 15,195 | | | | | $ | 12,338 | | | | | $ | 22,965 | | | | | $ | 29,119 | | | | | $ | 1 | | | | | $ | 555,869 | | | | ||
Pro forma net income:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
收购前净收益
|
| | | | | | | | | | (1,982) | | | | | | (25,998) | | | | | | 772 | | | | | | 8,384 | | | | | | (650) | | | | | | | | | | ||
Pro forma adjustments:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
(a) Transaction costs
|
| | | | | | | | | | (399) | | | | | | (1,461) | | | | | | (1,555) | | | | | | (439) | | | | | | (1,081) | | | | | | | | | | ||
(b) Post-acquisition
share-based compensation |
| | | | | | | | | | — | | | | | | (2,440) | | | | | | — | | | | | | — | | | | | | — | | | | | | | | | | ||
(C)无形摊销
|
| | | | | | | | | | (171) | | | | | | (853) | | | | | | (3,483) | | | | | | (387) | | | | | | (73) | | | | | | | | | | ||
预计调整总额
|
| | | | | | | | | $ | (571) | | | | | $ | (4,754) | | | | | $ | (5,037) | | | | | $ | (826) | | | | | $ | (1,153) | | | | | | | | | | ||
预计净收入合计
|
| | | $ | (92,771) | | | | | $ | (2,553) | | | | | $ | (30,752) | | | | | $ | (4,266) | | | | | $ | 7,558 | | | | | $ | (1,803) | | | | | $ | (124,587) | | | |
($ in thousands)
|
| |
Origin House
(ii) |
| |||
总体考虑 | | | | | | | |
Common shares issued
|
| | | $ | 396,575 | | |
Replacement awards
|
| | | | 31,671 | | |
Total consideration
|
| | | $ | 428,246 | | |
取得的可确认净资产(负债) | | | | | | | |
Cash
|
| | | $ | 32,984 | | |
Accounts receivable
|
| | | | 7,565 | | |
Inventory
|
| | | | 16,660 | | |
Other current assets
|
| | | | 2,197 | | |
Property and equipment
|
| | | | 18,079 | | |
Right-of-use assets
|
| | | | 17,984 | | |
长期应收贷款
|
| | | | 331 | | |
权益法投资
|
| | | | 4,302 | | |
Investments
|
| | | | 139 | | |
客户关系
|
| | | | 63,600 | | |
Trade names
|
| | | | 39,700 | | |
Licenses
|
| | | | 5,900 | | |
市场相关无形资产
|
| | | | 2,374 | | |
内部开发的软件
|
| | | | 380 | | |
获得的可识别资产总额
|
| | | $ | 212,195 | | |
($ in thousands)
|
| | | |
OriginHouse (Ii) |
| |
Short-term liabilities
|
| | | $ | (25,758) | | |
Lease liabilities
|
| | | | (18,002) | | |
延期和或有对价
|
| | | | (3,807) | | |
Notes payable
|
| | | | (22,045) | | |
递延纳税义务
|
| | | | (29,622) | | |
取得的可确认净资产
|
| | | $ | 112,961 | | |
采购价格分配 | | | | | | | |
取得的可确认净资产
|
| | | $ | 112,961 | | |
Goodwill
|
| | | | 315,285 | | |
Total consideration
|
| | | $ | 428,246 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
谷银或有对价
|
| | | $ | — | | | | | $ | 19,093 | | |
培养或有对价
|
| | | | 33,969 | | | | | | — | | |
月桂收获延期对价,短期
|
| | | | 37,847 | | | | | | — | | |
与短期 - 收购相关的递延对价、或有对价和其他应付款项合计
|
| | | $ | 71,816 | | | | | $ | 19,093 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
硅谷农业营运现金流考虑因素
|
| | | $ | 8,577 | | | | | $ | 7,247 | | |
月桂收获延期对价,长期
|
| | | | 9,074 | | | | | | — | | |
长期递延和或有对价合计
|
| | | $ | 17,651 | | | | | $ | 7,247 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
高级贷款,扣除未摊销债务发行成本后的净额
|
| | | $ | 400,000 | | | | | $ | — | | |
Amended Term Loan
|
| | | | — | | | | | | 200,000 | | |
Interest payable
|
| | | | 9,711 | | | | | | 3,656 | | |
Financing liability – leases
|
| | | | 97,797 | | | | | | 91,265 | | |
减少:未摊销债务发行成本 - 高级贷款
|
| | | | (22,501) | | | | | | — | | |
减去:未摊销债务发行成本 - 修订定期贷款
|
| | | | — | | | | | | (13,558) | | |
借款和应付利息总额
|
| | | $ | 485,007 | | | | | $ | 281,363 | | |
减去:短期借款和应付利息
|
| | | | (9,711) | | | | | | (15,071) | | |
减去:融资负债的当前部分 - 租赁
|
| | | | (10,217) | | | | | | (10,853) | | |
应付长期票据和贷款总额
|
| | | $ | 465,079 | | | | | $ | 255,439 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Wholesale
|
| | | $ | 414,908 | | | | | $ | 274,000 | | |
Dispensary
|
| | | | 406,774 | | | | | | 202,251 | | |
Total Revenue
|
| | | $ | 821,682 | | | | | $ | 476,251 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
衍生债务 - 权证的未实现收益(亏损)
|
| | | $ | 16,669 | | | | | $ | (8,659) | | |
衍生工具收益
|
| | | | 23,909 | | | | | | 2,938 | | |
计提 - 应收贷款损失
|
| | | | (753) | | | | | | (902) | | |
按公允价值持有的投资未实现亏损
|
| | | | (7,135) | | | | | | (162) | | |
债务清偿损失
|
| | | | (17,987) | | | | | | (977) | | |
处置资产损失
|
| | | | (886) | | | | | | (134) | | |
Loss on foreign currency
|
| | | | (1,228) | | | | | | (1,415) | | |
Other income (loss), net
|
| | | | 442 | | | | | | 1,016 | | |
其他收入(费用)合计,净额
|
| | | $ | 13,031 | | | | | $ | (8,295) | | |
| | | | | |
Year Ended
December 31, |
| |||||||||
($ in thousands)
|
| |
Classification
|
| |
2021
|
| |
2020
|
| ||||||
Operating Leases | | | | | | | | | | | | | | | | |
出租人拥有SLO的少数股权
|
| |
Rent expense
|
| | | $ | 1,563 | | | | | $ | 2,138 | | |
出租人拥有MedMar的少数股权
|
| |
Rent expense
|
| | | | 238 | | | | | | 140 | | |
出租人是MVS股东
|
| |
Rent expense
|
| | | | 1,168 | | | | | | 647 | | |
Finance Leases | | | | | | | | | | | | | | | | |
出租人拥有MedMar的少数股权
|
| |
Depreciation expense
|
| | | $ | 277 | | | | | $ | 151 | | |
出租人拥有MedMar的少数股权
|
| |
Interest expense
|
| | | | 310 | | | | | | 174 | | |
出租人是MVS股东
|
| |
Depreciation expense
|
| | | | 74 | | | | | | 64 | | |
出租人是MVS股东
|
| |
Interest expense
|
| | | | 88 | | | | | | 80 | | |
| | |
As of December 31, 2021
|
| |
As of December 31, 2020
|
| ||||||||||||||||||
($ in thousands)
|
| |
ROU Asset
|
| |
Lease Liability
|
| |
ROU Asset
|
| |
Lease Liability
|
| ||||||||||||
Operating Leases | | | | | | | | | | | | | | | | | | | | | | | | | |
出租人拥有SLO的少数股权
|
| | | $ | 6,996 | | | | | $ | 11,938 | | | | | $ | 4,926 | | | | | $ | 8,560 | | |
出租人拥有MedMar的少数股权
|
| | | | 1,525 | | | | | | 1,549 | | | | | | 1,146 | | | | | | 1,187 | | |
出租人是MVS股东
|
| | | | 6,314 | | | | | | 4,867 | | | | | | 6,334 | | | | | | 4,783 | | |
Finance Leases | | | | | | | | | | | | | | | | | | | | | | | | | |
出租人拥有MedMar的少数股权
|
| | | $ | 2,137 | | | | | $ | 2,457 | | | | | $ | 1,201 | | | | | $ | 1,365 | | |
出租人是MVS股东
|
| | | | 616 | | | | | | 1,063 | | | | | | 648 | | | | | | 678 | | |
| | |
December 31, 2021
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized Cost
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | 223,543 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 223,543 | | |
Restricted cash(1)
|
| | | | 2,559 | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,559 | | |
Security deposits
|
| | | | 3,941 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,941 | | |
Accounts receivable, net
|
| | | | 43,379 | | | | | | — | | | | | | — | | | | | | — | | | | | | 43,379 | | |
短期应收贷款
|
| | | | 747 | | | | | | — | | | | | | — | | | | | | 565 | | | | | | 1,312 | | |
长期应收贷款
|
| | | | 505 | | | | | | — | | | | | | — | | | | | | — | | | | | | 505 | | |
Investments
|
| | | | — | | | | | | 4,710 | | | | | | 542 | | | | | | 660 | | | | | | 5,912 | | |
财务负债: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 32,278 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 32,278 | | |
Accrued liabilities
|
| | | | 95,442 | | | | | | — | | | | | | — | | | | | | — | | | | | | 95,442 | | |
Short-term borrowings
|
| | | | 19,928 | | | | | | — | | | | | | — | | | | | | — | | | | | | 19,928 | | |
租赁负债的当期部分
|
| | | | 20,792 | | | | | | — | | | | | | — | | | | | | — | | | | | | 20,792 | | |
延期对价、或有对价和其他应付款项,短期
|
| | | | 5 | | | | | | 12 | | | | | | — | | | | | | 71,816 | | | | | | 71,833 | | |
短期衍生负债
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,172 | | | | | | 1,172 | | |
Lease liabilities
|
| | | | 118,936 | | | | | | — | | | | | | — | | | | | | — | | | | | | 118,936 | | |
延期对价和或有对价、长期对价
|
| | | | — | | | | | | — | | | | | | — | | | | | | 17,651 | | | | | | 17,651 | | |
长期应付票据和应付贷款
|
| | | | 465,079 | | | | | | — | | | | | | — | | | | | | — | | | | | | 465,079 | | |
| | |
December 31, 2020
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized
Cost |
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | 136,339 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 136,339 | | |
Restricted cash(1)
|
| | | | 4,435 | | | | | | — | | | | | | — | | | | | | — | | | | | | 4,435 | | |
Security deposits
|
| | | | 3,558 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,558 | | |
Accounts receivable, net
|
| | | | 29,943 | | | | | | — | | | | | | — | | | | | | — | | | | | | 29,943 | | |
短期应收贷款
|
| | | | 921 | | | | | | — | | | | | | | | | | | | 1,517 | | | | | | 2,438 | | |
长期应收贷款
|
| | | | 1,204 | | | | | | — | | | | | | — | | | | | | 20,019 | | | | | | 21,223 | | |
Investments(2) | | | | | 3,192 | | | | | | — | | | | | | 1,049 | | | | | | 119 | | | | | | 4,360 | | |
财务负债: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 23,231 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 23,231 | | |
Accrued liabilities
|
| | | | 130,469 | | | | | | — | | | | | | — | | | | | | — | | | | | | 130,469 | | |
Short-term borrowings
|
| | | | 25,924 | | | | | | — | | | | | | — | | | | | | — | | | | | | 25,924 | | |
租赁负债的当期部分
|
| | | | 18,040 | | | | | | — | | | | | | — | | | | | | — | | | | | | 18,040 | | |
延期对价、或有对价和其他应付款项,短期
|
| | | | — | | | | | | 22 | | | | | | — | | | | | | 19,093 | | | | | | 19,115 | | |
衍生负债 - 长期
|
| | | | — | | | | | | — | | | | | | — | | | | | | 17,505 | | | | | | 17,505 | | |
Lease liabilities
|
| | | | 74,468 | | | | | | — | | | | | | — | | | | | | — | | | | | | 74,468 | | |
延期对价和或有对价、长期对价
|
| | | | — | | | | | | — | | | | | | — | | | | | | 7,247 | | | | | | 7,247 | | |
长期应付票据和应付贷款
|
| | | | 255,439 | | | | | | — | | | | | | — | | | | | | — | | | | | | 255,439 | | |
($ in thousands)
|
| |
Valuation
classification |
| |
12/31/2021
|
| |
12/31/2020
|
| ||||||
短期应收贷款 - 灯塔
|
| |
Fair value
|
| | | $ | 565 | | | | | $ | 1,517 | | |
Interest receivable
|
| |
Amortized cost
|
| | | | 747 | | | | | | 921 | | |
短期应收贷款总额
|
| | | | | | $ | 1,312 | | | | | $ | 2,438 | | |
($ in thousands)
|
| |
Valuation
classification |
| |
12/31/2021
|
| |
12/31/2020
|
| ||||||
长期应收贷款 - Verdant
|
| |
Fair value
|
| | | $ | — | | | | | $ | 20,019 | | |
长期应收贷款 - 伊利诺伊州孵化器
|
| |
Amortized cost
|
| | | | 100 | | | | | | — | | |
长期应收贷款 - 其他
|
| |
Amortized cost
|
| | | | 405 | | | | | | 367 | | |
Interest receivable
|
| |
Amortized cost
|
| | | | — | | | | | | 837 | | |
长期应收贷款总额
|
| | | | | | $ | 505 | | | | | $ | 21,223 | | |
| | |
2021
|
| |
2020
|
| ||||||
无风险年利率
|
| | | | 0.15% | | | | | | 0.13% | | |
预期年度股息收益率
|
| | | | 0.0% | | | | | | 0.0% | | |
预期股价波动
|
| | | | 47.3% | | | | | | 83.0% | | |
认股权证的预期期限
|
| |
|
| |
1.8 years
|
| ||||||
Forfeiture rate
|
| | | | 0% | | | | | | 0% | | |
Share price at period end
|
| | | $ | 6.62 | | | | | $ | 9.86 | | |
期末执行价
|
| | | $ | 9.86 | | | | | $ | 9.82 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
0 to 60 days
|
| | | $ | 37,750 | | | | | $ | 28,280 | | |
61 to 120 days
|
| | | | 4,309 | | | | | | 1,134 | | |
120 days +
|
| | | | 3,540 | | | | | | 1,225 | | |
应收账款总额,毛
|
| | | | 45,599 | | | | | | 30,639 | | |
坏账准备
|
| | | | 2,220 | | | | | | 696 | | |
应收账款总额,净额
|
| | | $ | 43,379 | | | | | $ | 29,943 | | |
($ in thousands)
|
| |
|
| |
1 to 3 Years
|
| |
3 to 5 Years
|
| |
Total
|
| ||||||||||||
应付账款和应计负债
|
| | | $ | 127,720 | | | | | $ | — | | | | | $ | — | | | | | $ | 127,720 | | |
延期对价、或有对价和其他应付款
|
| | | | 71,833 | | | | | | — | | | | | | — | | | | | | 71,833 | | |
延期对价和或有对价
|
| | | | — | | | | | | 17,651 | | | | | | — | | | | | | 17,651 | | |
长期应付票据和应付贷款及短期借款
|
| | | | 19,928 | | | | | | — | | | | | | 465,079 | | | | | | 485,007 | | |
截至2021年12月31日的债务总额
|
| | | $ | 219,481 | | | | | $ | 17,651 | | | | | $ | 465,079 | | | | | $ | 702,211 | | |
| | |
December 31, 2021
|
| |
December 31, 2020
|
| ||||||||||||
($ in thousands)
|
| |
Cresco Labs
Michigan, LLC |
| |
Cresco Labs
Michigan, LLC |
| |
Cresco Labs,
LLC |
| |||||||||
Current assets
|
| | | $ | 36,850 | | | | | $ | 7,111 | | | | | $ | 830,828 | | |
Non-current assets
|
| | | | 36,320 | | | | | | 14,744 | | | | | | 143,449 | | |
Current liabilities
|
| | | | (72,476) | | | | | | (20,898) | | | | | | (849,691) | | |
非流动负债
|
| | | | (23,124) | | | | | | (2,986) | | | | | | (83,138) | | |
非控股权益
|
| | | | — | | | | | | — | | | | | | 97,180 | | |
可归因于Cresco Labs Inc.的赤字
|
| | | | (22,430) | | | | | | (2,029) | | | | | | (55,732) | | |
| | |
December 31, 2021
|
| |
December 31, 2020
|
| ||||||||||||
($ in thousands)
|
| |
Cresco Labs
Michigan, LLC |
| |
Cresco Labs
Michigan, LLC |
| |
Cresco Labs,
LLC |
| |||||||||
Revenue
|
| | | $ | 4,031 | | | | | $ | 2,916 | | | | | $ | 98,786 | | |
非控股权益应占净收益(亏损)
|
| | | | — | | | | | | — | | | | | | 6,666 | | |
可归因于Cresco Labs Inc.的净收益(亏损)
|
| | | | (9,120) | | | | | | (1,796) | | | | | | 10,204 | | |
Net income (loss)
|
| | | | (9,120) | | | | | | (1,796) | | | | | | 16,870 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Interest expense – leases
|
| | | $ | (4,053) | | | | | $ | (3,064) | | |
利息支出 - 应付票据和贷款
|
| | | | (29,661) | | | | | | (14,350) | | |
债务折扣的增加和递延融资费用的摊销
|
| | | | (5,153) | | | | | | (4,619) | | |
利息支出 - 融资活动以及销售和回租
|
| | | | (11,586) | | | | | | (10,568) | | |
Other interest expense
|
| | | | (1,696) | | | | | | (39) | | |
Interest income
|
| | | | 938 | | | | | | 1,411 | | |
总利息支出,净额
|
| | | $ | (51,211) | | | | | $ | (31,229) | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Current | | | | | | | | | | | | | |
Federal
|
| | | $ | 51,815 | | | | | $ | 27,821 | | |
State
|
| | | | 23,337 | | | | | | 11,936 | | |
Foreign
|
| | | | — | | | | | | — | | |
Total current
|
| | | $ | 75,152 | | | | | $ | 39,757 | | |
Deferred | | | | | | | | | | | | | |
Federal
|
| | | $ | (29,445) | | | | | $ | (6,253) | | |
State
|
| | | | (14,043) | | | | | | (4,394) | | |
Foreign
|
| | | | 5,759 | | | | | | (9,273) | | |
Total deferred
|
| | | $ | (37,729) | | | | | $ | (19,920) | | |
估值免税额变动
|
| | | $ | 2,684 | | | | | $ | 8,767 | | |
Total | | | | $ | 40,107 | | | | | $ | 28,604 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Deferred tax assets | | | | | | | | | | | | | |
基于股份的薪酬
|
| | | $ | 1,029 | | | | | $ | 360 | | |
Financing fees
|
| | | | 2,542 | | | | | | 2,920 | | |
Net operating losses
|
| | | | 36,096 | | | | | | 29,708 | | |
Inventory
|
| | | | 239 | | | | | | 967 | | |
Capital losses
|
| | | | — | | | | | | 336 | | |
Lease liabilities
|
| | | | 26,761 | | | | | | 22,284 | | |
Other
|
| | | | 730 | | | | | | 4,279 | | |
递延税金资产总额
|
| | | $ | 67,397 | | | | | $ | 60,854 | | |
递延纳税义务 | | | | | | | | | | | | | |
ROU assets
|
| | | $ | (7,824) | | | | | $ | (7,574) | | |
财产、厂房和设备
|
| | | | (11,885) | | | | | | (12,668) | | |
Intangible assets
|
| | | | (93,761) | | | | | | (48,499) | | |
Other
|
| | | | (1,948) | | | | | | (139) | | |
递延纳税负债总额
|
| | | $ | (115,418) | | | | | $ | (68,880) | | |
Valuation allowance
|
| | | $ | (31,085) | | | | | $ | (26,044) | | |
递延纳税净负债
|
| | | $ | (79,105) | | | | | $ | (34,071) | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
按法定税率计算的预期所得税费用
|
| | | $ | (53,912) | | | | | $ | (13,475) | | |
Tax rate differences
|
| | | | (1,109) | | | | | | (13,684) | | |
传递实体和非控制实体
|
| | | | (7,373) | | | | | | (4,775) | | |
State tax expense, net
|
| | | | 9,319 | | | | | | 7,517 | | |
IRC Section 280E disallowance
|
| | | | 47,100 | | | | | | 35,376 | | |
递延对价的价值变动
|
| | | | (10,103) | | | | | | 3,116 | | |
债务修改损失
|
| | | | 7,554 | | | | | | — | | |
不确定的税务处理
|
| | | | (4,749) | | | | | | 755 | | |
基于股份的薪酬
|
| | | | 3,941 | | | | | | 3,159 | | |
Goodwill impairment
|
| | | | 45,314 | | | | | | — | | |
估值免税额变动
|
| | | | 2,684 | | | | | | 8,768 | | |
Other
|
| | | | 1,440 | | | | | | 1,847 | | |
Income tax expense
|
| | | $ | 40,107 | | | | | $ | 28,604 | | |
Effective tax rate
|
| | | | (15.6)% | | | | | | (44.6)% | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Balance at January 1
|
| | | $ | 4,749 | | | | | $ | 3,993 | | |
根据与本年度相关的纳税头寸进行的增加
|
| | | | — | | | | | | 556 | | |
新增往年纳税头寸
|
| | | | — | | | | | | 200 | | |
前几年税收头寸减少
|
| | | | (4,749) | | | | | | — | | |
年终余额
|
| | | $ | — | | | | | $ | 4,749 | | |
| | |
Three Months Ended
December 31, |
| |
Year Ended
December 31, |
| ||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
2021
|
| |
2020
|
| ||||||||||||
工资和员工成本
|
| | | $ | 33,451 | | | | | $ | 22,107 | | | | | $ | 133,143 | | | | | $ | 81,080 | | |
销售和营销费用
|
| | | | 4,734 | | | | | | 8,375 | | | | | | 29,733 | | | | | | 19,218 | | |
基于股份的薪酬
|
| | | | 4,496 | | | | | | 5,313 | | | | | | 24,988 | | | | | | 16,373 | | |
折旧及摊销
|
| | | | 4,484 | | | | | | 4,141 | | | | | | 21,602 | | | | | | 17,133 | | |
Excise taxes
|
| | | | 4,867 | | | | | | 4,642 | | | | | | 15,998 | | | | | | 13,167 | | |
Facility expenses
|
| | | | 7,990 | | | | | | 4,194 | | | | | | 22,611 | | | | | | 15,672 | | |
咨询和专业服务
|
| | | | 3,615 | | | | | | 2,943 | | | | | | 13,503 | | | | | | 17,418 | | |
Computer and software
|
| | | | 3,282 | | | | | | 2,317 | | | | | | 13,302 | | | | | | 7,744 | | |
Business insurance
|
| | | | 1,170 | | | | | | 1,549 | | | | | | 8,087 | | | | | | 4,676 | | |
Rental fees
|
| | | | 2,090 | | | | | | 1,744 | | | | | | 7,385 | | | | | | 6,069 | | |
Accounting
|
| | | | 1,346 | | | | | | 586 | | | | | | 4,675 | | | | | | 2,982 | | |
Legal
|
| | | | 1,484 | | | | | | 1,029 | | | | | | 8,863 | | | | | | 5,825 | | |
差旅和员工费用
|
| | | | 1,531 | | | | | | 536 | | | | | | 4,570 | | | | | | 3,081 | | |
Other expenses
|
| | | | 4,980 | | | | | | 14,677 | | | | | | 9,344 | | | | | | 18,508 | | |
销售、一般和管理费用合计
|
| | | $ | 79,520 | | | | | $ | 74,153 | | | | | $ | 317,804 | | | | | $ | 228,946 | | |
| | |
Three Months Ended
December 31, |
| |
Year Ended
December 31, |
| ||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
2021
|
| |
2020
|
| ||||||||||||
衍生债务 - 权证的未实现收益(亏损)
|
| | | $ | 5,996 | | | | | $ | (8,830) | | | | | $ | 16,669 | | | | | $ | (8,659) | | |
衍生工具的收益(亏损)
|
| | | | 7,829 | | | | | | (7,022) | | | | | | 23,909 | | | | | | 2,938 | | |
计提 - 应收贷款损失
|
| | | | (666) | | | | | | (482) | | | | | | (753) | | | | | | (902) | | |
按公允价值持有的投资未实现亏损
|
| | | | (548) | | | | | | — | | | | | | (7,135) | | | | | | (162) | | |
债务清偿损失
|
| | | | — | | | | | | (977) | | | | | | (17,987) | | | | | | (977) | | |
处置资产损益
|
| | | | — | | | | | | 3 | | | | | | (886) | | | | | | (134) | | |
外币损益
|
| | | | 46 | | | | | | (1,199) | | | | | | (1,228) | | | | | | (1,415) | | |
Other (loss) income
|
| | | | (1,746) | | | | | | 38 | | | | | | 442 | | | | | | 1,016 | | |
其他收入(费用)合计,净额
|
| | | $ | 10,911 | | | | | $ | (18,469) | | | | | $ | 13,031 | | | | | $ | (8,295) | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||||||||||||||||||||||||||||||||||||||
| | |
Q4
|
| |
Q3
|
| |
Q2
|
| |
Q1
|
| |
Q4
|
| |
Q3
|
| |
Q2
|
| |
Q1
|
| ||||||||||||||||||||||||
Revenue, net
|
| | | $ | 217,787 | | | | | $ | 215,483 | | | | | $ | 209,975 | | | | | $ | 178,437 | | | | | $ | 162,317 | | | | | $ | 153,298 | | | | | $ | 94,256 | | | | | $ | 66,380 | | |
运营利润(亏损)
|
| | | | 15,557 | | | | | | (264,018) | | | | | | 14,872 | | | | | | 16,238 | | | | | | 329 | | | | | | 24,935 | | | | | | (20,938) | | | | | | (27,788) | | |
Net (loss) attributable
to Cresco Labs Inc. |
| | | | (14,732) | | | | | | (270,645) | | | | | | (4,827) | | | | | | (29,393) | | | | | | (54,636) | | | | | | 15,457 | | | | | | (36,433) | | | | | | (26,545) | | |
Basic EPS
|
| | | $ | (0.08) | | | | | $ | (1.00) | | | | | $ | (0.02) | | | | | $ | (0.12) | | | | | $ | (0.25) | | | | | $ | 0.07 | | | | | $ | (0.18) | | | | | $ | (0.13) | | |
Diluted EPS
|
| | | $ | (0.08) | | | | | $ | (1.00) | | | | | $ | (0.02) | | | | | $ | (0.12) | | | | | $ | (0.22) | | | | | $ | 0.04 | | | | | $ | (0.18) | | | | | $ | (0.13) | | |
| | |
截至12月31日的三个月
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
Revenue
|
| | | $ | 217,787 | | | | | $ | 162,317 | | | | | $ | 55,470 | | | | | | 34.2% | | |
Cost of goods sold
|
| | | | (107,765) | | | | | | (87,835) | | | | | | (19,930) | | | | | | 22.7% | | |
Gross profit
|
| | | | 110,022 | | | | | | 74,482 | | | | | | 35,540 | | | | | | 47.7% | | |
总运营费用
|
| | | | 94,465 | | | | | | 74,153 | | | | | | 20,312 | | | | | | 27.4% | | |
Total other (expense), net
|
| | | | (3,940) | | | | | | (27,335) | | | | | | 23,395 | | | | | | (85.6)% | | |
Income tax expense
|
| | | | (23,528) | | | | | | (14,181) | | | | | | (9,347) | | | | | | 65.9% | | |
Net (loss)(1)
|
| | | $ | (11,911) | | | | | $ | (41,187) | | | | | $ | 29,276 | | | | |
|
(71.1)%
|
| |
| | |
Year Ended December 31,
|
| |||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
Revenue, net
|
| | | $ | 821,682 | | | | | $ | 476,251 | | | | | $ | 128,534 | | |
Loss from operations
|
| | | | (217,351) | | | | | | (23,462) | | | | | | (61,607) | | |
Cresco,Inc.造成的亏损
|
| | | | (319,597) | | | | | | (102,157) | | | | | | (51,594) | | |
Basic and Diluted EPS
|
| | | $ | (1.22) | | | | | $ | (0.49) | | | | | $ | (0.44) | | |
($ in thousands)
|
| |
December 31,
2021 |
| |
December 31,
2020 |
| |
December 31,
2019 |
| |||||||||
Total Assets
|
| | | $ | 1,780,463 | | | | | $ | 1,232,596 | | | | | $ | 589,646 | | |
非流动租赁负债
|
| | | | 118,936 | | | | | | 74,468 | | | | | | 35,780 | | |
非流动金融负债总额
|
| | | | 465,079 | | | | | | 255,439 | | | | | | 65,000 | | |
| | |
Year Ended December 31,
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
Revenue
|
| | | $ | 821,682 | | | | | $ | 476,251 | | | | | $ | 345,431 | | | | | | 72.5% | | |
Cost of goods sold
|
| | | | (415,335) | | | | | | (269,550) | | | | | | (145,785) | | | | | | 54.1% | | |
Gross profit
|
| | | | 406,347 | | | | | | 206,701 | | | | | | 199,646 | | | | | | 96.6% | | |
总运营费用
|
| | | | 623,698 | | | | | | 230,163 | | | | | | 393,535 | | | | | | 171.0% | | |
Total other (expense), net
|
| | | | (39,376) | | | | | | (40,705) | | | | | | 1,329 | | | | | | (3.3)% | | |
Income tax expense
|
| | | | (40,107) | | | | | | (28,604) | | | | | | (11,503) | | | | | | 40.2% | | |
Net (loss)(1)
|
| | | $ | (296,834) | | | | | $ | (92,771) | | | | | $ | (204,063) | | | | |
|
220.0%
|
| |
| | |
截至12月31日的三个月
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
$ Change
|
| |
% Change(2)
|
| ||||||||||||
Net (loss)(1)
|
| | | $ | (11,911) | | | | | $ | (41,187) | | | | | $ | 29,276 | | | | | | (71.1)% | | |
折旧及摊销
|
| | | | 8,197 | | | | | | 8,616 | | | | | | (419) | | | | | | (4.9)% | | |
Interest expense, net
|
| | | | 14,851 | | | | | | 7,939 | | | | | | 6,912 | | | | | | 87.1% | | |
Income tax expense
|
| | | | 23,528 | | | | | | 14,181 | | | | | | 9,347 | | | | | | 65.9% | | |
EBITDA (non-GAAP)
|
| | | $ | 34,665 | | | | | $ | (10,451) | | | | | $ | 45,116 | | | |
nm
|
| |||
Other (income) expense, net
|
| | | | (10,911) | | | | | | 18,469 | | | | | | (29,380) | | | | | | (159.1)% | | |
权益法投资亏损
|
| | | | — | | | | | | 927 | | | | | | (927) | | | | | | (100.0)% | | |
收购库存的公允价值加价
|
| | | | 8,407 | | | | | | — | | | | | | 8,407 | | | | | | 100.0% | | |
收购和其他非核心成本的调整
|
| | | | 4,954 | | | | | | 15,540 | | | | | | (10,586) | | | | | | (68.1)% | | |
Impairment loss
|
| | | | 14,945 | | | | | | — | | | | | | 14,945 | | | | | | 100.0% | | |
基于股份的薪酬
|
| | | | 4,933 | | | | | | 5,545 | | | | | | (612) | | | | | | (11.0)% | | |
Adjusted EBITDA (non-GAAP)
|
| | | $ | 56,993 | | | | | $ | 30,030 | | | | | $ | 26,963 | | | | | | 89.8% | | |
| | |
Year Ended December 31,
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
$ Change
|
| |
% Change(2)
|
| ||||||||||||
Net (loss)(1)
|
| | | $ | (296,834) | | | | | $ | (92,771) | | | | | $ | (204,063) | | | | | | 220.0% | | |
折旧及摊销
|
| | | | 38,640 | | | | | | 31,788 | | | | | | 6,852 | | | | | | 21.6% | | |
Interest expense, net
|
| | | | 51,211 | | | | | | 31,229 | | | | | | 19,982 | | | | | | 64.0% | | |
Income tax expense
|
| | | | 40,107 | | | | | | 28,604 | | | | | | 11,503 | | | | | | 40.2% | | |
EBITDA (non-GAAP)
|
| | | $ | (166,876) | | | | | $ | (1,150) | | | | | $ | (165,726) | | | | |
|
网管
|
| |
Other (income) expense, net
|
| | | | (13,031) | | | | | | 8,295 | | | | | | (21,326) | | | | | | (257.1)% | | |
权益法投资亏损
|
| | | | 1,196 | | | | | | 1,181 | | | | | | 15 | | | | | | 1.3% | | |
收购库存的公允价值加价
|
| | | | 23,441 | | | | | | 3,749 | | | | | | 19,692 | | | | | | 网管 | | |
收购和其他非核心成本的调整
|
| | | | 15,803 | | | | | | 28,654 | | | | | | (12,851) | | | | | | (44.8)% | | |
Impairment loss
|
| | | | 305,894 | | | | | | 1,194 | | | | | | 304,700 | | | | | | 网管 | | |
基于股份的薪酬
|
| | | | 27,536 | | | | | | 18,839 | | | | | | 8,697 | | | | | | 46.2% | | |
Adjusted EBITDA (non-GAAP)
|
| | | $ | 193,963 | | | | | $ | 60,762 | | | | | $ | 133,201 | | | | | | 219.2% | | |
($ in thousands)
|
| |
Total
|
| |
Operating Leases
|
| |
Finance Leases
|
| |||||||||
2022
|
| | | $ | 24,242 | | | | | $ | 18,971 | | | | | $ | 5,271 | | |
2023
|
| | | | 24,260 | | | | | | 18,832 | | | | | | 5,428 | | |
2024
|
| | | | 24,593 | | | | | | 18,989 | | | | | | 5,604 | | |
2025
|
| | | | 26,102 | | | | | | 20,348 | | | | | | 5,754 | | |
2026
|
| | | | 26,423 | | | | | | 20,528 | | | | | | 5,895 | | |
Thereafter
|
| | | | 207,288 | | | | | | 174,141 | | | | | | 33,147 | | |
Total lease payments
|
| | | $ | 332,908 | | | | | $ | 271,809 | | | | | $ | 61,099 | | |
Less: imputed interest
|
| | | | (184,810) | | | | | | (154,871) | | | | | | (29,939) | | |
少:租户改善津贴
|
| | | | (8,370) | | | | | | (7,671) | | | | | | (699) | | |
租赁负债现值
|
| | | | 139,728 | | | | | | 109,267 | | | | | | 30,461 | | |
减去:短期租赁负债
|
| | | | (20,792) | | | | | | (16,348) | | | | | | (4,444) | | |
长期租赁负债现值
|
| | | $ | 118,936 | | | | | $ | 92,919 | | | | | $ | 26,017 | | |
($ in thousands)
|
| |
|
| |
1 to 3 Years
|
| |
3 to 5 Years
|
| |
Total
|
| ||||||||||||
应付账款和应计负债
|
| | | $ | 127,720 | | | | | $ | — | | | | | $ | — | | | | | $ | 127,720 | | |
延期对价、或有对价和其他应付款项,短期
|
| | | | 71,833 | | | | | | — | | | | | | — | | | | | | 71,833 | | |
延期对价和或有对价、长期对价
|
| | | | — | | | | | | 17,651 | | | | | | — | | | | | | 17,651 | | |
长期应付票据和应付贷款及短期借款
|
| | | | 19,928 | | | | | | — | | | | | | 465,079 | | | | | | 485,007 | | |
截至2021年12月31日的债务总额
|
| | | $ | 219,481 | | | | | $ | 17,651 | | | | | $ | 465,079 | | | | | $ | 702,211 | | |
| | | | | |
Year Ended December 31,
|
| |||||||||
($ in thousands)
|
| |
Classification
|
| |
2021
|
| |
2020
|
| ||||||
Operating Leases | | | | | | | | | | | | | | | | |
出租人拥有SLO的少数股权
|
| | Rent expense | | | | $ | 1,563 | | | | | $ | 2,138 | | |
出租人拥有MedMar的少数股权
|
| | Rent expense | | | | | 238 | | | | | | 140 | | |
出租人是MVS股东
|
| | Rent expense | | | | | 1,168 | | | | | | 647 | | |
Finance Leases | | | | | | | | | | | | | | | | |
出租人拥有MedMar的少数股权
|
| |
Depreciation expense
|
| | | $ | 277 | | | | | $ | 151 | | |
出租人拥有MedMar的少数股权
|
| | Interest expense | | | | | 310 | | | | | | 174 | | |
出租人是MVS股东
|
| |
Depreciation expense
|
| | | | 74 | | | | | | 64 | | |
出租人是MVS股东
|
| | Interest expense | | | | | 88 | | | | | | 80 | | |
| | |
As of December 31, 2021
|
| |
As of December 31, 2020
|
| ||||||
($ in thousands)
|
| |
ROU Asset
|
| |
Lease Liability
|
| |
ROU Asset
|
| |
Lease Liability
|
|
Operating Leases | | | | | | | | | | | | | |
出租人拥有SLO的少数股权
|
| |
$6,996
|
| |
$11,938
|
| |
$4,926
|
| |
$8,560
|
|
出租人拥有MedMar的少数股权
|
| |
1,525
|
| |
1,549
|
| |
1,146
|
| |
1,187
|
|
出租人是MVS股东
|
| |
6,314
|
| |
4,867
|
| |
6,334
|
| |
4,783
|
|
Finance Leases | | | | | | | | | | | | | |
出租人拥有MedMar的少数股权
|
| |
$2,137
|
| |
$2,457
|
| |
$1,201
|
| |
$1,365
|
|
出租人是MVS股东
|
| |
616
|
| |
1,063
|
| |
648
|
| |
678
|
|
| | |
2021
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized Cost
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | 223,543 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 223,543 | | |
Restricted cash(1)
|
| | | | 2,559 | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,559 | | |
Security deposits
|
| | | | 3,941 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,941 | | |
Accounts receivable, net
|
| | | | 43,379 | | | | | | — | | | | | | — | | | | | | — | | | | | | 43,379 | | |
短期应收贷款
|
| | | | 747 | | | | | | — | | | | | | — | | | | | | 565 | | | | | | 1,312 | | |
长期应收贷款
|
| | | | 505 | | | | | | — | | | | | | — | | | | | | — | | | | | | 505 | | |
Investments
|
| | | | — | | | | | | 4,710 | | | | | | 542 | | | | | | 660 | | | | | | 5,912 | | |
财务负债: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 32,278 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 32,278 | | |
Accrued liabilities
|
| | | | 95,442 | | | | | | — | | | | | | — | | | | | | — | | | | | | 95,442 | | |
Short-term borrowings
|
| | | | 19,928 | | | | | | — | | | | | | — | | | | | | — | | | | | | 19,928 | | |
租赁负债的当期部分
|
| | | | 20,792 | | | | | | — | | | | | | — | | | | | | — | | | | | | 20,792 | | |
延期对价、或有对价和其他应付款项,短期
|
| | | | 5 | | | | | | 12 | | | | | | — | | | | | | 71,816 | | | | | | 71,833 | | |
短期衍生负债
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,172 | | | | | | 1,172 | | |
Lease liabilities
|
| | | | 118,936 | | | | | | — | | | | | | — | | | | | | — | | | | | | 118,936 | | |
延期对价和或有对价,
long-term |
| | | | — | | | | | | — | | | | | | — | | | | | | 17,651 | | | | | | 17,651 | | |
长期应付票据和应付贷款
|
| | | | 465,079 | | | | | | — | | | | | | — | | | | | | — | | | | | | 465,079 | | |
| | |
2020
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized Cost
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | 136,339 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 136,339 | | |
Restricted cash(1)
|
| | | | 4,435 | | | | | | — | | | | | | — | | | | | | — | | | | | | 4,435 | | |
Security deposits
|
| | | | 3,558 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,558 | | |
Accounts receivable, net
|
| | | | 29,943 | | | | | | — | | | | | | — | | | | | | — | | | | | | 29,943 | | |
短期应收贷款
|
| | | | 921 | | | | | | — | | | | | | | | | | | | 1,517 | | | | | | 2,438 | | |
长期应收贷款
|
| | | | 1,204 | | | | | | — | | | | | | — | | | | | | 20,019 | | | | | | 21,223 | | |
Investments(2) | | | | | 3,192 | | | | | | — | | | | | | 1,049 | | | | | | 119 | | | | | | 4,360 | | |
财务负债: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 23,231 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 23,231 | | |
Accrued liabilities
|
| | | | 130,469 | | | | | | — | | | | | | — | | | | | | — | | | | | | 130,469 | | |
Short-term borrowings
|
| | | | 25,924 | | | | | | — | | | | | | — | | | | | | — | | | | | | 25,924 | | |
租赁负债的当期部分
|
| | | | 18,040 | | | | | | — | | | | | | — | | | | | | — | | | | | | 18,040 | | |
延期对价、或有对价和其他应付款项,短期
|
| | | | — | | | | | | 22 | | | | | | — | | | | | | 19,093 | | | | | | 19,115 | | |
长期衍生负债
|
| | | | — | | | | | | — | | | | | | — | | | | | | 17,505 | | | | | | 17,505 | | |
Lease liabilities
|
| | | | 74,468 | | | | | | — | | | | | | — | | | | | | — | | | | | | 74,468 | | |
延期对价和或有对价,
long-term |
| | | | — | | | | | | — | | | | | | — | | | | | | 7,247 | | | | | | 7,247 | | |
长期应付票据和应付贷款
|
| | | | 255,439 | | | | | | — | | | | | | — | | | | | | — | | | | | | 255,439 | | |
Securities
|
| |
Number of Shares
(in thousands) |
| |||
已发行且未偿还的 | | | | | | | |
Super Voting Shares
|
| | | | 500 | | |
从属表决权股份(3)
|
| | | | 269,971 | | |
比例投票权股份(1)
|
| | | | 20,667 | | |
特殊从属表决权股份(2)
|
| | | | 1 | | |
Redeemable Shares
|
| | | | 109,441 | | |
Warrants
|
| | | | 9,842 | | |
Stock Options
|
| | | | 23,610 | | |
Restricted Stock Units
|
| | | | 1,093 | | |
| | | | Yours truly, | |
| | | | (signed) “Thomas J. Manning” | |
| | | |
Thomas J. Manning
董事会执行主席 |
|
Name of
Shareholder |
| |
Number and
Percentage of Super Voting Shares Beneficially Owned, or Controlled or Directed, Directly or Indirectly |
| |
Number and
Percentage of Proportionate Voting Shares Beneficially Owned, or Controlled or Directed, Directly or Indirectly(1)(2)(3) |
| |
Number and
Percentage of Subordinate Voting Shares Beneficially Owned, or Controlled or Directed, Directly or Indirectly(2) |
| |
Number and
Percentage of Special Subordinate Voting Shares Beneficially Owned, or Controlled or Directed, Directly or Indirectly(2)(4) |
| |
Percentage of
Votes Attaching to All Outstanding Shares Beneficially Owned, or Controlled or Directed, Directly or Indirectly(5) |
|
Charles Bachtell(6)
|
| |
100,000
|
| |
4,363(5)
|
| |
103,886
|
| |
0
|
| |
15.9%
|
|
|
(20%)
|
| |
(3.32%)
|
| |
(
|
| |
(0%)
|
| | | | ||
Joseph Caltabiano
|
| |
100,000
|
| |
200
|
| |
2,780,000(7)
|
| |
0
|
| |
16.0%
|
|
|
(20%)
|
| |
(0.15%)
|
| |
(1.17%)
|
| |
(0%)
|
| | | | ||
Brian McCormack
|
| |
100,000
|
| |
0
|
| |
61,700
|
| |
0
|
| |
15.8%
|
|
|
(20%)
|
| |
(0%)
|
| |
(
|
| |
(0%)
|
| | | | ||
Robert M. Sampson
|
| |
100,000
|
| |
4
|
| |
0
|
| |
0
|
| |
15.8%
|
|
|
(20%)
|
| |
(
|
| |
(0%)
|
| |
(0%)
|
| | | | ||
Dominic A. Sergi
|
| |
100,000
|
| |
0
|
| |
0
|
| |
0
|
| |
15.8%
|
|
|
(20%)
|
| |
(0%)
|
| |
(0%)
|
| |
(0%)
|
| | | |
Name and Province or
居住地国家和州 |
| |
Director Since
|
| |
Principal Occupation
for Past Five Years |
| |
Voting Shares
Beneficially Owned, Controlled or Directed, Directly or Indirectly(1) |
|
Charles Bachtell(2)
Chicago, IL, United States |
| |
November 2018
|
| |
公司首席执行官;曾任住宅抵押贷款公司Guaraned Rate执行副总裁兼总法律顾问。
|
| |
100,000 Super Voting Shares
103,886 Subordinate Voting Shares
4363份比例投票权股份
13,102,342 Cresco Redeemable Units
|
|
Robert M. Sampson(3)
美国伊利诺伊州唐纳斯格罗夫 |
| |
November 2018
|
| |
CrossCountry Mortgage,Inc.执行副总裁;前首席运营官The Corporation,Bountgage首席执行官和住宅抵押贷款公司Guaraned Rate首席运营官。
|
| |
100,000 Super Voting Shares
100,000 Subordinate Voting Shares
4份比例投票权股份
13,001,049 Cresco Redeemable Units
|
|
Name and Province or
居住地国家和州 |
| |
Director Since
|
| |
Principal Occupation
for Past Five Years |
| |
Voting Shares
Beneficially Owned, Controlled or Directed, Directly or Indirectly(1) |
|
John R. Walter(4)
Naples, FL, United States |
| |
November 2018
|
| |
咨询公司阿什林管理公司董事长兼首席执行官。
|
| |
1,177股比例投票权股份
|
|
Gerald F. Corcoran(2)(5)
美国伊利诺伊州温尼特卡 |
| |
November 2018
|
| |
期货经纪公司R.J.O‘Brien&Associates,LLC董事会主席兼首席执行官。
|
| |
18,500 Subordiante Voting Shares
997,395 Cresco Redeemable Units
|
|
Thomas J. Manning(6)
美国伊利诺伊州埃文斯顿 |
| |
November 2018
|
| |
公司董事会执行主席,曾任数据分析公司Dun and BradStreet董事长兼首席执行官。
|
| |
500份比例投票权股份
|
|
Randy D. Podolsky(3)(7)
美国伊利诺伊州莱克福里斯特 |
| |
December 2016
|
| |
房地产公司Podolsky Circle Corfac International(现为高力国际)的管理负责人。
|
| |
814,387 Cresco Redeemable Units
|
|
Marc Lustig
加拿大不列颠哥伦比亚省温哥华 |
| |
January 2020
|
| |
公司资本市场主管;自2019年以来担任IM Cannabis Corp.非执行主席;自2016年以来担任CannaRoyalty Corp.(Dba Origin House)创始人、董事长兼首席执行官;2012年至2014年担任Dundee Capital Markets资本市场主管。
|
| |
63,868,296特殊从属表决权股份
|
|
Michele Roberts(8)
美国纽约州纽约市 |
| |
June 2020
|
| |
自2014年起担任美国国家篮球运动员协会执行董事。在此之前,罗伯茨是世达律师事务所的律师。
|
| |
—
|
|
Name and Province or
居住地国家和州 |
| |
Director Since
|
| |
Principal Occupation
for Past Five Years |
| |
Voting Shares
Beneficially Owned, Controlled or Directed, Directly or Indirectly(1) |
|
Carol Vallone(2)(9)
美国马萨诸塞州曼彻斯特 |
| |
July 2020
|
| |
麦克莱恩医院董事会主席,麻省理工学院健康专业学院董事会成员,麻省总医院财务委员会成员,贝恩资本双重影响投资组合公司Arosa的董事会成员,伯克希尔合伙公司的董事顾问,以及专注于医疗保健的风险增长公司经度资本的顾问委员会成员;前首席执行官和流星学习公司董事会成员。
|
| |
—
|
|
Tarik Brooks
美国加利福尼亚州洛杉矶 |
| |
April 2021
|
| |
康姆斯企业总裁。在此之前,布鲁克斯先生是Bridgewater Associates的客户管理和交易首席运营官,以及RLJ Companies的执行副总裁。
|
| |
—
|
|
Sidney Dillard
Chicago, IL, United States |
| |
May 2021
|
| |
Loop Capital合伙人兼企业投资银行部主管。Dillard女士是Loop Capital管理委员会和公平与估值委员会的成员。
|
| |
—
|
|
| | |
不包括薪酬证券的薪酬表
|
| |||||||||||||||||||||||||||||||||||||||
Name and position
|
| |
Year
|
| |
Salary,
consulting fee, retainer or commission ($US) |
| |
Bonus
($US) |
| |
Committee
or meeting fees(1) ($US) |
| |
Value of
perquisites ($US) |
| |
Value of all
other compensation ($US) |
| |
Total
compensation ($US) |
| |||||||||||||||||||||
Charles Bachtell
|
| | | | 2020 | | | | | $ | 450,000 | | | | | $ | 87,500 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 537,500 | | |
Director and Chief
Executive Officer(1) |
| | | | 2019 | | | | | $ | 350,000 | | | | | $ | 275,000 | | | | | $ | 50,000 | | | | | $ | 1,200(4) | | | | | | — | | | | | $ | 676,200 | | |
Ken Amann
|
| | | | 2020 | | | | | $ | 274,995 | | | | | $ | 31,250 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 306,245 | | |
Former Chief
Financial Officer(2) |
| | | | 2019 | | | | | $ | 250,000 | | | | | $ | 125,000 | | | | | | — | | | | | $ | 3,300 | | | | | | — | | | | | $ | 378,300 | | |
Dennis Olis
|
| | | | 2020 | | | | | $ | 201,515 | | | | | | — | | | | | | — | | | | | $ | 600 | | | | | | — | | | | | $ | 201,515 | | |
Chief Financial
Officer(2) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |||||
David Ellis
|
| | | | 2020 | | | | | $ | 291,667 | | | | | $ | 59,375 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 351,042 | | |
Former Chief
Operating Officer(3) |
| | | | 2019 | | | | | $ | 200,000 | | | | | $ | 87,500 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 287,500 | | |
| | |
补偿证券(1)
|
| ||||||||||||||||||
Name and position
|
| |
Type of
compensation security(2) |
| |
Number of
compensation securities, number of underlying securities, and percentage of class |
| |
Date of
issue or grant |
| |
Issue,
conversion or exercise price ($US) |
| |
Closing
price of security or underlying security on date of grant ($CDN) |
| |
Closing
price of security or underlying security at year end ($CDN) |
| |
Expiry
date |
|
查尔斯·巴切特尔董事兼首席执行官
|
| |
Options
|
| |
1500,000股从属投票股可行使的1500,000份期权
(0.6%) |
| |
May 20, 2020
|
| |
$6.55
|
| |
$4.56
|
| |
$12.55
|
| |
May 20, 2030
|
|
Thomas J. Manning
董事和执行主席 |
| |
Options
|
| |
200,000,000从属投票股可行使的200,000,000份期权
(0.8%) |
| |
May 29, 2020
|
| |
$4.56
|
| |
$6.77
|
| |
$12.55
|
| |
May 29, 2030
|
|
Dennis Olis
首席财务官 |
| |
Options
|
| |
500,000股从属投票股可行使的500,000份期权
(0.2%) |
| |
June 30, 2020
|
| |
$4.11
|
| |
$5.60
|
| |
$12.55
|
| |
June 30, 2030
|
|
Randy D. Podolsky
Director |
| |
Options(3)
|
| |
79,359股从属投票股可行使的79,359份期权
( |
| |
54,825 on May 20, 2020 and 24,534 on December 16, 2020
|
| |
$4.56 and $10.19, respectively
|
| |
$6.34 and $13.00, respectively
|
| |
$12.55
|
| |
May 20, 2030 and December 16, 2030, respectively
|
|
John R. Walter
Director |
| |
Options(3)
|
| |
79,359股从属投票股可行使的79,359份期权
( |
| |
54,825 on May 20, 2020 and 24,534 on December 16, 2020
|
| |
$4.56 and $10.19, respectively
|
| |
$6.34 and $13.00, respectively
|
| |
$12.55
|
| |
May 20, 2030 and December 16, 2030, respectively
|
|
Gerald F. Corcoran
Director |
| |
Options(3)
|
| |
79,359股从属投票股可行使的79,359份期权
( |
| |
54,825 on May 20, 2020 and 24,534 on December 16, 2020
|
| |
$4.56 and $10.19, respectively
|
| |
$6.34 and $13.00, respectively
|
| |
$12.55
|
| |
May 20, 2030 and December 16, 2030, respectively
|
|
Robert M. Sampson
Director |
| |
Options(3)
|
| |
79,359股从属投票股可行使的79,359份期权
( |
| |
54,825 on May 20, 2020 and 24,534 on December 16, 2020
|
| |
$4.56 and $10.19, respectively
|
| |
$6.34 and $13.00, respectively
|
| |
$12.55
|
| |
May 20, 2030 and December 16, 2030, respectively
|
|
Michele Roberts
Director |
| |
Options(3)
|
| |
62,432个从属表决权股份可行使的62,432个期权
( |
| |
37,898 on June 29, 2020 and 24,534 on December 16, 2021
|
| |
$4.56 and $10.19, respectively
|
| |
$5.48 and $13.00, respectively
|
| |
$12.55
|
| |
June 29, 2030 and December 16, 2030, respectively
|
|
| | |
补偿证券(1)
|
| ||||||||||||||||||
Name and position
|
| |
Type of
compensation security(2) |
| |
Number of
compensation securities, number of underlying securities, and percentage of class |
| |
Date of
issue or grant |
| |
Issue,
conversion or exercise price ($US) |
| |
Closing
price of security or underlying security on date of grant ($CDN) |
| |
Closing
price of security or underlying security at year end ($CDN) |
| |
Expiry
date |
|
Carol Vallone
Director |
| |
Options(3)
|
| |
46,078个从属表决权股份可行使的46,078个期权
( |
| |
21,544 on July 30, 2020 and 24,534 on December 16, 2020
|
| |
$5.39 and $10.19, respectively
|
| |
$7.56 and $13.00, respectively
|
| |
$12.55
|
| |
July 30, 2030 and December 16, 2030, respectively
|
|
Dominic Sergi
Former Director |
| |
Options(3)
|
| |
79,359股从属投票股可行使的79,359份期权
( |
| |
54,825 on May 20, 2020 and 24,534 on December 16, 2020
|
| |
$4.56 and $10.19, respectively
|
| |
$6.34 and $13.00, respectively
|
| |
$12.55
|
| |
May 20, 2030 and December 16, 2030, respectively
|
|
Brian McCormack
Former Director |
| |
Options(3)
|
| |
54,825个从属表决权股份可行使的54,825个期权
( |
| |
May 20, 2020
|
| |
$4.56
|
| |
$6.34
|
| |
$12.55
|
| |
May 20, 2030
|
|
David Ellis
前首席运营官 |
| |
Restricted Share Units(4)
|
| |
59,880股限售股可转换为59,880股从属表决权股
( |
| |
September 30, 2020
|
| |
$6.00
|
| |
$8.00
|
| |
$12.55
|
| |
N/A
|
|
| | |
董事和指定高管行使补偿证券
|
| ||||||||||||||||||
Name and position
|
| |
Type of
compensation security |
| |
Number of
underlying securities exercised |
| |
Exercise
price per security ($US) |
| |
Date of
exercice |
| |
Closing
price per security on date of exercise ($US) |
| |
Difference
between exercise price and closing price on date of exercise ($US) |
| |
Total value
on exercise date ($US)(1) |
|
Carol Vallone
Director |
| |
Options
|
| |
2,000 Subordinate Voting Shares
|
| |
$5.39
|
| |
December 23, 2020
|
| |
$10.09
|
| |
$4.70
|
| |
$9,400
|
|
Charles Bachtell
董事和首席执行官 |
| |
Options
|
| |
100,000 Subordinate Voting Shares
|
| |
$1.14
|
| |
July 22, 2020
|
| |
$5.29
|
| |
$4.15
|
| |
$415,000
|
|
Ken Amann
前首席财务官 |
| |
Options
|
| |
62,500 Subordinate Voting Shares
|
| |
$2.25
|
| |
January 1, 2020
|
| |
$6.86
|
| |
$4.61
|
| |
$288,125
|
|
Name
|
| |
Name of Reporting Issuer
|
| |
Name of
Exchange or Market |
| |
Position
|
| |
From
|
|
Thomas J. Manning | | |
CommScope Holding Company,Inc.
|
| |
NASDAQ
|
| | Director | | |
2014
|
|
Marc Lustig
|
| |
IM大麻公司(前身为Navasota Resources Inc.)
|
| |
CSE
|
| |
董事非执行主席
|
| |
2019
|
|
| PharmaCeielo Ltd.(前身为AAJ Capital 1 Corp.) | | |
TSXV
|
| | Lead Director | | |
2020
|
| ||
| Aequus PharmPharmticals Inc. | | |
TSXV
|
| | Director | | |
2021
|
|
| Gerald F. Corcoran | | | Independent | | | 懂金融的 | |
| Robert M. Sampson | | | Not Independent | | | 懂金融的 | |
| Randy D. Podolsky | | | Independent | | | 懂金融的 | |
Financial Year Ending
|
| |
Audit Fees(1)
|
| |
Audit-Related
Fees(2) |
| |
Tax Fees
|
| |
All Other Fees
|
| ||||||
December 31, 2020
|
| |
US$1,512,525
|
| |
US$61,800
|
| | | | — | | | | | | — | | |
December 31, 2019
|
| |
US$1,061,415
|
| |
US$66,435
|
| | | | — | | | | | | — | | |
Plan Category
|
| |
Number of Subordinate
Voting Shares to be issued upon exercise of outstanding options, warrants and rights |
| |
加权平均锻炼
price of outstanding options, warrants and rights |
| |
Number of Subordinate
Voting Shares remaining available for future issuance under equity compensation plans |
| |||||||||
由
批准的股权薪酬计划
security holders |
| | | | 23,481,042 | | | | | 美元 | 4.07 | | | | | | 11,542,492 | | |
股权薪酬计划未获批准
by security holders |
| | | | — | | | | | | — | | | | | | — | | |
Total
|
| | | | 23,481,042 | | | | | 美元 | 4.07 | | | | | | 11,542,492 | | |
| | |
December 31, 2021
|
| ||||||||||||||||||||||||
| | |
Columbia Care,
Inc. |
| |
Cresco Labs
Inc. |
| |
Pro-forma
Adjustments |
| | | | |
Pro-forma
Combined |
| ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | 82,198 | | | | | $ | 223,543 | | | | | | | | | | | | | | $ | 305,741 | | |
应收账款,净额
|
| | | | 18,302 | | | | | | 43,379 | | | | | | (598) | | | |
(a)
|
| | | | 61,083 | | |
Inventory
|
| | | | 94,567 | | | | | | 136,643 | | | | | | (266) | | | |
(b)
|
| | | | 230,944 | | |
预付费用和其他流动资产
|
| | | | 29,252 | | | | | | 18,190 | | | | | | | | | | | | | | | 47,442 | | |
待售资产
|
| | | | 2,120 | | | | | | — | | | | | | | | | | | | | | | 2,120 | | |
流动资产总额
|
| | | | 226,439 | | | | | | 421,755 | | | | | | (864) | | | | | | | | | 647,330 | | |
财产和设备,净额
|
| | | | 339,692 | | | | | | 369,092 | | | | | | | | | | | | | | | 708,784 | | |
使用权资产
|
| | | | 245,541 | | | | | | 88,017 | | | | | | | | | | | | | | | 333,558 | | |
Goodwill
|
| | | | 184,018 | | | | | | 446,767 | | | | | | | | | | | | | | | 630,785 | | |
无形资产,净额
|
| | | | 367,787 | | | | | | 437,644 | | | | | | | | | | | | | | | 805,431 | | |
其他非流动资产
|
| | | | 13,035 | | | | | | 17,188 | | | | | | | | | | | | | | | 30,223 | | |
Total assets
|
| | | $ | 1,376,512 | | | | | $ | 1,780,463 | | | | | $ | (864) | | | | | | | | $ | 3,156,111 | | |
负债和股权 | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
流动负债: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
应付账款
|
| | | $ | 44,007 | | | | | $ | 32,278 | | | | | $ | (598) | | | |
(a)
|
| | | | 75,687 | | |
应计费用和其他流动负债
|
| | | | 126,954 | | | | | | 95,442 | | | | | | 30,324 | | | |
(f)
|
| | | | 252,720 | | |
应付所得税
|
| | | | 26,537 | | | | | | 46,949 | | | | | | (72) | | | |
(g)
|
| | | | 73,414 | | |
延期对价和或有对价
|
| | | | 29,345 | | | | | | 71,833 | | | | | | | | | | | | | | | 101,178 | | |
租赁责任的当期部分
|
| | | | 14,148 | | | | | | 20,792 | | | | | | | | | | | | | | | 34,940 | | |
长期债务的当期部分,净额
|
| | | | 1,884 | | | | | | 19,928 | | | | | | 38,582 | | | |
(e)
|
| | | | 60,394 | | |
衍生负债
|
| | | | — | | | | | | 1,172 | | | | | | | | | | | | | | | 1,172 | | |
持有待售的负债
|
| | | | 1,122 | | | | | | — | | | | | | | | | | | | | | | 1,122 | | |
流动负债总额
|
| | | | 243,997 | | | | | | 288,394 | | | | | | 68,237 | | | | | | | | | 600,628 | | |
长期债务,净额
|
| | | | 159,017 | | | | | | 465,079 | | | | | | (38,200) | | | |
(e)
|
| | | | 585,896 | | |
递延纳税义务
|
| | | | 79,477 | | | | | | 85,666 | | | | | | | | | | | | | | | 165,143 | | |
长期租赁责任
|
| | | | 246,272 | | | | | | 118,936 | | | | | | | | | | | | | | | 365,208 | | |
延期对价和或有对价
|
| | | | 11,595 | | | | | | 17,651 | | | | | | | | | | | | | | | 29,247 | | |
衍生负债
|
| | | | 6,795 | | | | | | — | | | | | | | | | | | | | | | 6,795 | | |
其他长期负债
|
| | | | 78,535 | | | | | | 7,001 | | | | | | | | | | | | | | | 85,536 | | |
总负债
|
| | | | 825,689 | | | | | | 982,727 | | | | | | 30,037 | | | | | | | | | 1,838,453 | | |
Stockholders’ Equity: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
股本和额外实收资本
|
| | | | 1,039,726 | | | | | | 1,597,461 | | | | | | 28,851 | | | | | | | | | 2,666,038 | | |
累计赤字
|
| | | | (468,335) | | | | | | (841,907) | | | | | | (59,752) | | | |
(a) (b) (c) (d)
|
| | | | | | |
| | | | | | | | | | | | | | | | | | | | |
(e) (f) (g)
|
| | | | (1,369,994) | | |
公司应占权益
|
| | | | 571,391 | | | | | | 755,554 | | | | | | (30,901) | | | | | | | | | 1,296,044 | | |
非控股权益
|
| | | | (20,568) | | | | | | 42,182 | | | | | | | | | | | | | | | 21,614 | | |
Total equity
|
| | | | 550,823 | | | | | | 797,736 | | | | | | (30,901) | | | | | | | | | 1,317,658 | | |
负债和权益合计
|
| | | $ | 1,376,512 | | | | | $ | 1,780,463 | | | | | $ | (864) | | | | | | | | $ | 3,156,111 | | |
| | |
Year ended December 31, 2021
|
| |||||||||||||||||||||||||||
| | |
Columbia Care,
Inc. |
| |
Cresco Labs
Inc. |
| |
Pro-forma
Adjustments |
| | | | | | | |
Pro-forma
combined |
| ||||||||||||
| | |
Year ended December 31, 2021
|
| |||||||||||||||||||||||||||
扣除折扣后的收入
|
| | | $ | 460,080 | | | | | $ | 821,682 | | | | | $ | (6,367) | | | | | | (a) | | | | | $ | 1,275,395 | | |
与库存生产相关的销售成本
|
| | | | (266,065) | | | | | | (415,335) | | | | | | 6,101 | | | | | | (a) | | | | | | (675,299) | | |
Gross profit
|
| | | | 194,015 | | | | | | 406,347 | | | | | | (266) | | | | | | | | | | | | 600,096 | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
销售、一般和行政
|
| | | | 232,052 | | | | | | 317,804 | | | | | | 59,175 | | | |
(b) (d)
|
| | | | 609,031 | | | |||
减值损失
|
| | | | 72,328 | | | | | | 305,894 | | | | | | | | | | | | | | | | | | 378,222 | | |
总运营费用
|
| | | | (304,380) | | | | | | (623,698) | | | | | | (59,175) | | | | | | | | | | | | (987,253) | | |
运营亏损
|
| | | | (110,365) | | | | | | (217,351) | | | | | | (59,441) | | | | | | | | | | | | (387,157) | | |
Other expense: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
租赁利息支出,净额
|
| | | | (5,280) | | | | | | (4,100) | | | | | | — | | | | | | | | | | | | (9,380) | | |
利息支出,净额
|
| | | | (24,734) | | | | | | (47,111) | | | | | | (382) | | | | | | (c) | | | | | | (72,227) | | |
其他(费用)收入,净额
|
| | | | (6,335) | | | | | | 11,835 | | | | | | — | | | | | | | | | | | | 5,500 | | |
其他费用合计
|
| | | | (36,349) | | | | | | (39,376) | | | | | | (382) | | | | | | | | | | | | (76,107) | | |
计提所得税准备前的亏损
|
| | | | (146,714) | | | | | | (256,727) | | | | | | (59,823) | | | | | | | | | | | | (463,264) | | |
所得税(费用)福利,净额
|
| | | | (139) | | | | | | (40,107) | | | | | | 72 | | | | | | (e) | | | | | | (40,174) | | |
净亏损和综合亏损
|
| | | | (146,853) | | | | | | (296,834) | | | | | | (59,752) | | | | | | | | | | | | (503,439) | | |
可归因于非控股的净亏损收入
interests |
| | | | (3,756) | | | | | | 22,763 | | | | | | — | | | | | | | | | | | | 19,007 | | |
股东应占净亏损
|
| | | $ | (143,097) | | | | | $ | (319,597) | | | | | $ | (59,752) | | | | | | | | | | | $ | (522,446) | | |
加权平均每股收益 - 基本和稀释后使用的股数
|
| | | | 338,754,694 | | | | | | 262,326,138 | | | | | | (144,415,901) | | | | | | (f) | | | | | | 456,664,931 | | |
可归属于股票的收益(基本收益和稀释收益)
|
| | | $ | (0.42) | | | | | $ | (1.22) | | | | | $ | (0.41) | | | | | | | | | | | $ | (1.14) | | |